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Intestinal epithelial cells (IECs) regulate the mucosal immune responses upon 
a variety of stimuli, including lactic acid bacteria (LAB). LAB are a group of related 
bacteria that produce lactic acid as a result of carbohydrate fermentation. Lactobacilli, 
bifidobacteria, enterococi and streptococci are important members of this group. In 
infants, bifidobacteria, enterococci account for more than 90% of the total intestinal 
bacteria. Lactobacilli and streptococci are regularly present and increased in older 
infants when they are switched to a diet of cow's milk or solid food. However, the 
nature of the associations between human and their intestinal commensal bacteria is 
still unclear.  
Usually, the host and bacteria are thought to interact in a dynamic manner. 
Both of them derive benefits from each other.  The commensal bacteria derive from 
the host a supply of nutrients and a stable environment, while the host obtains from 
the normal flora certain nutritional benefits, stimulation of the innate and adaptive 
immune system, and colonization strategies that exclude potential pathogens at the 
site. Recently, clinical studies in infants showed that babies who developed allergy 
were less often colonized with enterococci during the first month of life and with 
bifidobacteria during the first year of life (Bengt Bjorksten, 2001). Thus these LAB 
may play a critical role in the regulation of the immune system even in the early stage 
of human life. With the growth of the human, LAB play an even more critical role in 
the maintenance of the intestinal immune system. There is accumulating evidence that 
 xx
the imbalance of the intestinal bacteria might cause inflammatory disorders such as 
allergy, inflammatory bowel disease (IBD), and even colon cancer.  
Studies showed that inflammation can be activated through many pathways. 
Toll like receptors (TLRs), which is important in the innate immune system, could 
respond to many pathogens and lead to the initiation of inflammation by secreting 
proinflammatory cytokines such as IL-8 and TNF-α. These cytokines might be 
expressed continuously in chronic inflammatory tissues. Also, there are some other 
signaling pathways that lead to proinflammatory cytokines production which thus 
activate inflammatory responses. Mitogen-activated protein kinase (MAPK) and NF-
κB signaling pathways can be activated by responding to proinflammatory cytokines 
(e.g. IL-1β and TNF-α) and pathogens to further activate inflammation. Therefore, 
suppression of proinflammatory cytokines and pathways such as MAPK and NF-κB 
can inhibit inflammatory responses. 
Since inflammation causes serious diseases in the intestine, many approaches 
have been used to suppress inflammatory responses in the intestine. Clinical studies 
have suggested that LAB or so-called probiotics may be an effective therapy in IBD. 
They could boost immune system in the early stage of life and also, they could 
regulate many inflammatory responses in the intestine through inner cellular signaling 
pathways. However, the molecular mechanisms of their regulation are still undefined. 
Moreover, the possible molecules on LAB which might be involved in the 
immunosuppressive responses are still unknown. Therefore, it would be very 
interesting to explore the underlying mechanisms and to demonstrate the possible 
molecules which participate in the immunosuppressive responses.  
E. faecalis is the second most common bacterium in the human intestine. Its 
function in the human intestine remains unclear. It is nevertheless used as probiotics 
 xxi
in food industry but is also an opportunistic pathogen in immunodeficient hosts. 
Therefore, it is necessary to verify how E. faecalis interacts with the human intestine.  
In the present study, 56 strains of human intestinal LAB isolated from 3 days 
and 1 month old infants together with LAB isolated from fermented milk and 
obtained from our culture collections, their anti-inflammatory effects were 
investigated in human colon cell lines (Caco-2, HT-29 and HCT116). It was 
demonstrated that E. faecalis was the main immune modulator among the intestinal 
LAB.  However, the effect was limited to only a few strains of E. faecalis. 
Carbohydrates on bacterial cell surface were involved in both its adhesion to intestinal 
cells and regulation of inflammatory responses in the host. Also, E. faecalis from new 
born infants, which showed a strong ability to suppress inflammatory responses in 
human IECs, attenuates proinflammatory cytokine secretion especially IL-8 via 
distinct pathways.  They suppressed JNK and p38 and further downregulated c-JUN 
protein expression to inhibit inflammatory responses. Furthermore, the inhibition of 
inflammatory responses by E. faecalis bypassed NF-κB signaling pathways. Cytokine 
receptors but not TLRs may play the key role in the modulation of immune responses 
in IECs. Some other signaling pathways like PIN1 and E2F1 might also be involved 
in the immune regulation by E. faecalis in the host. These findings highlight new 
cellular targets and approaches for therapeutic treatment of inflammatory diseases in 
human.  
Chapter 1 Introduction 
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1.1 INTRODUCTION 
Human gastrointestinal (GI) tract represents a complex ecosystem in which the 
intestinal microbes and the host maintain a delicate balance. A dynamic and huge 
number of microbes, which are mainly comprised of facultative anaerobes and 
obligate anaerobes, can be found in human GI tract. Prior to birth, the intestine is 
sterile. However, bacteria begin to colonize in the intestine during the birth process. 
Within 1 to 3 days of birth, large numbers of enterobacteria and streptococci could be 
found in infant’s GI tract. Shortly thereafter, depending on the food ingested, the GI 
tract becomes populated with a variety of genera of bacteria. Studies showed that 
colons of breast-fed infants become dominated by bifidobacteria species (Gueimonde 
et al., 2007) while enterococci predominate in bottle-fed infants. During weanling, 
bifidobacteria and enterococci decrease as colon begins to adopt a more adult profile 
mostly based on diet (Topping et al., 2001; Shahani et al., 1980). The dominant 
microorganisms in GI are illustrated in Figure 1.1. 
 
Figure 1.1 Micro-organisms in GI tract. 
Chapter 1 Introduction 
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Colon, which accounts for the majority of the bacteria in GI tract, contains a 
range between 1011 to 1012 colony-forming units (CFU) per milliliter (ml) of bacteria 
(Figure 1.1). The adult colon’s contents are about 35-50% (dry weight) bacteria. In 
fact, the population of microbes in the colon is estimated to be 10 times that of the 
total number of human cells (Topping et al., 2001; Backhed et al., 2005; Cummings et 
al., 1991). Genera that are prominently represented include Bacteroides, 
Bifidobacterium, Lactobacillus, Enterococcus, Escherichia, Peptococcus, 
Peptostreptococcus, Clostridium, Fusobacterium, Eubacterium, and Veillonella (Xu 
et al., 2003; Topping et al., 2001). More than 800 species (>7,000 strains) of bacteria 
are estimated to inhabit the colon. These include species that are commensal which 
cause no harm in the intestine, and those that are potentially pathogenic (Backhed et 
al., 2005). Among the microbes, most colonic microbes provide beneficial effects and 
are necessary for proper colon function. Some of these effects include absorption of 
water, electrolytes and other nutrients, synthesis of certain vitamins (e.g., vitamins K, 
B and biotin), and digestion of dietary fibers (Xu et al., 2003; Hill et al., 1997; 
Bengmark et al., 2000).  
Other functions of the intestinal microbes are their importance for maturation 
of the immune system (Kelly et al., 2007), the development of normal intestinal 
morphology and maintaining immunological balanced responses. The microbes 
reinforce the barrier function of the intestinal mucosa, helping in the prevention of the 
attachment of pathogenic microorganisms and the entry of allergens. Alteration of the 
microbial flora of the intestine due to the antibiotic use, disease and aging, can 
negatively affect the host. In addition, an imbalance in microbial populations often 
favors the proliferation of pathogenic species, leading to infectious diseases, chronic 
inflammation diseases such as inflammatory bowel diseases (IBD) and even colon 
Chapter 1 Introduction 
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cancer. Therefore, it is very important to maintain the balance of the microbial 
population especially the population of beneficial intestinal microbes.  
When one considers beneficial intestinal microbes, lactobacilli and 
bifidobacteria are the two most common genera that come to mind. However, specific 
species and strains of other genera, even those generally considered to be potentially 
pathogenic, have been shown to provide healthful benefits. Some examples include 
Enterococcus, Clostridium and Escherichia (Kanauchi et al., 2005; Bondarenko et al., 
2004). Among the “good” bacteria, lactobacilli, bifidobacteria and enterococci are 
Gram positive. They belong to lactic acid bacteria (LAB) which is an important group 
in maintaining human health. 
The role of intestinal microflora, such as several strains of lactic acid bacteria 
(LAB) in priming the immune system during ontogeny to limit allergy and chronic 
inflammatory responses has been brought to attention in recent years (Cross et al., 
2001; Marteau, 2002; Iwabuchi et al., 2007). Clinical and experimental studies have 
put forward that intestinal microflora is essential for the maintenance of intestinal 
homeostasis by altering microbial balance or by specifically interacting with intestine 
immune system (Kelly et al., 2004), and their influence may extend beyond the gut, 
modifying systemic immunity. However, the mechanisms of how they interact with 
the host and the role that they play in the intestine immune system especially in the 
context of chronic inflammation are still unclear. 
LAB are a group of related bacteria that produce lactic acid as a result of 
carbohydrate fermentation. The production of lactic acid results a very low pH which 
is low enough to inhibit the growth of most other microorganisms including the most 
common human pathogens. Since these organisms lack many biosynthetic capabilities 
and generally have complex nutritional requirements, LABs are usually abundant only 
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in communities where these requirements can be provided such as intestines (e.g., 
Enterococcus faecalis), plant leaves (Lactobacillus) as well as decaying plant or 
animal matter. Studies also showed that metabolic and functional properties of 
probiotic LAB in the human intestinal ecosystem are related to many beneficial health 
effects (Haller et al., 2001). Lactic acid bacteria contribute to both the processes of 
decomposition and reconstruction in the intestinal tract. They supply digestive 
enzymes that help break down food, while simultaneously micro-activate vital 
nutrients. The genera Lactobacillus, Bifidobacteria, Enterococus and Streptococcus 
are important members of this group. These microbes are broadly used in the 
production of fermented food such as yogurt, cheeses, and sausage.  
Most of Lactobacillus is rod-shaped, Gram positive, non-spore-forming, 
belonging to the family of lactobacillaceae. They can ferment glucose into lactose 
with the production of lactic acid. The most common application of Lactobacillus is 
industrial, specifically for dairy production like sour milk and yogurt. Lactobacillus is 
generally harmless to humans and rarely inciting harmful infections or diseases.  
The other important group of LAB is Enterococcus faecalis. Prior to 1984, E. 
faecalis was known as Streptococcus faecalis (Schleifer, 1984). They were classified 
as Group D streptococci due to the fact that they have the Lancefield Group D antigen 
(glycerol teichoic acid antigen) in their cell walls. E. faecalis are nonmotile, Gram-
positive, facultative anaerobic spherical bacterium of Streptococcaceae family. They 
are usually catalase negative, although sometimes tests can come out slightly positive. 
Most strains are non-hemolytic. 
E. faecalis normally inhabit in the intestines of animals and humans. However, 
they also can be found in soil, vegetation, and surface water, probably due to 
contamination by animal excrement. In human, E. faecalis usually colonize the large 
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intestine (~107 organisms per gram of feces) and urinary tract. They can be observed 
singly, in pairs, or in short chains. E. faecalis have a fermentative metabolism in 
which they convert carbohydrates to lactic acid. Therefore, they belong to LAB. In 
addition, E. faecalis play a key role in the fermentation of nonabsorbed sugars in the 
gastrointestinal tract. They have a large number of sugar uptake systems, and 
considerably more than any other sequenced bacteria. Moreover, the cation 
homeostasis mechanisms of E. faecalis contribute to their resistance to pH, salt, metal, 
and desiccation. E. faecalis can grow at a range of temperatures from 10°C-45°C, and 
also capable of growing in hypotonic, hypertonic, acidic, and alkaline environments. 
The genus Enterococcus especially E. faecalis is a controversial group of LAB. 
This controversial nature of E. faecalis has prompted an enormous pro/contra groups 
in scientific papers and reviews in recent years. In the following text, I will examine 
the properties of E. faecalis from these two sides. Currently, Enterocuccus and several 
other species of LAB, which are usually derived from human intestinal bacteria, are 
used for starter cultures in dairy products and are also marketed as medical probiotic 
preparations to enhance the host immune responses (Domann et al., 2007; Shimada et 
al., 2007). E. faecalis, one of the representative strains, has been utilized as live 
bacteria products with balancing activity of intestines since the 1950s. Studies on the 
microbes of many traditional cheeses have indicated that enterococci play an 
important role in the ripening of these cheeses, probably through proteolysis, lipolysis, 
and citrate breakdown, hence contributing to their typical taste and flavour (Foulquie´ 
Moreno et al., 2006). Enterococci are also present in other fermented foods, such as 
sausages and olives. They were reported to be dominant in freshly fermentation 
products however much less in spoil products (Johanna et al., 2004) although their 
roles in these products have not been fully elucidated. At the same time, E. faecalis 
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have been associated with a number of human infections. A number of the strains are 
natural antibiotic resistance and they are the leading cause of hospital-acquired 
secondary infections (Domanna et al., 2007). Several virulence factors have been 
described and the number of vancomycin-resistant E. faecalis is increasing.  
In most cases, E. faecalis cause no infection. They were classically considered 
more as commensal bacteria of the gastrointestinal tract of humans and animals rather 
than a specialized human pathogen. In some people though, E. faecalis can cause 
clinical problems. These include opportunistic urinary tract infections and wound 
infections.  
Interestingly, a new strain called “Enterococcus faecalis TH10” isolated from 
fermented food is proving to be highly effective against even the most deadly 
antibiotic-resistant bacterial strains, including methicillin-resistant Staphylococcus 
aureus (MRSA). Enterococcus faecium SF68 is another probiotic strain that has been 
used in the management of diarrheal illnesses.  Bengt et al demonstrated that E. 
faecalis could be found in three-day old babies, and most importantly, babies who 
developed allergy were less often colonized with Enterococcus during the first month 
of life compared with healthy infants (Bengt et al., 2001). Therefore, E. faecalis might 
affect intestinal immune system development in the early stage of life. However, the 
possible underlying mechanism of E. faecalis in the modulation of intestinal immune 
responses is not clear.  
Shimada et al showed that E. faecalis FK-23 could suppress inflammatory 
responses in IBD and other inflammatory diseases in the intestine (Shimada et al., 
2004; 2007). They claimed that E. faecalis might have an effect on the immune 
balance between Th1 and Th2 immunity (Shimada et al., 2004; Kropec et al., 2005). 
Also, some clinical studies demonstrated that E. faecalis could compete with anti-
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antiboitic strains in some serious condition of inflammatory diseases to eradicate the 
pathogenic strains. Although many clinical studies have been done on its effects on 
inflammatory diseases, none of them has shown how E. faecalis act on the intestine 
and how they communicate with the intestinal epithelial cells. 
In the human intestine, epithelial cells provide the first barrier and contact 
with all kinds of bacteria. They express numerous receptors, adhesion molecules and 
proinflammatory mediators and act as the sentinel of the mucosal immune system. 
Therefore, they have a pivotal role in the bacteria-host communication and the 
functional changes of the epithelial cells may contribute to many pathological features 
of intestinal inflammation (Jijon, 2002). Disruption of the immune regulatory 
functions of the epithelial cells by an imbalanced microflora could lead to exacerbated 
effector responses and chronic inflammatory diseases. IBD is a chronic relapsing 
disorder involving a dysregulated host–microbe interaction. Evidence supporting the 
hypothesis that intestinal bacteria play a role in the pathogenesis of IBD includes the 
observation that inflammation and lesions generally occur in intestinal regions with 
the highest bacterial concentrations (i.e. the ileum and colon) (Thompson-Chagoyan 
et al., 2005). It has been shown that IBD patients possess an increased risk for the 
development of colorectal cancer (Mark et al., 2007). Many solutions for the 
therapeutic treatment of IBD have been studied. Recently, the focus has been placed 
on LAB or so called probiotics, which aims to restore balance to the intestinal 
microflora and to reduce intestinal inflammation. In vitro/vivo studies and some 
clinical trials have demonstrated the potential therapeutic benefits of these microbes 
that can suppress inflammatory responses in the intestine (Bai and Ouyang, 2006; 
Bengmark, 2007). LAB exert their beneficial effects through a variety of mechanisms 
that are unique to each strain (Fedorak et al., 2004; Sartor et al., 2004; De et al., 
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2006). They competitively exclude undesirable bacteria through binding to mucosal 
border and thus prevent pathogenic bacteria from crossing the cell wall, because they 
align themselves closer to the microvillus than many pathogenic bacteria (Elmer, 
2001; Zhong et al., 2004). They also prevent adhesion and translocation of pathogenic 
bacteria, which is probably important in preventing bacterial antigens from reaching 
the lamina propria and mucosal immune system. Enterocin, which is a product of E. 
faecalis showed antimicrobial properties. Research using E. faecalis and the 
combination of other four antimicrobial chemicals demonstrated that the inhibitory 
effect of E. faecalis contributed significantly to the overall anti-S. aureus effect (Kerry 
et al., 2006). In addition, LAB stimulate immunoglobulin release into the lumen. 
They change the mucosal immune system with a resultant less proinflammatory 
response and a greater anti-inflammatory response. Therefore, these LAB may be 
efficient means to treat inflammatory diseases in the human intestine.  
LAB have not only been demonstrated to manipulate the intestinal microbes 
and reduce the inflammatory responses but also increase the natural resistance of the 
host to infections since a balance intestinal microflora could resist the invasion of 
pathogens. When we are considering LAB for the treatment of diseases, the safety 
should be ensured. Lactobacilli and bifidobacteria are two commonly used LAB 
(Biavati et al., 2000). They have a long history of safe use as microbial adjunct 
nutrition (Salminen et al., 1998) and are rarely implicated in human gastrointestinal 
and extraintestinal infections in the presence of predisposing factors (Charteris et al., 
1997). However, the safety for consumption should still be considered. Many studies 
have been conducted to test their antibiotics resistance property. It is reported that 
most lactobacilli and bifidobacteria strains are susceptible to ampicillin, bacitracin, 
clindamycin, dicloxacillin, erytromycin, novobiocin, penicillin G and rifampicin, 
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however, resistant to aztreonam, cycloserin, kanamycin, nalidixic acid, polymyxin B 
and spectinomycin (D'Aimmo et al., 2007). Among all LAB species, Enterococcus, 
especially E. faecalis, is a controversial group. Therefore, the safety of LAB, 
especially E. faecalis, for their applications in food and pharmaceutical industries 
must be ensured.  
To modulate human immunity, LAB must “talk” to the host that is endowed 
with recognition receptors or otherwise is sensitive to bacteria-derived products (e.g. 
metabolites and cell wall components). Much attention has been paid to the adhesive 
properties of these LAB (Vesterlund et al., 2006). Their ability to adhere to host cells 
or mucus is commonly considered as a requirement for LAB to conduct their anti-
inflammation function. Some in vitro studies have shown that E. faecalis adhesive 
ability is strain dependent (Carlors et al., 1991). Interestingly, Morita et al showed 
that there was no correlation between adhesive capacity on human epithelium and 
cytokine induction (Morita et al., 2000). However, the importance of LAB-epithelial 
cells adhesion and its role in the inflammatory responses are not fully understood. 
Studies showed that carbohydrate residues present on the bacterial cell surface might 
mediate the adherence (Carlors et al., 1991). The determination of the structure of 
carbohydrates on bacterial surface is important for the understanding of their 
biological function such as anti-inflammatory responses in the host. Lectins are useful 
in the investigation of protein-carbohydrate interactions (Naeem et al., 2007). 
Moreover, it has been shown that carbohydrate and protein structures present on the 
bacterial surface are involved in several immune and biological responses in health 
and inflammatory conditions (Carlors et al., 1991; Mizoguchi and Mizoguchi, 2007).  
Normal GI microflora populations are crucial for the maturation of acquired 
immunity. Beneficial intestinal bacteria can stimulate the synthesis and secretion of 
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IgA, the antibody that coats and protects mucosal surfaces against microbial infection 
(Forchielli and Walker, 2005). The GI microflora also assists in the development of 
normal immunity by its effects on antigen-presenting cells (APCs). APCs are 
macrophages, B lymphocytes and dendritic cells that process antigens and then 
present them to T helper (Th) cells for recognition and appropriate response. 
Dendritic cells are the APCs of the colon that reside in the lamina propria just beneath 
the mucosal surface and extend their dendrites through the epithelial cell layer into the 
lumen of the gut. When a dendrite comes in contact with an antigen, it releases the 
antigen by phogocytosis or endocytosis, and then presents the epitope to a Th cell that 
also resides within the lamina propria. The Th cell then determines whether or not the 
antigen requires further attention, and appropriate action can be initiated.  
A study demonstrated the specificity of colonic dendrites regarding their 
reaction to various species of bacteria found in the gut. Undifferentiated human 
monocytes produced higher levels of interleukin (IL)-12 (p70) and tumor necrosis 
factor (TNF) in response to Lactobacillus plantarum and Bifidobacterium 
adolescentis, two healthful colonic bacteria, than to potentially pathogenic 
Escherichia coli and Veillonella parvula (John, 2006). On the other hand, human 
monocytes that had differentiated into dendritic cells in the gut secreted large amounts 
of IL-12 (p70), TNF, IL-6 and IL-10 in response to E. coli and V. parvula, but were 
practically non-responsive to L. plantarum and B. adolescentis. This evidence 
suggests that dendritic cells in the gut recognize and respond to potential pathogenic 
bacteria, but do not respond to healthful bacteria (Karlsson, 2004). 
The means by which the intestinal microflora assists immune development are 
not fully understood, although it is now known that polysaccharides play a critical 
part in this process. Researchers using a human commensal bacterium, Bacteroides 
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fragilis, in germ-free mice showed that this bacterium was sufficient to correct T cell 
deficiencies normally seen in these animals. But more than that, investigators 
discovered that polysaccharide on the commensal bacterial cell wall was the critical 
factor in Th1/Th2 imbalances (Mazmanian, 2005). Thus, at least in this case, a 
bacterial carbohydrate is the requisite molecule for trigging the development of the 
immune system.  
A balanced Th cell response is important in the modulation of inflammatory 
reactions. The Th1 subset of lymphocytes is responsible for many cell-mediated 
responses, and is associated with promotion of inflammation and tissue injury. The 
Th2 subset promotes the humoral response, and supports allergic reactions. Therefore, 
an imbalance favoring a Th1 response can contribute to inflammatory bowel diseases 
(Neuman, 2007), and an imbalance that favors the Th2 response can promote atopic 
diseases (Kuby, 1997). TH17 and T reg cells are also important in the regulation of 
host responses upon commensal and pathogenic bacteria. Appropriate colonization of 
GI microflora helps to maintain proper Th cell responses, thus reducing the risk of 
these diseases.     
Inflammatory diseases have a close relationship with intestinal bacteria. 
Patients with IBD demonstrate immunological reactivity to their own commensal 
bacteria (Duchmann et al., 1995; Cohavy et al., 2000) and fecal diversion is effective 
in modifying intestinal inflammation (Rutgeerts et al., 1991; Janowitz et al., 1998; 
Sartor, 1998). Manipulation of the bacterial flora either through the use of antibiotics 
or probiotics is effective in ameliorating IBD (Sandborn et al., 2000; Sartor, 2000; 
Gionchetti et al., 2000; Rembacken et al., 1999; Prantera et al., 1996). Ulcerative 
colitis (UC) and Crohn’s disease are one form of IBD. The most serious IBD is colon 
cancer. It has long been noted that cancer arises from regions of chronic inflammation 
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(Osawa et al., 2006). In cancer tissues, inflammatory cells and cytokines of the 
immune system are more likely to contribute to their growth and progression.  
Cytokines are small secreted polypeptides or glycoproteins (≤ 30KDa) which 
mediate and regulate immunity, inflammation, and hematopoiesis. They generally act 
over short distances and short time spans and at very low concentration. Cytokines 
produce their actions by binding to specific high affinity cell surface receptors, which 
then signal the cell via second messengers, often tyrosine kinases, to alter gene 
expression in the target cells. Responses to cytokines include increasing or decreasing 
expression of membrane proteins including cytokine receptors, proliferation, and 
secretion of effector molecules. 
It is common for different cell types to secrete the same cytokines or for a 
single cytokine to act on several different cell types. Cytokines are redundant in their 
activity, meaning that different cytokines can do similar functions. Moreover, 
cytokines are often produced in a cascade, as one cytokine stimulates its target cells to 
make additional cytokines. Cytokines can also act synergistically or antagonistically. 
Several interested cytokines are illustrated in the following Table 1.1.  
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Table 1.1 Selected immune cytokines and their activities 
 
Cytokine Producing   Cell Target   Cell Function 
Th cells co-stimulation 
B cells maturation and proliferation 















activated B cells 
proliferation and 
differentiation 
IgG1 and IgE 
synthesis 
macrophages MHC Class II 
IL-4 Th2 cells 
T cells proliferation 




activated B cells differentiation into plasma cells 
plasma cells antibody secretion






various acute phase response 
IL-8 Macrophages, epithelial cells, endothelial cells neutrophils 
Chemotaxis; 
Inflammation 
macrophages cytokine production IL-10 Th2 cells 
B cells activation 
activated T cells 
differentiation into 
CTL 
(with IL-2) IL-12 
macrophages 
B cells 
NK cells activation 
T cells Activation 
IL-17 T cells 
various inflammation 
IL-18 
keratinocytes, small intestine 
epithelial cells, adrenal cells, 
macrophages, pancrease, skeletal 
muscle, liver, lung and PBMC 
activated T and 
B cells, NK cells IFN-γ production




activated B cells Ig class switch to IgG2a 
Th2 cells proliferation 
IFN-γ Th1 cells,  T cells, NK cells 




macrophages IL-1 synthesis 
activated B cells IgA synthesis 
TGF-β T cells, monocytes 
various proliferation 
macrophages cytokine expression 
tumor cells cell death TNF-α macrophages, mast cells, NK cells 
tumor cells cell death 
tumor cells Proliferation 
Neurtophil Inflammation ICAM1 Vascular endothelium, epithelial cells, macrophages and lymphocytes.
Lymphocyte Ligand for LFA-1
CTL: cytotoxic T lymphocytes; DC: dendritic cells; IL: interleukin; IFN: Interferon; TGF: 
Tumor Growth Factor; TNF: Tumor Necrosis Factor; MHC: Major histocompatibility 
complex; Th: T helper; PBMC: peripheral blood mononuclear cells; ICAM1: intercellular 
adhesion molecule 1; LFA-1: lymphocyte function-associated antigen 1. ** Italicized 
activities are inhibited. 
Adapted from “Immunology Tutorials” online: 
http://microvet.arizona.edu/Courses/MIC419/Tutorials/cytokines.html 
Among the immune cells, I would like to emphasize that T helper cells have 
two important functions: one is to stimulate cellular immunity and inflammation, and 
the other is to stimulate B cells to produce antibody. Two functionally distinct subsets 
of T cells secrete cytokines which promote these different activities. Th1 cells 
produce IL-2 and IFN-γ, which activate T cells and macrophages to stimulate cellular 
immunity and inflammation. Th2 cells secrete IL-4, IL-5, IL-6 and IL-10, which 
stimulate antibody production by B cells. IL-4 stimulates Th2 activity and suppresses 
Th1 activity, while IL-12 promotes Th1 activities. Th1 and Th2 cytokines are 
antagonistic in activity. The balance between Th1 and Th2 activity may steer the 
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immune response in the direction of cell-mediated or humoral immunity. However, 
the imbalance between Th1 and Th2 cells might contribute to inflammatory responses 
thus leading to diseases. Evidence indicates that a dysregulation of mucosal immunity 
in the gut of IBD causes an overproduction of inflammatory cytokines and trafficking 
of effector leukocytes into the bowel, thus leading to an uncontrolled intestinal 
inflammation (Nakamura et al., 2006). IL-8 and TNF-α, which are important 
proinflammatory cytokines that were upregulated in IBDs, together with intercellular 
adhesion molecule-1 (ICAM-1), which is an important adhesion molecule which play 
a key role in many inflammatory diseases will be discussed in the following text. IL-
18, which is emerged as a potential therapeutic target in inflammatory/autoimmune 
disorders recently, will also be further explored. 
IL-8, which is a prototypic human chemokine, is found expressed in many 
inflammatory tissues. It is barely detectable in healthy tissues. However, it is rapidly 
induced by 10 to 100 folds in response to proinflammatory cytokines such as TNF-α 
or IL-1β, bacterial or viral products and cellular stress. In human intestine, IL-8 can 
be expressed by IECs in response of various stimulations. Hence, epithelial cell 
derived IL-8 may mediate neutrophil chemoattraction in infection or inflammation 
and also, by virtue of its angiogenic properties (Koch et al., 1992; Szekanecz et al., 
1994), revascularization in the subsequent resolution of inflammation. In addition, 
malignant transformed colonic epithelial continually expressed IL-8 suggesting the 
involvement of IL-8 in carcinoma progression. Studies also showed that IL-8 is 
expressed in a majority of human colorectal carcinomas, which suggested that IL-8 
may also play an autocrine role in the growth of colon carcinoma cells (Brew et al., 
1996).  Furthermore, IL-8 is elevated in the context of various other intestinal 
pathologies including Crohn’s diseases, UC (Reddy et al., 2007), and possibly 
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intestinal neoplasia (Van, 1997; Eckmann, 1993).  Therefore, the examination of 
signals that trigger IL-8 secretion is relevant to multiple cellular processes. In addition, 
IL-8 production was regulated by several well-known signaling pathways like NF-κB 
and MAPK pathways. Upon stimulation, NF-κB and JNK pathways are activated to 
induce transcription, and the resulting mRNA is rapidly stabilized by the p38 MAPK 
pathway (Hoffmann et al., 2002). In this way, cells are able to rapidly increase and at 
the same time to fine tune the amount of IL-8 secreted and thereby control the extent 
of leukocytes attracted to sites of tissue injury. Increased IL-8 production is thought to 
play important functions in inflammation and angiogenesis and consequently in 
healing and tumor development (Zheng and Martins-Green, 2007). Suppression of IL-
8 might result in the inhibition of inflammation in the tissue and further tumor growth.  
TNF-α is another important proinflammatory cytokine which is abundantly 
expressed in the gut of IBD (Murch, 1993; Breese, 1994; Braegger, 1992). It is 
synthesized by monocytes, macrophages, neutrophils, mast cells, natural killer (NK) 
cells and T cells (Table 1.1) (Tracey, 1997). During the inflammatory process, it 
orchestrates the initiation of further leukocytic infiltration via adhesion molecule 
upregulation, dendritic cell maturation and survival, macrophage activation, and 
driving Th1 cell responses within tissues in many experimental and clinical 
autoimmune diseases. Increased TNF-α expression in inflammatory cell has been seen 
in many experimental autoimmune diseases. TNF-α is also thought to facilitate on-
going T cell effector responses, possibly through the activation of anti-apoptotic 
pathways dependent on TNF-induced nuclear factor NF-κB activation (Wang et al., 
1998). In animal models of experimental colitis, treatment with anti-TNF-α antibody 
has been shown to be effective in the suppression of intestinal inflammation (Powrie 
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et al., 1994; Kosiewicz et al., 2001). As a result, this cytokine was considered to be an 
attractive target for the treatment of IBD and several anti-TNF reagents have thus 
been developed. All the anti-TNF reagents have been demonstrated to be effective in 
reducing intestinal inflammation.  Therefore, reagents that could suppress TNF-α 
might be an effective “drug” in the therapy of inflammatory intestinal diseases like 
IBD. 
Inflammation is a complex interaction between a noxious stimulus and 
leukocytes, vessel walls, and connective tissue with its cellular and noncellular 
constituents. A complex of cytokines and growth factors controls cell-to-cell 
communication during progress of the inflammatory process (Fuss, 2003). Whereas a 
distinct set of cell surface molecules, collectively designated cell adhesion molecules 
(CAMs), is required for the binding of leukocytes to tissue components and 
presumably also for the directional movement of leukocytes toward inflamed areas 
(Springer, 1990; 1994). Over the last few decades, extensive research on the 
expression and function of CAMs in chronic inflammatory disorders has resulted in 
the development and testing of drugs specifically aimed at interfering with the effects 
of these adhesion receptors (Van Assche, 2002). These include an antisense 
oligonucleotide inhibitor of intercellular adhesion molecule-1 (ICAM-1). The ICAM-
1 molecule is an immunoglobulin-like glycoprotein which is constitutively expressed 
on the surface of a variety of cells including endothelial and epithelial cells, 
fibroblasts, lymphocytes and monocytes (Roebuck, 1999). The primary function of 
ICAM-1 is to promote adhesion between leucocytes and endothelial cells, in order to 
facilitate tissue-specific localisation of leucocytes for immune and inflammatory 
responses (Mazzone, 1995; Albelda, 1994; Springer, 1994; Bevilacqua, 1993). ICAM-
1 plays an important role, not only in the stabilization of leukocyte interactions with 
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the vasculature, but also in signaling initiations (Van et al., 2007). Results show, 
however, that ICAM-1 is also involved in several of the subsequent steps of the 
inflammatory cascade. ICAM-1 activation has been well characterized in human 
umbilical vein endothelial cells (HUVECs) in response to stimulation with TNF-α, 
lipopolysaccharide(LPS) or oxidised low density lipoproteins (LDLs) (Niessen et al., 
2002). Association between IBD and polymorphism in the gene encoding ICAM-1 on 
chromosome 19 has been demonstrated recently (Braun et al., 2001; Matsuzawa et al., 
2003; Papa et al., 2004; Low et al., 2004) suggesting that ICAM-1 plays a specific 
role in the pathogenesis of IBD. The connection between neutrophil dominance 
during the active phases of UC, the interaction between ICAM-1 and neutrophils, and 
the linkage between UC and the ICAM-1 gene make UC an obvious target for anti-
ICAM-1 treatment. In addition, a number of animal studies have shown evidence of 
anti-ICAM-1 antibodies providing protection against ischaemia reperfusion injury, 
effects associated with reduced neutrophil infiltration (Ma et al., 1992; Lefer et al., 
2002).  
Therefore, the crucial role of adhesion molecules in IBD and other 
inflammatory diseases makes them a very interesting target for drug development. 
Indeed, manipulating adhesion molecule is also being considered in multiple 
inflammatory diseases, including multiple sclerosis (O’Connor et al., 2004; Vollmer 
et al., 2004; Tremlett et al., 2005), rheumatoid arthritis (Maksymowych et al., 2002) 
and psoriasis (Elices et al., 2003; Gewirtz et al., 2001). Since leukocyte–endothelial 
adhesion plays a central role in leukocyte extravasations and it represents a key 
feature of tissue inflammation, disrupting such an interaction could be beneficial to 
intestinal inflammation. Therefore, any reagents that inhibited ICAM-1 expression in 
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inflammatory tissue would suppress the inflammatory responses and acted as therapy 
for the diseases.  
Besides the adhesion molecules (ICAM-1) and proinflammatory cytokines 
(IL-8 and TNF-α), IL-18 is another emerging important cytokine that attract a 
profound interest as a potential therapeutic target in autoimmune/inflammatory 
diseases. It was originally termed interferon-inducing factor, which can be produced 
by various cell types (Table 1.1). IL-18 is a multi-functional cytokine with structural 
similarities to the IL-1 cytokine family (Okamura et al., 1995).  Studies showed that 
the activation of caspase-1 could release IL-1β and IL-18 from the cells (Li et al., 
2007). However, the mechanism for processing and secretion of IL-18 remains 
somewhat of a mystery. The activation of caspase-1 occurs independently of gene 
expression.  IL-18 may also be processed by stimuli other than caspase-1. In addition, 
IL-18 has been shown to promote both Th1 and Th2 responses (Okamura et al., 1995). 
Increased IL-18 levels have been reported in both Th1 and Th2 dominated diseases. 
Moreover, the effects of IL-18 appear to depend on the presence of other cytokines. 
Co-administration of IL-18 and IL-12 was shown to inhibit IgE production in 
helminth-infected mice in an IFN-γ dependent fashion (Yoshimoto et al., 1997).  In 
different animal studies, IL-18 caused increased production of IgE and Th2 cytokines 
(Kumano et al., 1999; Yoshimoto et al., 1999, 2000; Wild et al., 2000). Moreover, IL-
18 alone in relatively high doses induced IgE production in vivo. Furthermore, IL-18 
was found expressed at the site of many inflammation related disease like IBD 
(Pizarro et al., 1999), Rheumatoid arthritis (Gracie et al., 1999; Bombardieri et al., 
2007).  However, it is not very clear whether IL-18 is a marker of the diseased state or 
has an important effector function in acute or chronic diseases. Interestingly, 
administration of IL-18 to mice infected with a lethal dose of virulent strain of S. 
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typhimurium reduces the bacterial number in the tissues, rescuing them from death. 
On the other hand, macrophage infected with S. typhimurium exhibited reduced 
expression of IL-18, suggesting the ability of this pathogen to suppress production of 
IL-18 (Elhofy and bost, 1999; John et al., 2002). A more recent study showed that IL-
18 has an effective anti-tumor effect by developing a long-lasting protective immunity 
including both innate and adaptive immunity in the host (Xu et al., 2007). Therefore, 
IL-18 might be involved in a complex regulation mechanism in the inflammatory 
responses.  
Cytokines act on their target cells by binding to specific membrane receptors. 
The receptors and their corresponding cytokines have been divided into several 
families based on their structure and activities: Hematopoietin family receptors (e.g. 
GM-SF and IL-5 receptors), interferon family receptors (e.g. IFN receptors), tumor 
necrosis factor family receptors (e.g. TNF receptors) and chemokine family receptors 
(e.g. IL-8RA, and IL-8RB). Cytokine activity can be blocked by antagonists, 
molecules which bind cytokines or their receptors. During immune responses, 
fragments of membrane receptors may be shed and then compete for cytokine binding. 
Microbes also influence cytokine activities. They can affect the expression of the 
receptors and also the cytokine’s binding. In the following text, I will further examine 
TNF receptor family and the chemokine family receptors.  
The TNF receptor family include a variety of receptors (e.g. TNFR1, TNFR2 
and TNFRSF11A) which mediate or initiate diverse biologic responses though TNF.  
TNFR1 is generally considered to be responsible for the majority of biologic actions 
of soluble TNF. Direct signaling through TNFR2 occurs less extensively and appears 
to be confined mainly to cells of the immune system and maybe important during cell-
cell contact (Kriegler et al., 1988). TNFRSF11A, another TNF receptor which mainly 
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respond to TNFSF11, is a NF-κB activator. It is expressed on cells of the 
monocyte/macrophage lineage which include preosteoclasts. In addition, 
TNFRSF11A can be expressed in the colonic mucosa by subpopulations of activated 
macrophages or dendritic cells at higher levels in IBD compared to normal colon 
(Franchimont et al., 2004). However, most of the studies on TNFRSF11A were 
related to bone homeostasis (Nakao et al., 2007). Recent studies showed that the 
binding of the Receptor Activator of NF-κB Ligand (RANL also named as TNFSF11) 
to its receptor (TNFRSF11A), increases osteoclast development, osteoclast activity 
and survival upon the stimulation of proinflammatory cytokines (Walsh et al., 2003). 
Alternatively, TNFSF11 could also be produced in the gut and act in an endocrine 
manner on bone metabolism. In physiological conditions, TNFSF11 is not highly 
expressed in the intestine but TNFSF11 expression in both T-cells and osteoblastic 
cells is known to be tightly regulated (Anderson et al., 1997; Theill et al., 2002). 
Studies showed that the TNFRSF11A and TNFSF11 interaction results in an increase 
in dendritic cell (DC) survival and DC production of cytokines (Cremer et al., 2002; 
Josien et al., 1999). TNFRSF11A-expressing cells were mainly localized in the colon 
mucosa and had morphological features of large mononuclear cells suggestive of the 
monocyte-macrophage and/or dendritic cell lineages. Studies also showed that 
increased densities of TNFRSF11A expressing cells in CD patients in non-disease 
colon tissue (Franchimont et al., 2004). Therefore, inhibition of TNFRSF11A in 
inflammation intestine contributes to the host immune balance.  
Chemokines/cytokines exert their function through binding to their receptors. 
All chemokine receptors are membrane-bound molecules composed of seven 
transmembrane domains and are coupled to G proteins at the carboxylterminal portion 
and possibly the third intracellular loop (Murphy et al., 2000; Murdoch, 2000). 
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Following ligand binding, chemokine receptors are presumed to be internalized and 
subsequently recycled, reappearing on the cell surface within 1h on the human IL-8 
receptor system (Samanta et al., 1990). In the case of the human IL-8 receptor system, 
the inhibition of recycling reduced IL-8 mediated chemotaxis, suggesting its 
important role in the chemokine-mediated chemotaxis. IL-8 binds to two distinct 
types of receptors, IL-8RA and IL-8RB with similar high affinity (Murphy and 
Tiffany, 1991; Holmes et al., 1991). IL-8 activates the receptors IL-8RA and IL-8RB 
to induce chemotaxis in leukocytes, but only IL-8RA mediates cytotoxic and cross-
regulatory signals. This may be due to the rapid internalization of IL-8RB 
(Richardson et al., 2003). In addition, IL-8RA but not IL-8RB mediated signals 
attenuated the response to other types of chemoattractants without any effects on their 
receptor expression (Richardson et al., 1998). However, IL-8RA and IL-8RB tune the 
responses to IL-8 in a coordinated manner. In intestinal epithelial cells (Caco-2, HT-
29 and HCT116), all cells expressed IL-8RA however the expression of IL-8RB was 
weak (Brew et al., 2000). Both bind IL-8 with high affinity but IL-8RA is specific for 
IL-8, whereas IL-8RB also binds other chemokines with a similar affinity (Lee et al., 
1992). Since epithelial cells express IL-8 receptors, IL-8 may have an autocrine 
function in epithelial regeneration, as has been proposed for Melanoma growth 
stimulatory activity factor (MGSA) in wound healing (Nanney et al., 1995). Therefore, 
the regulation of IL-8RA in intestine would also be important in the modulation of 
inflammatory responses especially those involved IL-8. 
Since inflammation causes some serious diseases in the intestine, many 
approaches have been used to suppress inflammatory responses in the intestine. 
Crohn’s disease and ulcerative colitis are two idiopathic IBD. So far, many drugs 
have been used to treat IBD in clinical trials, e.g. 5-aminosalicylic acid compounds, 
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corticosteroids, immunomodulators and calcineurin inhibitors.  Emerging novel 
therapies—including biological therapies—directed at cytokines (e.g. infliximab, 
adalimumab, certolizumab pegol) (Franchimont et al., 2004) and receptors (e.g. 
visilizumab, abatacept) involve T-cell activation, selective adhesion molecule 
blockers (e.g. natalizumab, MLN-02, alicaforsen), anti-inflammatory cytokines (e.g. 
IL-10) and leucocyte apheresis. Many monoclonal antibodies, small molecules,  
recombinant growth factors, and MAP kinase inhibitors are targeting at various 
inflammatory cells and pathways (Baumgart and Sandborn, 2007). Besides the 
biochemicals that suppress inflammatory responses, clinical studies have suggested 
that probiotic bacteria may be effective therapeutic agents in IBD treatment although 
the molecular mechanisms of their regulation are still undefined. Probiotics have been  
used in the treatment of a number of inflammatory conditions including arthritis 
(Baharav et al., 2004), atopic eczema (Isolauri et al., 2000 and Viljanen et al., 2005), 
pouchitis (Gionchetti et al., 2000; Gionchetti et al., 2003; Katz, 2003; Kuisma et al., 
2003; Gosselink et al., 2004 and Mimura et al., 2004), chemotherapy-induced 
mucositis (Tooley et al., 2006), ulcerative colitis (Rembacken et al., 1999; Bibiloni et 
al., 2005 and Furrie et al., 2005), Crohn's disease (Prantera et al., 2002 and Schultz et 
al., 2004; March, 2006), antibiotic-induced diarrhoea (Kim et al., 2003) and 
experimental colitis (Madsen et al., 1999; Steidler et al., 2000, O'Mahony et al., 2001; 
Shibolet et al., 2002; Dieleman et al., 2003; Moon et al., 2004; Rachmilewitz et al., 
2004; Gaudier et al., 2005; Herias et al., 2005 and Moller et al., 2005, Foligne et al., 
2007).  
Studies suggest that altered bacterial species in the intestine may be a cause 
rather than a consequence of the IBD (Fedorak, 2007). Patients with IBD appear to 
have a genetically determined loss of immunologic tolerance, as evidenced by specific 
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cell-mediated and humoral immune responses targeting commensal gut bacteria 
(Duchmann et al., 1995; Macpherson et al., 1996). The mechanisms of action of 
probiotics treatment in IBD are currently a topic of much investigation. Probiotic 
strains exert their beneficial effects through a variety of mechanisms that are unique 
to each strain (Fedorak et al., 2004; Sartor et al., 2004). They competitively exclude 
undesirable bacteria through binding to mucosal border thus prevent pathogenic 
bacteria from crossing the cell wall, because they align themselves closer to the 
microvillus than many pathogenic bacteria. They also prevent adhesion and 
translocation, which is probably important in preventing bacterial antigens from 
reaching the lamina propria and mucosal immune system. In addition, probiotics 
stimulate immunoglobulin release into the lumen. They change the mucosal immune 
system with a resultant less Th1 proinflammatory response and a greater T-regulatory 
anti-inflammatory response. Furthermore, probiotics have antimicrobial activity. They 
are able to secrete defensins and other products like lactic acid that inhibit and kill 
pathogenic bacteria. Moreover, they enhance the barrier integrity by direct and 
indirect effects on tight junctions. Therefore, probiotics might be efficient and safer 
means to treat inflammatory diseases in human intestine. However, not all probiotics 
function via the same mechanisms; thus, not all probiotics are effective therapeutic 
agents in the treatment of all inflammatory diseases.  
Given the diversity of inflammatory or immune responses that can be mounted 
by the intestinal epithelium, association of  LAB with epithelial cells could be 
sufficient to trigger signaling cascades that ultimately activate underlying immune 
cells in the lamina propria. Alternatively, LAB may also release soluble factors that 
themselves trigger signaling cascades at the level of the epithelium or associated 
immune system (Madsen et al., 2001; Menard et al., 2004; Hoarau et al., 2006). Many 
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studies have been conducted to elucidate how pathogen virulence factors trigger 
inflammatory immune responses in the intestine. Little is known on how commensal 
bacteria control the innate immunity and inflammatory responses at the level of 
epithelial cells. Kelly et al using Bacteroides thetaiotaomicron, a prevalent anaerobe 
of the human intestine, showed that they could attenuate inflammation by regulating 
nuclear-cytoplasmic shuttling of PPAR-γ and RelA (Kelly et al., 2004).  Although the 
study demonstrated a new cellular target involved in commensal bacteria regulation, 
given the complex mechanisms defining host-bacteria communication, the possibility 
still exists that the immune system in the intestine is regulated by various bacteria at 
different levels. Studies using intestinal epithelial cell (IEC) lines have suggested that 
commensal bacteria may “program” IECs to prevent or down-modulate pro-
inflammatory responses by interfering with Toll-like receptors (TLRs) expression 
(Abreu et al., 2001; Lan et al., 2005).  
Toll-like receptors (TLRs) are a family of transmembrane receptors which are 
homologues to the drosophila Toll protein (Mushegian, 2001; Akira et al., 2001; 
Muzio et al., 2000). 13 mammalian TLRs have been identified so far: 10 human 
(TLR1–10) and 12 murine (TLR1–9 and TLR11–13) receptors, of which some are 
homologues and 2 NLRs (NOD1 and NOD2) (Mitchell et al., 2007; Rock et al., 1998). 
They are a class of pattern recognition molecules with unique functions in the innate 
and the acquired immune systems. The extracellular domain of Toll receptors contains 
leucine-rich repeat (LRR), whereas the cytoplasmic domain shows striking homology 
with that of interleukin receptors (IL-Rs), and is referred to as Toll/IL-R (TIR) 
domain. These domains are responsible for the recognition of pathogen-associated 
molecular patterns (PAMPs), present on diverse microbes including Gram-positive, 
Gram-negative bacteria, fungi, and viruses.  TLR ligand recognition occurs via 
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interaction of the extracellulular TIR domain with its PAMP and results in the 
activation of multiple intracellular signaling events like the activation of NF-κB 
signaling pathway and the production of cytokines such as IL-8 and TNF-α.  
TLR4 is the most extensively studied PRR and it recognizes a variety of 
ligands but is mostly known as the lipolysaccharide (LPS) receptor (Hoshino et al., 
1999). TLR2 also recognizes a broad range of ligands, such as bacterial lipopeptides, 
peptidoglycan (PGN) and lipoteichoic acid (LTA) from Gram-positive bacteria. The 
variety of ligands recognized is believed to be due to heterodimer formation of TLR2 
with two other TLRs, TLR1 or TLR6, which can discriminate subtle changes in the 
ligand structure (Bauer et al., 2001; Sugawara et al., 2003; Takeuchi et al., 1999).  
Mutations in TLR2 are associated with severe mycobacterial, staphylococcal infection 
and lepromatous leprosy (Takeuchi et al., 2000; Lorenz et al., 2000; Kang et al., 
2001). TLR5 detects a conserved domain on flagellin monomers, the main structural 
protein that forms the flagella on Gram-negative and positive bacteria, thus to induce 
mobilisation of NF-κB to the nucleus and promote expression of proinflammatory 
cytokines in mammalian cells (Cristofaro and Opal, 2006). TLR9 recognizes nucleic 
acids such as hypomethylated CpG, motifs, which are common among bacterial and 
viral DNA (Cristofaro and Opal, 2006). Bacterial DNA stimulates proinflammatory 
cytokines, metric oxide and thus promotes B-cell activation and induces a Th1 type 
cytokine response (Cristofaro and Opal, 2006). TLR3 recognizes nucleic acids like 
TLR9, but confined to single-stranded (ss) and double-stranded (ds) RNA rather than 
DNA (Sen and Sarkar, 2005). TLR3 and TLR9 are reported to response to Gram-
positive bacteria. The expression of TLRs differs with cell types and cellular 
localization where some have been found to be expressed primarily extracellularly 
(TLR1, TLR2, TLR4, TLR5, TLR6 and TLR11) and others intracellularly (TLR3, 
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TLR7, TLR8 and TLR9) on numerous myeloid cells (e.g. macrophages, dendritic 
cells, neutrophils, T and B cells) and also on nonmyeloid cells (e.g. epithelial cells 
and fibroblasts). 
Upon recognition of their cognate ligands, TLRs dimerize and initiate a 
signaling cascade that leads to the activation of a proinflammatory response (Akira, 
2006). Ligand binding induces two signaling pathways, one is MyD88-dependent and 
the other is MyD88-independent inducing the production of proinflammatory 
cytokines and type I interferons (IFNs) (Kawai and Akira, 2006). These two distinct 
responses are mediated via the selective usage of adaptor molecules recruited to the 
TIR domains of the TLRs after ligand recognition and binding. Four adaptor 
molecules have been identified so far, MyD88, TIR-associated protein (TIRAP), TIR 
domain containing adaptor protein-inducing IFN-β (TRIF) and TRIF-related adaptor 
molecules (TRAM) (O’Neill et al., 2003; Wang et al., 2004; Yamamoto et al., 2002, 
2003, 2003). MyD88 and TIRAP are responsible for the induction of proinflammatory 
genes and TRIF, and TRAM for the induction of the IFNs. A disturbance of anti-
inflammatory and immunosuppressive mechanisms in the gut is believed to lead to 
colitis, driven by a hyperresponsiveness to the commensal flora. TLR signaling may 
have a dual role in gut homeostasis as it was shown to be required for commensal-
dependant colitis in IL-10-deficient mice but not in mice deficient in IL-2 (Rakoff-
Nahoum et al., 2004, 2006; Rakoff-Nahoum and Medzhitov, 2006). The mechanisms 
by which the intestinal microflora suppresses inflammatory signaling may be 
dependent on the noninvasive nature of these organisms, as it was recently reported 
that activation of TLR9 located in the apical surface domain resulted in tolerance to 
TLR activation, whereas activation of TLR9 in the basolateral region, only reachable 
by invasive bacteria caused immune activation (Lee et al., 2006; 2007). Previous 
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studies in human IBD showed increased TLR expression and NF-κB activity in 
lamina propria macrophages and the epithelium under conditions of chronic intestinal 
inflammation (Hausmann et al., 2002; Cario and Podolsky, 2000; Schreiber et al., 
1998; Rogler et al., 1998; Andresen et al., 2005), suggesting that the continuous 
activation of downstream TLR effector systems including the activation of the 
transcription factor NF-κB could potentially lead to persistent inflammation. 
Therefore, the communication of bacteria with the host through TLRs is important in 
the initiation of inflammatory responses. Better understanding of these basic 
molecular mechanisms of TLRs and their downstream pathways regulated by 
commensal bacteria would have profound impacts on understanding of the 
inflammatory processes in human intestine.  
TLRs could be activated by pathogens leading to the initiation of 
inflammation by secreting pro-inflammatory cytokines such as interleukin-8 (IL-8) 
and tumor necrosis factor (TNF)-α (Janeway, 2001). IECs are a source of IL-8 which 
recruits neutrophils into the infected intestine. Appropriate neutrophil recruitment 
results in prevention of bacterial invasion. However, excessive IL-8 expression or 
neutrophil influx into the intestine contributes to the development of chronic 
inflammation diseases. It was demonstrated in the animal and clinical trials that 
inhibition of pro-inflammatory cytokines production and the supplementation of anti-
inflammatory cytokines reduced inflammation reaction (MacDermott, 1996).  Recent 
studies have suggested that chronic inflammation can be instrumental in both 
initiation and progression of many epithelial tumors (Balkwill and Mantovani, 2001; 
Coussens and Werb, 2002; Greten et al., 2004; Hussain et al., 2003; Ying et al., 2005). 
Therefore, better understanding of the regulation of IL-8 production in the human 
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intestine can be useful in the development of effective therapies for inflammatory 
diseases and even cancers in the intestine.  
In addition, emerging evidences suggest that changes in the homeostasis of 
bacteria- and host-derived signal transduction at the epithelial cell level may lead to 
functional and immune disturbances of the intestinal epithelium. It has become clear 
from numerous studies that LAB in the intestine are critical components in the 
development and prevention/treatment of chronic intestinal inflammation. Signal-
specific activation of mitogen-activated protein kinases (MAPK), interferon-regulated 
factors (IRF) and the transcription factor NF-κB through pattern recognition receptor 
signaling effectively induce inflammatory defense mechanisms.  
Mitogen-activated protein kinases (MAPKs) are another family of proteins 
able to transduce extracellular signals into inflammatory gene transcription. MAPK 
signaling pathway is one of the most important intracellular signaling cascades 
conserved from yeast to mammals. MAPKs are a family of serine/ threonine kinases 
in which three distinct groups of MAPKs have been identified in mammals, including 
the extracellular signal-regulated kinases (ERKs), the c-JUN NH2 terminal kinases 
(JNKs), and p38. Of these, the most extensively studied are the ERKs, which are 
acutely stimulated by growth and differentiation factors, heterotrimeric G protein-
coupled receptors, and cytokine receptors (Humberto, 2002). JNKs and p38 family 
members are generally implicated in responses to cellular stress, inflammation and 
apoptosis (Cobb, 1999; Lewis, 1998). Activation of any of the MAPK family 
members requires dual phosphorylation on serine/threonine and tyrosine residues by 
their upstream kinases termed as MAPK kinases (MKK). ERK, JNK and p38 family 
members are activated by MKK1/2, MKK4/7 and MKK3/6 respectively. MKKs, in 
turn, are activated by MKK kinases. To date, twelve member proteins of the MAPK 
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family have been identified in mammalian cells, and these can be grouped into five 
subfamilies on the basis of sequence homology and function (Garrington and Johnson, 
1999). Seven MKKs and fourteen MKKKs have been functionally identified in 
mammalian cells. The combination of twelve MAPKs, seven MKKs and fourteen 
MKKKs, seems extraordinarily complex. However, the complex combination and 
diversity of regulatory domains in different MKKKs give the family of MAPK 
modules the flexibility to respond to a wide range of cellular stimuli. Moreover, 
beside the activation model of MKKK-MKK-MAPK, MAPK family members also 
can be autophosphorylated triggered by the interaction of MAP3K7IP1/TAB1 protein 
with the kinase. 
Dephosphorylation of one or both of the regulatory residues (serine/threonine 
and tyrosine) induces deactivation of MAPK family members. MAPK 
dephosphorylation is carried out by some phosphatases, similar to the dual specificity 
MAPK phosphatases (DUSPs) also known as MKPs, which simultaneously 
dephosphorylate both serine/threonine and tyrosine residues (Tonks and Neel, 1996; 
Vicent et al., 2004; Liu et al., 2007). The first characterized member of this family 
was DUSP1 (also known as MKP1). It is encoded by an early response gene, which is 
transiently induced by mitogens and stress signals. Although ERK, JNK, and p38 are 
known substrates of DUSP1, the ability to dephosphorylate each one of these kinases 
varies depending on the cell system and its environmental conditions (Vicent et al., 
2004). 
MAPK signaling pathways can be activated by a variety of stimuli like 
proinflammatory cytokines. IL-1β could activate ERK, p38, and JNK. These three 
MAPK kinases may co-operatively mediate IL-1β stimulated receptor activator of 
nuclear factor-kappaB ligand (RANKL also know as TNFRSF11A) expression and its 
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activity in human periodontal ligament cells (Oikawa et al., 2007).  Furthermore, JNK 
and p38 are the most important kinases implicated during inflammation mediated by 
activating cytokine gene expression (Kyriakis et al., 2001). JNK and p38 modulate 
gene expression by different mechanisms. They can target transcription factors 
directly by enhancing their ability to activate transcription or may modulate formation 
of new transcriptional factors as the activation protein-1 (AP-1) complex after 
phosphorylation of c-JUN and the activating transcription factor-2 (ATF-2). They 
control chromatin access by histone phosphorylation and then modulate gene 
expression by remodeling the structure of chromatin. P38 and JNK are also involved 
in posttranscriptional control of gene expression by stabilizing mRNAs as JNK for 
interleukin IL-2 transcripts (Chen, 1998) and p38 for IL-8 transcripts (Hoffmann et al., 
2002). JNK, like NF-κB, are strongly activated under most conditions that induce IL-8. 
The observation that JNK are in fact essential for IL-8 (and IL-6) expression was 
made initially in human epithelial cells by blocking JNK activation by stable 
expression of antisense RNA or by dominant-negative mutants (Krause et al., 1998). 
The JNK inhibition was specific and did not affect NF-κB or p38 MAPK activation 
(Krause et al., 1998). The absolute requirement of JNK for IL-6 expression was later 
confirmed in JNK2-/- fibroblasts (Chu et al., 1999). In contrast to the findings above, 
the JNK inhibitor had no effect on IL-8 expression in lipopolysaccharide (LPS)-
stimulated human monocytes (Bennett et al., 2001). Furthermore, MAPK activation 
would lead to the induction of other proinflammatory cytokines such as IL-1β, TNF-α, 
IFN-γ (Malamut et al., 2006) and IL-12 (Parrello et al., 2000) and the suppression of 
anti-inflammatory cytokines such as IL-10 (Foey et al., 1998) and IL-11 (Bamba et al., 
2003). Thus, MAPK pathway appears as a central therapeutic target to control 
inflammation. 
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MAPK signaling pathways can be activated by a variety of stimuli like 
proinflammatory cytokines. JNK and p38 are the most important kinases implicated 
during inflammation mediated by activating cytokine gene expression (Kyriakis et al., 
2001). JNK and p38 modulate gene expression by different mechanisms. They can 
target transcription factors directly by enhancing their ability to activate transcription 
or may modulate formation of new transcriptional factors as the activation protein-1 
(AP-1) complex after phosphorylation of c-JUN and activating transcription factor-2 
(ATF-2). MAPK activation would lead to the induction of proinflammatory cytokines 
such as IL-1β, TNF-α, IL-8 (Matsumoto et al., 2007), IFN-γ (Malamut et al., 2006) 
and IL-12 (Parrello et al., 2000) and the suppression of anti-inflammatory cytokines 
such as IL-10 (Foey et al., 1998), IL-11 (Bamba et al., 2003). NF-κB is another 
important signaling pathway involved in the inflammatory responses in the host.  
In vertebrates, NF-κB transcription factor stand out as master regulators of 
innate and adaptive immunity, inflammatory responses, organ development and cell 
survival (Papa et al., 2006). They have also been recognized as a major regulator of 
pathogen- and inflammatory cytokine-inducible gene regulation (Baeuerle and Henkel, 
1994).  NF-κB is a dimeric transcription factor composed of a family of five subunits, 
namely NF-κB1 (p50 and its precursor p105), NF-κB2 (p52 and its precursor p100), 
and c-Rel, RelA (p65), and RelB (Baeuerle and Baltimore, 1996). These five subunits 
are characterized by the so-called Rel homology domain (RHD), which mediates 
DNA binding, dimerization and association with inhibitory proteins of IκB group. 
Normally, NF-κB is retained in the cytoplasm in an inactivate state by its binding to 
inhibitory proteins (IκB). IκB phosphorylation by IκB kinases (IKK) complex which 
consists of three subunits, IKKα (IKKA), IKKβ (IKKB) and IKKγ/NEMO, results in 
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ubiquitination and rapid degradation of IκBs by the proteasome, allowing NF-κB to 
translocate to the nucleus where they activate expression of distinct sets of target 
genes encoding numerous cytokines, chemokines, adhesion molecules, growth factors, 
immune receptors and prosurvival proteins. Through the induction of these genes, 
NF-κB marshals and coordinates innate and adaptive immunity, inflammation, cell 
differentiation and cell survival. But enhanced NF-κB-induced transcriptional activity 
might additionally require phosphorylation of the subunits as well as binding of 
coactivators (Baeuerle and Baltimore, 1996; Schmitz et al., 2001). At the level of 
DNA, NF-κB synergizes with many additional transcription factors that may 
determine cell type-specific expression of genes and the input from other signal 
transduction pathways in their regulation.  
There are two main pathways for NF-κB activation (Bonizzi et al., 2004). One 
is the canonical pathway, triggered in response to microbial products, stress and 
proinflammatory cytokines, depends on the activity of IKKβ and mainly results in the 
nuclear translocation of NF-κB1/RelA and NF-κB1/Rel dimers. The alternative 
pathway, activated by certain members of the TNF receptor (TNFR) family such as 
lymphotoxin (LT)β and BAFF receptors, depends instead on IKKα and causes 
activation of NF-κB2/RelB complexes by inducing the proteolytic processing of the 
NF-κB2/p100 precursor(Bonizzi et al., 2004; Hayden, 2004; Siebenlist et al., 2005). 
NF-κB signaling pathway can be activated by a wide spectrum of stimuli including 
microbial infection, chemicals, UV light (Pahl, 1999; Adachi et al., 2003) and 
proinflammatory cytokines like TNF-α and IL-1β. TNF-α is the key initiator of 
inflammation. Its deregulation causes many disorders including IBD, rheumatoid 
arthristis, and toxic shock syndrome. The binding of TNF-α to its receptor triggers a 
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series of intracellular events, resulting in the activation of transcription factors, 
including NF-κB, CEBR and AP-1 (Baud and Karin, 2001; Chen and Goeddel, 2002). 
However different cellular processes seem to be differentially regulated by specific 
signal transduction pathways. TNF-α causes activation of IKKs, kinases that 
phosphorylate IκB and induce its degradation, which results in activation of NF-κB. 
Importantly, a knock out IKKB is defective in signaling from TNF-α to NF-κB. 
Therefore, IKKB might play an important role in the regulation of NF-κB activation 
in response to proinflammatory cytokines. Experiments using chromatin 
immunoprecipitation, binding of p65 NF-κB to the endogenous IL-8 promoter and 
subsequent recruitment of RNA polymerase II are found rapidly, within one-half hour 
of IL-1 stimulation, underscoring the important role of NF-κB in IL-8 transcription 
(Hoffmann et al., 2002). Additional experimental evidence for the importance of NF-
κB in directing proinflammatory processes under conditions of chronic inflammation 
was elegantly shown in trinitrobenzene sulfonic acid (TNBS)-treated mice (Neurath et 
al., 1996). On the other hand, but equally important, the inhibition of NF-κB activity 
with pharmacological inhibitors during the resolution phase of carrageenan-induced 
acute inflammation had adverse effects on the host (Lawrence et al., 2001), 
suggesting dual functions of activated NF-κB including protective and detrimental 
mechanisms during the course of inflammation.  
They can be activated by a wide spectrum of stimuli including microbial 
infection, chemicals, UV light (Pahl, 1999; Adachi et al., 2003) and proinflammatory 
cytokines like TNF-α and IL-1β. NF-κB conducts its function by translocating to the 
nucleus where it activates expression of distinct sets of target genes encoding 
numerous cytokines, chemokines, adhesion molecules, growth factors, immune 
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receptors and pro-survival proteins. Through the induction of these genes, NF-κB 
coordinates innate and adaptive immunity, inflammation and cell survival.  
However, unbalanced activation of these innate signaling pathways because of 
host genetic predispositions and/or the lack of adequate anti-inflammatory feedback 
mechanisms may turn a physiological response into a pathological situation including 
failure of bacteria clearance and development of chronic inflammation. Therefore, it 
is very important for a healthy crosstalk between the bacteria and the innate signaling 
network of the intestinal epithelium in order to shape the extent and duration of 
inflammatory processes. The progress of the inflammatory process is controlled by a 
complex of cytokines and growth factors during LAB-to-host communication (Fuss, 
2003).  IL-2 and interferon (IFN)-γ are efficient in activating cellular immune 
responses that promote inflammatory responses thus eliminate intracellular pathogens. 
IL-4, IL-5 and IL-10 could promote humoral immune responses further to inhibit 
inflammatory responses. IL-4 and IL-10 have been implicated in the inhibition of IL-8 
formation (Kasama et al., 1994; Meda et al., 1994; Wertheim et al., 1993). IL-5 has 
long been associated with several allergic diseases including allergic rhinitis and 
asthma (Shen et al., 2003). TGF-β, which is an important inflammation regulatory 
cytokine, is important in the suppression of proinflammatory cytokines production. 
IL-12 could promote IFN-γ production, however, IFN-γ together with IL-2 augment 
IL-6 and TNF-α. Increased TNF-α expression in inflammatory cell has been seen in 
many experimental autoimmune diseases. In addition, IL-17 is characterized as 
cytokine-inducing cytokine that exhibits pleiotropic biologic activities on various cell 
types. It can activate IL-8 in IECs. In addition to inducing cytokines and chemokines, 
IL-17 presents itself with certain other unique functions. It enhances surface 
expression of intercellular adhesion molecule-1 (ICAM-1) in human fibroblasts. 
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ICAM-1 is also involved in several of the subsequent steps of the inflammatory 
cascade. It is usually found in inflamed colonic tissues, mediates the arrest and further 
migration of neutrophils. In addition, increased IL-18 levels have been reported in 
both Th1 and Th2 dominated diseases. Interestingly, administration of IL-18 to mice 
infected with a lethal dose of virulent strain of S. typhimurium reduces the bacterial 
number in the tissues, rescuing them from death. Therefore, suppression of pro-
inflammatory factors/cytokines such as ICAM-1, IL-2, IL-6, IL-12, IL-17, TNF-α and 
IFN-γ and upregulation of IL-4, IL-10 and TGF-β could inhibit the inflammatory 
responses in the host. IL-18 may also be involved in the immune responses in the host 
upon the stimulation of bacteria. 
Another important aspect in the network of cytokine actions during the 
inflammatory responses is the modulation of the level of cytokine receptors 
expression. The activation of cytokines can affect their own or other cytokines’ 
receptors. However, the exact mechanism of cytokine receptors involving in the 
bacteria-host interaction and inflammatory responses has not been fully studied. 
Although NF-κB and MAPK signaling pathways are the main pathways that 
regulate the inflammatory reactions inside the cells, there are some other signaling 
pathways that might be involved in the regulation. JAKs, Stats, SOCS and PIAS, 
which are involved in cytokine signaling, might also be important in the inflammatory 
responses. A recently identified signaling pathway related with MAPK and NF-κB 
might also involve in the inflammatory responses in the host. The prolyl isomerase 
PIN1 is a conserved enzyme that is intimately involved in diverse biological process 
and pathological conditions (Yeh and Means, 2007). By catalyzing cis-trans 
interconversion of certain motifs containing phosphorylated serine or threonine 
residues followed by a proline residue, PIN1 has profound effects on phosphorylation 
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signaling (Wulf et al., 2005).  PIN1 can target the pTHR254-Pro motif in the 
p65/RelA subunit of NF-κB and prevent NF-κB from binding to its inhibitor IκB. 
This prevents p65/RelA nuclear export and its subsequent degradation by an 
ubiquitin-mediated pathway (Ryo et al., 2003). This leads to enhanced nuclear 
accumulation, protein stability and transcriptional activity of NF-κB towards its target 
genes such as cyclinD1 and IκB (Ryo et al., 2003). CyclinD1 is an important cell-
cycle regulator that is known to have a key role in the development of many cancers 
(Yu et al., 2001; Lamb et al., 2003).  PIN1 regulates cyclinD1 expression through 
multiple mechanisms. It stabilizes cyclinD1 through directly binding to its pThr286-
pro motif thus inhibiting its nuclear export and ubiquitin-mediated degradation (Liou 
et al., 2002).  PIN1 also inhibits negative feedback of MAPK signaling (Dougherty et 
al., 2005). Raf kinase is activated by Ras and then triggers a protein kinase cascade, 
leading to the activation of MAPKs. MAPKs can phosphorylate and inactivate Raf in 
a negative feedback mechanism (Dougherty et al., 2005). PIN1 prevents Raf kinase 
from been turned off after growth stimulation by promoting dephosphorylation of Raf.  
In addition, PIN1 is transcriptionally regulated by the E2F1 family of transcription 
factors in the response of growth factors and other stimulating conditions.  E2F1 has 
been found to be released from Rb and activating its target genes in breast cancer 
(Zhang et al., 2000) and chronic inflammation disease such as IBD (Ying et al., 2005). 
Furthermore, PIN1 increases the protein half–life of p53 by inhibiting its binding to 
the MDM2 ubiquitin ligase, which regulates the degradation of p53. Therefore, PIN1, 
which is a specific phosphorylase, closely involves in an array of biological and 
pathological processes. It is involved in the regulation of NF-κB and MAPK signaling 
pathways thus might also regulate inflammatory responses in the host. 
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Above all, we know that the LAB-host interaction is pivotal in the regulation 
of host immune responses. The imbalance composition of microbes in the human 
intestine would cause inflammatory responses. The presence of some LAB would 
help to inhibit the inflammatory responses and thus maintain the intestine homeostasis. 
However, the population of microbes harbored in the human intestine is dynamic and 
varies with age. It was reported that infants who developed allergy were often found 
to possess less enterococci in the intestines than healthy infants during the first month 
of life (Björkstén et al., 1999; 2001; Kirjavainen et al., 2002). Enterococcus faecalis 
is a major commensal gastrointestinal flora in humans (Fuller, 1991; Lammers et al., 
2002). It is one of the earliest bacterial strains which colonized the human intestine 
after birth. So far, it is not clear if the depletion of enterococci in allergic children is a 
cause or effect of allergy. Although there are some reports that E. faecalis caused 
infections in immune deficient mice (Ruiz et al., 2005), many studies also showed 
that E. faecalis could suppress the proliferation of intestinal pathogens and thus may 
prevent infection and the induction of inflammation (Giraffa, 1995; Harris et al., 1989; 
Lsolauri et al., 2002; McKay, 1990).  Another study showed that E. faecalis lysate 
could relieve the clinical symptoms of Japanese cedar pollinosis (Shimada et al., 
2004). However, the role and effect of E. faecalis in inflammation reactions are not 
clear. It is the intention of this study to shed light on the mechanisms of anti-
inflammatory effect of E. faecalis. This knowledge could provide a therapeutic 
window and development of treatments or prophylaxis of intestinal infectious, 
inflammatory and allergic reactions and perhaps carcinogenesis. 
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1.2 AIMS OF THE STUDY 
Knowing how commensal bacteria, especially LAB, interact with host has 
become very important for human health due to the increasing number of population 
who suffered from all kinds of intestinal diseases because of the acute or chronic 
inflammation. Recently, there are great interests in finding out how these bacteria can 
suppress the inflammatory responses in the human intestine. However, the 
mechanisms how these LAB regulate immune responses in human are still unclear.  
The purpose of this study was to examine the immunomodulating effects of 
LAB, especially some newly isolated human intestinal E. faecalis strains from the 
human intestine and to further investigate their underlying cellular and molecular 
mechanisms in the immunemodulating effects in human.  To understand the roles that 
LAB, especially E. faecalis, play in the human intestinal homeostasis, the following 
are described in this thesis: 
1. How LAB, especially E. faecalis, interact with intestinal epithelial cells and 
their corresponding responses to them.   
2. How E. faecalis regulates the inflammatory responses in intestinal epithelial 
cells and the possible molecules that may be involved. 
3. How bacteria modulate MAPK signaling pathway during the host-bacteria 
interaction processes. 
4. How bacteria modulate NF-κB signaling pathway. 
5. How E. faecalis is involved in other possible signaling pathways during the 
communication with intestinal epithelial cells. 
The study focused on the LAB, E. faecalis, which dominates the infant 
intestinal microflora. This study intended to show the possible mechanisms that E. 
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faecalis participates in the immunomodulation in the human intestine. These 
mechanisms could underpin the myth how LAB interact with host, thus to highlight 
new cellular targets and approaches for therapeutic intervention in the treatment of 
inflammatory diseases. Moreover, the identification of the effector molecules on E. 
faecalis involved in the immune regulation may open a new therapeutic window for 
human inflammatory bowel diseases and also other inflammatory conditions. 
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2.1 BACTERIA STRAINS 
2.1.1 Bacteria Culture 
The origin of the bacterial strains used in the experiment is indicated in Table 
2.1. All Lactobacillus strains were grown and subcultured weekly on de Man, Rogosa 
and Sharpe (MRS) Agar (Merck, USA) at 37°C in a 5% CO2 incubator (Forma, USA), 
except for Lactobacillus casei subsp casei NCIMB 11970, which was maintained at 
30°C. Enterococci were grown and subcultured monthly on Tryptone Soy Agar (TSA) 
(Merck, USA) at 37°C in a 5% CO2 incubator. Streptococcus thermophilus NCIMB 
10387 (10387) was grown on M17 medium (Oxoid, England). S. typhimurium 14028 
(Salm) was maintained on Luria-Bertani (LB) Agar (BBL, Cockeyville, MD, USA). 
Bifidobacterium were grown on Reinforced Clostridial Medium (RCM) at 37°C in an 
aerobic chamber (Lee Hung, Singapore). 
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Table 2.1 The LAB tested for their anti-inflammatory properties 
 
Lactic Acid Bacteria 
(LAB) Origin Remark 
Bifidobacterium 
adolescentis ATCC15703 Infant intestine - 
B. brevi ATCC15700 Infant intestine - 
B. dentium scardori & 
crociani ATCC27534 Dental carries - 
B. longum ATCC15707 Adult intestine - 
Enterococcus faecalis EC1 Infant feces Age: 1 month 
Identified by phenotypic 
characterization and sequence analysis 
of 16S rDNA 
Enterococcus faecalis EC3 Infant feces Age: 3 days 
Identified by phenotypic 
characterization and sequence analysis 




Age: 3 days 
Identified by phenotypic 
characterization and sequence analysis 




Age: 3 days 
Identified by phenotypic 
characterization and sequence analysis 
of 16S rDNA 
Other 22 strains of 
enterococci and lactobacilli 
Infant feces 
Age: 3 days to 
1 month 
Identified by phenotypic 
characterization and sequence analysis 
of 16S rDNA 
Lactobacillus acidophilus 
ATCC4356 Human - 
L. brevis K7 Fermented milk 
Identified by phenotypic 
characterization and sequence analysis 
of 16S rDNA 
L. brevis T1 Fermented milk 
Identified by phenotypic 
characterization and sequence analysis 
of 16S rDNA 
L. brevis T6 Fermented milk 
Identified by phenotypic 
characterization and sequence analysis 
of 16S rDNA 
L. casei ATCC11578 Oral - 
L. casei IS7257 Fermented milk 
Identified by phenotypic 
characterization and sequence analysis 
of 16S rDNA 
L. casei subsp. casei 
NCIMB11970 Cheese - 
L. casei Shirota Human Commercial probiotic 
L. delbrueckii subsp. 
bulgaricus NCIMB11778 
Bulgarian 
yogurt Commercial probiotic 




Identified by phenotypic 
characterization and sequence analysis 
of 16S rDNA 
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L. lactis subsp. lactis B4 Fermented milk 
Identified by phenotypic 
characterization and sequence analysis 
of 16S rDNA 
L. lactis subsp. lactis B9 Fermented milk 
Identified by phenotypic 
characterization and sequence analysis 
of 16S rDNA 
L. lactis subsp. lactis B12 Fermented milk 
Identified by phenotypic 
characterization and sequence analysis 
of 16S rDNA 
L. lactis subsp. lactis K5 Fermented milk 
Identified by phenotypic 
characterization and sequence analysis 
of 16S rDNA 
L. lactis subsp. lactis K6 Fermented milk 
Identified by phenotypic 
characterization and sequence analysis 
of 16S rDNA 
L. lactis subsp. lactis K7 Fermented milk 
Identified by phenotypic 
characterization and sequence analysis 
of 16S rDNA 
L. paracasei LP33 Fermented milk Commercial probiotic 
Lactobacillus paracasei 
Chamyto Yogurt 
Identified by phenotypic 
characterization and sequence analysis 
of 16S rDNA 
L. paracasei subsp. 
paracasei ATCC11974 Dental carries - 
L. paracasei subsp. 
paracasei NCIMB8001 - - 
L. rhamnusus NCIMB6375 Oral  
L.rhamnosus GG Human feces Commercial probiotic 
L. rhamnosus NCIMB 





Identified by phenotypic 
characterization and sequence analysis 




Yogurt Commercial probiotic 
 
2.1.2 Identification of Bacteria 
The bacterial stains from healthy baby gut and fermented milk were identified 
by the following methods. 
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2.1.2.1 Phenotypic Characterization 
Bacteria were first Gram stained. Carbohydrate fermentation patterns of the 
bacteria were determined using the API 50 CH test strips for rod-shaped bacteria and 
rapid ID 32 STREP test for the coccal shaped strains. The cocobacilli shaped strains 
were determined using two of the above tests. The data were analyzed by BioMerieux 
software (BioMerieux, Nurtingen, Germany). 
2.1.2.2 Genotypic Characterization 
2.1.2.2.1 Extraction of Total DNA 
Cell cultures (3ml) in the late exponential growth phase were centrifuged at 
8,000g for 10min and the cell pellets were washed and resuspended in 0.5ml of TE-
buffer (10mM Tris–HCl, 1mM EDTA; pH 8.0). The suspension was transferred to a 
2ml screw-capped tube containing 0.3g of sterile zirconium beads (diameter, 0.1mm), 
homogenized in a bead-beater (Biospec Products, Bartlesville, UK) at 5,000 rpm for 
3min and cooled on ice. The homogenate was centrifuged at 13,000g for 5min and the 
supernatant fluid was stored at -20 °C until use. 
2.1.2.2.2 PCR and Sequence Analysis of the 16s rDNA 
PCR amplification was performed with Taq DNA polymerase Recombinant 
(Invitrogen-Life Technologies, UK) using primers 7f 5V-
AGAGTTTGATC/TA/CTGGCTCAG-3V and 1510 rev 5V-ACGG(C/T) 
ACCTTGTTACGACTT-3V (Lane, 1991; Cinzia, 2004). DNA was amplified using 
the program as follow: 94°C for 3min; 30 cycles of 94°C for 30s, 52°C for 30s and 
68°C for 1.5min; and finally, 68°C for 7min. 
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The amplified PCR products were purified with the Qiaquick PCR purification 
kit (Qiagen Hilden, Germany) for sequence analysis. 8µl of PCR product of the 16S 
rDNA were directly sequenced using primer 1100 reverse 5V-
GGGTTGCGCTCGTTG-3V to obtain partial sequence of the 16S rDNA (Lane, 1991; 
Cinzia, 2004). Homology searches of the 16S rDNA sequences were performed using 
the Pubmed Nucleic acid sequence search service available in the internet. The 
website can be accessed at http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi.  
2.1.2.3 Protease Analysis 
Protease analysis was only carried on E. faecalis (EC1, EC3, EC15, EC16, 
ATCC 29212). DNA was harvested using DNA extraction kit according to 
manufacture’s instruction (Qiagen Hilden, Germany).  









TGTCAACAAAATGAAGCAAC ForwardEF0706 GGCGATTTAAGATTTCAATG Reverse 45 402 
CCAACAGTTATTGAACAATC ForwardEF0771 




ATGAAGAACAAACGAACTGT ForwardEF1679 TTACCTCGGACTTTTGAGAC Reverse 45 503 
ATGTACGACAATACGGATAA ForwardEF1917 CATTATAGTCAGCAGATTGTAG Reverse 45 517 
ATTGAAAAAATGACAACCACGC ForwardEF2355 
 CGACCAATGATTGGATCTTG Reverse 45 548 
TCACATTCATTATTGTCTTCGG ForwardEF2380 AATGCGTTGCGATAATTTCG Reverse 45 503 
ATGAAGAAACAGGAAATTCG ForwardEF2821 GGTCTGAACTATAATCCCAA Reverse 45 403 
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PCR amplification was performed with Taq DNA Polymerase Recombinant 
(New England BioLabs, Beverly, MA) using primers as listed in Table 2.2. DNA was 
amplified with a total volume of 30µl using the program as follows: 94°C for 2min; 
30 cycles of 94°C for 30s, 45°C for 30s and 72°C for 2min; and finally, 72°C for 
5min.  
2.1.2.4 Antibiotics Resistance Test 
In this test, small filter paper disks (6 mm) impregnated with a standard 
amount of antibiotic are placed onto an agar plate to which bacteria have been 
swabbed. The plates are incubated overnight, and the zone of inhibition of bacterial 
growth is used as a measure of susceptibility. Large zones of inhibition indicate that 
the organism is susceptible, while small or no zones of inhibition (6mm) indicate 
resistance. 
2.1.2.5 Gene Tree of the Bacteria 
Phylogenetic tree calculation is based on a sequence distance method and 
utilizes the Neighbor Joining (NJ) algorithm of Saitou and Nei (Saitou, N. and Nei, M. 
1987).   
2.1.3 Conversion Factors 
For each strain of bacteria, the conversion factor is shown in Apendix1. The 
conversion factors were derived using Miles and Misra techniques. Briefly, 3-5 
colonies of freshly cultured bacteria were inoculated into 4ml bacteria specific broth 
and kept at 37°C for 24 hours without shaking. A 5% inoculum was then made by 
adding 1ml of the culture into 20ml appropriate broth and further incubating at 37°C 
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to reach their late exponential phases with shaking at a speed of 120rpm. 10ml of 
culture was then harvested and centrifuged at 5,000g at 4°C for 5 minutes. The 
pellet was washed three times and resuspended in 10ml saline (0.85% w/v NaCl). 
This suspension was diluted 2, 5, 10 and 20 times for measuring absorbance at 600nm. 
Each of these 4 dilutions was further serially diluted from 101 to 108 times, and 25µl 
of each serial diluted bacterial suspension was dropped onto two surface dried agar 
plates. Colony counts (Valid range from 5-50 colonies) were made after a 48h 
incubation at 37°C in a 5% CO2 incubator, and the absorbance at 600nm (y-axis) was 
plotted against the average colony forming unit per ml (CFU/ml) (x-axis) to obtain a 
trend line with acceptable R2 value greater than 0.96 (Appendix 1). 
2.1.4 Preparation of Bacteria Strains 
To prepare for the bacteria for experimental treatments, 3-5 colonies were 
taken from a fresh cultured plate and transferred into 10ml specific bacterial broth in a 
15ml Falcon tube (BD bioscience, San Diego, CA). The broth was then cultured 
overnight at 37°C without shaking. The fresh cultured bacteria were further inoculated 
into 50ml broth in a 250ml flask with a 5% inoculum. To reach their exponential 
phases, the flask was shaken at a speed of 120rpm at 37°C. The bacteria were then 
pelleted down by centrifugation at 5,000g for 5min. Pellets were washed using serum-
free medium three times and then resuspended in complete medium. To get the proper 
number of bacteria for experimental treatment, OD reading at 600nm was taken. 
According to the conversion factor we obtained in section 2.1.3, the number of the 
bacteria was estimated. The desired concentration of bacteria was achieved by proper 
dilution in complete medium. 
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2.2 CELL CULTURE 
2.2.1 Intestinal Cell Lines and Monocyte Cell Line Culture 
All solutions and media for cell culture were prepared under aseptic condition 
in a laminar flow cupboard (Gelman Science, Australia) or biohazard hood (Nuaire, 
USA). Cells were grown in sterile plastic tissue culture flasks (Nalge Nunc 
International, USA) or 24-well/6-well Multidishes Nunclon™ plates from (Nalge 
Nunc International, USA). They were cultured in a humidified incubator at 37°C with 
5% CO2.  
Caco-2, HT-29, HCT116, THP1 and CRL-1790 cells were obtained from 
American Type Culture Collection (Manassas, VA). Caco-2 and HT-29 are human 
colonic adenocarcinoma cells. Differentiated Caco-2 are enterocyte-like cells (Amano, 
and Oshima. 1999) whereas HCT116 is human colon carcinoma cells. All cells were 
cultured at 37°C in a 5% CO2 atmosphere.  Caco-2 cells were cultured in MEM 
(GIBCO, Grand Island, NY) containing 20% fetal bovine serum (FBS) (Bioclot, 
Germany) and 1% nonessential amino acids (GIBCO). HT-29 and HCT116 cells were 
cultured in DMEM (GIBCO) containing 10% FBS (Bioclot, Germany).  THP1 is 
human acute monocytic leukemia cell line. They were cultured in RPMI1640 (GIBCO) 
with 10% FBS at 37°C in a 5% CO2 incubator. CRL-1790, which is a normal human 
colon cell line, were cultured in 1:1 Ham’s F12 medium and DMEM mixture 
contained 0.02mg/ul insulin, 50µm Hydrocortisone, 1ng/ml epidermal growth factor, 
0.5mM sodium pyrurate, 2mM L-glutamine and 10% FBS.  All culture media were 
supplemented with 100U/ml penicillin and 100µg/ml streptomycin (GIBCO).  
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2.2.2 Preparation of Cell Lines 
After the cells were 70%--80% confluent, the old medium was decanted off.  
Cells in the flask were washed with 10ml phosphate buffered saline (PBS) (Appendix 
3) for three times. 3.5ml (Caco-2 and HT-29) or 1ml (HCT116) 1xTrypsin-EDTA 
(GIBCO) were added into the flask and then incubated at room temperature for 5min 
(HCT116 for 1min) to obtain single cells. Cells were then resuspended in 10ml fresh 
medium and transferred to a sterile falcon tube.  For THP1 cell line, supernatants were 
taken out directly from the flask to a sterile falcon tube. After pelleted down by 
centrifugation at 800g for 5min, cells were resuspended in an appropriate amount of 
fresh medium. Cell viability was assessed by Hemo Cytometry method exclusion 
technique. In brief, 100µl cell suspension was mixed well with 100µl Trypan blue 
vital dye (GIBCO-BRL, USA). The mixture was loaded to chambers from sample 
loading point (Pic 1). Totally eight corners of the two chambers were counted 
(illustrated in Pic 2). The final cell number is n = N (total number)/8 x 2 x 104 cells/ml. 
Appropriate dilution were made to get the proper number of cells. 1ml of the culture 
medium containing 105cells/ml was then added into each well on a 24-well plate 
(Nalge Nunc International, USA). The plate was incubated at 37°C with 5% CO2 for 
24h and ready for use. To harvest protein, 106cells/ml were seeded into the 6-well 
plates (Nalge Nunc International, USA) and cultured at 37°C with 5% CO2 for 24h. 
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Figure 2.1 Left: overview of the Hemocytometer. Right: the picture of one counting 
chamber. The black dots on it represent cells to be counted. Only four big corner-
squares were counted in this method. 
2.3 TREATMENT OF CELLS 
Biological triplicates were done for the following experiments. 
2.3.1 Co-culture of Bacteria and Cells 
To obtain a polarized monolayer of intestinal epithelial cells (IECs), 1x105 
Caco-2 cells were grown in a sterile 24-well plate (Nalge Nunc International, USA) to 
confluence and then for 2 additional weeks to reach full differentiation and 
polarization. The cultured medium was changed every two days. For HT-29 and 
HCT116 cell lines, 1x105 cells were cultured in sterile 24-well flat-bottom plates 
(Nalge Nunc International, USA) for 24 hours before the infection experiments as 
described in section 2.2.2. For the infection study, Caco-2, HT-29 and HCT116 cells 
were incubated in fresh medium with bacteria at a multiplicity of infection (MOI) of 
100 or 1,000 for 6 hours at 37°C with 5% CO2. For protein harvesting, a MOI of 100 
was applied to HCT116 and Caco-2 cells.  
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 THP1 cells were treated with E. faecalis, L.GG, S.  thermophillus 10387 
(10387) with a MOI of 1, 10, 100 or 1000 for 30min, 1h, 2h, 4h, 6h and 24h.  LPS 
were used at a concentration of 100ng/ml to stimulate the cells for 3h, E. faecalis 
strains were then added into them. In another experiment, E. faecalis strains were first 
added into the THP1 cells for 1h and then LPS at a final concentration of 100ng/ml 
was added and incubated for another 3h. Sonicated E. faecalis EC3 cells (Described 
in section 2.5.2) were also used to treat the THP1 cells at a MOI of 1 for 1h and a 
MOI of 100 for 6h.  Supernatants were harvested for Enzyme-linked immunosorbent 
assay (ELISA) assay and cell lysates were harvested for protein measurement. RNAs 
were extracted using the method described in section 2.7.1 for gene expression 
analysis.  
2.3.2 TNF-α and IL-1β Induced Cytokine Secretion and Protein 
Production 
The Caco-2 and HCT116 cells were prepared as described in section 2.2.2, 
TNF-α (Preproteck, INC, rocky hill, NJ) was added at a concentration of 200ng/ml 
and IL-1β (Preproteck, INC, rocky hill, NJ) at a concentration of 2ng/ml. E. faecalis 
EC16 was prepared as section 2.1.4. Cells were then infected with E. faecalis EC16 
with or without TNF-α / IL-1β. TNF-α and IL-1β were also used to treat the cells 
individually. The cells were then cultured at 37°C with 5% CO2 for 30mins, 1h, 2h, 
4h and 6h. Supernatants were collected and the concentration of IL-4, IL-10, IL-6, IL-
8, TGF-β and IL-12(p70) were determined by ELISA. Other cytokines like IL-18, 
IFN-γ, TNF-α, IL-2, IL-5, IL-17 and ICAM-1 were determined using cytokine assay. 
The proteins were harvested for Western blotting assay. 
Chapter 2 Materials and Methods 
 54
2.3.3 S. typhimurium Induced Cytokine Secretion and Protein 
Production 
The Caco-2 and HCT116 cells were prepared as in section 2.2.2. E. faecalis 
EC16 and S. typhimurium were prepared as in section 2.1.4. They were then added to 
cells individually with a MOI of 100.  In order to see whether E. faecalis EC16 could 
suppress the inflammation activated by S. typhimurium, E. faecalis EC16 and S. 
typhimurium  were added to the cells with a total bacteria number at a (MOI) of 100. 
Supernatants were collected for ELISA and cytokine assay. Proteins were harvested 
for Western blotting assay. 
2.3.4 Protein Inhibitors Study 
The Caco-2 and HCT116 cells were prepared as in section 2.2.2. 
Phosphorylated p38 inhibitor SB203580 iodo (SB), Phosphorylated JNK inhibitor 
SP600125 (SP) and DUSP1 inhibitor Triptolide (TRI) were purchased from 
Calbiochem (La Jolla, CA). A final concentration of 10µM of SB and SP was 
employed to the cells. For Triptolide, we used a final concentration of 1µM. Cells 
were cultured with these inhibitors or a combination of SB and SP for 30min, 1h, 2h 
and 6h in an incubator at 37°C with 5% CO2. Moreover, inhibitors were also added 
into the cells with the presence of 2ng/ml IL-1β. Supernatants were harvested for 
ELISA assay and proteins were harvested for Western blotting analysis. 
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2.3.5 Adhesion Study 
Monolayers of HCT116 were prepared by inoculating on 2-chamber slides 
(Lab-Tek Chamber Slide, Nunc, Inc., USA) with 1.4 x 105 cells per chamber in 2ml of 
complete DMEM 24h before the adhesion assay. After 24h, the monolayers were 
washed twice in 1ml of sterile PBS. Bacterial strains were prepared and 2ml of each 
suspension was added to a chamber of the slide and incubated at 37°C with 5% CO2 
for 1h. After incubation, the monolayers were washed twice with sterile PBS then 
Gram stained and examined microscopically. The numbers of adherent bacteria per 
100 HCT116 cells were counted in 10 random microscope areas. 
2.3.5.1 Gram Staining 
After washing the cells, the slides were flooded with crystal violet and stood 
for 1min. The crystal violet was then washed away for 5s with running water. After 
that, the slides were covered with iodine solution and stood for 1min as well. When 
time has expired, the slides were rinsed with running water for 5sec and then applied 
with 95% ethanol to wash off crystal violet. The slides were then rinsed with running 
water to wash away ethanol. The final step involved the application of the 
counterstain safranin. The slides were flooded with the dye for 1min. And again the 
slides were rinsed with water to remove any excess dye. The slides were then blotted 
to dry and examined under microscope. 
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2.4 MEASUREMENT OF CYTOKINES 
2.4.1 ELISA 
Cytokines in cell culture supernatants were assayed by Enzyme Linked 
Immunosorbent Assays (ELISAs). After the infection (described in section 2.3), 
supernatants were harvested and centrifuged for 10min at 12,000g to remove the 
bacteria. IL-8, IL-4, IL-10, TGF-β, IL-6 and IL-12(P70) measurements were 
performed as the instructions in the ELISAs kits (BD bioscience, San Diego, CA). 
Individual samples were tested in triplicate and the concentration of cytokines was 
determined using the standard provided by the manufacture. To get the accurate 
results, samples with a high production of the cytokines were diluted to make the 
readings fall within the standard range. To test IL-8 expressed inside the cells using 
total protein harvested, a 50x dilution was done. In Brief, a 96 well plate (Nune, 
Roskilde. Denmark) was coated with 100µl per well of capture antibody diluted in 
coating buffer (Appendix 4). The plate was sealed and incubated overnight at 4°C. 
The wells were then washed 3 times with 300µl/well wash buffer (Appendix 4). For 
each wash, invert plate and blot on absorbent paper to remove any residual buffer. 
The plate was further blocked with 200µl/well assay diluents (Appendix 4). Incubate 
the plate at room temperature (RT) for 1h. And wash as above. The standard and 
sample were prepared in assay diluents. 100µl of each standard, sample, and control 
were added into appropriate wells. Again, the plate was sealed and incubated for 2h at 
RT. The plate was washed as described above but with 5 total washes. 100µl of 
prepared working detector (Detection Antibody + Avidin-HRP reagent) were applied 
to each well and incubate for 1h at RT. After this step, the plate was washed total 7 
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times with 30sec to 1min incubation with wash buffer for each wash. 100µl of 
substrate solution (BD bioscience, San Diego, CA) was then added into each well and 
plate was incubated for 30min at room temperature without sealer in the dark. After 
30min, 50µl of stop solution (Appendix 4) were added into each well. And 
absorbance was read at 450nm within 30min of stopping reaction. An absorbance at 
570nm was subtracted from absorbance 450nm to obtain the more accurate readings. 
For TGF-β assays, 100µl supernatants were transiently acidified with 2µl 1M 
HCL for 1 hour at 4°C, and then neutralized with 2µl 1M NaOH. The supernatants 
were then applied to TGF-β ELISAs (BD bioscience, San Diego, CA) according to 
the manufacturer’s instructions.  
2.4.2 Cytokine Assay 
The level of IL-18, ICAM-1, IFN-γ, TNF-α, IL-2, IL-5, and IL-17 in the 
culture supernatants was determined using Bio-Plex Cytokine Assay (Bio-Rad, USA) 
according to the manufacture’s instruction.  In brief, a 96-well filter plate was pre-wet 
with 150µl of Bio-Plex assay buffer. The buffer were then removed by vacuum 
filtration using MultiScreen Vaccum Manifolds (Millipore, USA) and the bottom of 
the filter plate was blotted to dry with a clean paper towel. 50µl of pre-mixed 
multiplex beads (Anti-cytokine conjugated) was added per well and the buffer was 
removed by vacuum filtration. The beads were then washed twice with 100µl of Bio-
plex wash buffer. 50µl of sample obtained as described in section 2.3 was added into 
each well. The filter plate was sealed with plate sealing tape and wrapped with 
aluminum foil to protect the beads from light. Room temperature incubation was 
applied to the plate with shaking at 1,100rpm for the first 30sec and 300rpm for the 
next 30min. The buffer was then removed and the beads were washed three times 
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with 100µl of wash buffer before 25µl of 50x Bio-Plex detection antibody adding to 
each well. The plate was sealed, covered with aluminum foil and incubated at the 
same condition as described above for 30min. The buffer was then removed and beads 
were washed for three times with 100µl wash buffer. 100x Streptavidin-PE was 
diluted and vortexed before adding 50µl/well. The plate was then sealed and shaken at 
1,100rpm for 30sec, then 300rpm for 10min in the dark. The buffer was then removed 
and beads were washed three times with 100µl wash buffer. The beads were then 
resuspended with 125µl of Bio-Plex assay buffer and the plate was shaken at   
1,100rpm for 30sec immediately before reading the plate on Bio-Plex System (Bio-
Rad, USA). 
2.5 BACTERIA MACRO-MOLECULES ANALYSIS 
2.5.1 Conditional Medium and Cell Inserts 
In order to test for the location of the active components on the bacteria which 
might play a role in the suppression of inflammatory responses, the cell culture 
supernatants obtained from section 2.3.1 were harvested sterilely and conditional 
media were then added to the cell cultures prepared as described in section 2.2. In 
addition, bacteria themselves were also cultured with the control supernatants 
obtained from section 2.2 treatments. All the treated cells were then incubated at 37°C 
with 5% CO2 for 6h. The supernatant were then collected for cytokines assay. 
For cell inserts test, HCT116 cells were plated in wells of Transwell® (USA) 
multiple well plate and incubated at 37°C with 5% CO2 for 24h. Accompanying 
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inserts were added 1h before co-culturing. 100µl of bacterial suspensions were added 
to each insert.  
Triplicates of each condition were done and supernatants were harvested for 
cytokine assay. 
2.5.2 Cell Wall Component and Crude Cell Extract Preparation 
Before sonication, a protease inhibitior with 2mM 
phenylmethylsulfonylfluoride (PMSF), 1mM dithiothreitol (DTT) and 1mM sodium 
metavanadate was added to bacterial suspensions. The bacterial cells were then 
disrupted by sonication (MSE Soniprep 150, SANYO, Japan) on ice for 10 cycles 
with 30sec pulses and 1min rest (Shon et al., 2005). 100µl of the sonicated bacteria 
was then observed under microscope to ensure disruption of the cells. Cell debris was 
pelleted down by centrifugation at 15,000g for 60min at 0°C. The bacterial culture 
supernatant was aseptically kept on ice for use. The remaining pellet was resuspended 
in an appropriate volume of complete DMEM such that cell debris in each ml of pellet 
suspension was equal to the amount in 1ml of whole bacteria cells. 1ml of each 
supernatant, cell debris suspension and un-centrifuged sonicated extract were added to 
the cell culture.  Biologically triplicates were done on this experiment. 
2.5.3 Protein Digestion and Carbohydrate Oxidation of Bacterial 
Cell Wall 
4ml of appropriate amount of bacterial cells were pelleted by centrifugation at 
12,000g at 0°C for 10min. The bacterial cells were then washed once in PBS and then 
suspended in 1.5ml of one of the following solutions in Table 2.3: 
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Table 2.3 Chemicals and enzyme solutions for treatment of bacteria 
 
 Solution In buffer pH
1 0.05M sodium m-periodate A: 5.0M LiCl in water; 0.1M citrate-phosphate-0.1M NaCl 4.5
2 0.05M sodium iodate A: 5.0M LiCl in water; 0.1M citrate-phosphate-0.1M NaCl 4.5
3 5.0mg of trypsin per ml of buffer B: 0.05M Tris-HCl-0.1M NaCl 8.0
4 5.0mg of chymotrypsin per ml in buffer B: 0.05M Tris-HCl-0.1M NaCl 8.0
5 5.0mg of pepsin per ml in buffer C: 0.05M glycine-HCl-0.1M NaCl 2.2
 
The bacterial cells were incubated with the five solutions for 1h at 37°C. After 
that, the bacteria were centrifuged at 12,000g at 0°C for 10min, washed twice in 1ml 
of PBS and resuspended in 4 ml of complete DMEM.  1ml of the each re-suspension 
was added to 1 well containing cell culture. Biological triplicates of each condition 
were done. 
2.5.4 Blocking of Specific Carbohydrate Ligands and Receptors 
on Cell Wall 
3ml of bacterial cells and broth culture supernatant were separated by 
centrifugation at 12,000g at 0°C for 10min. The bacterial cells were then washed once 
in PBS and then suspended in 3ml of one of the following solutions-15µg/ml 
Concanavalin A (ConA) in PBS; 15µg/ml succinyl Concanavalin A (succinyl ConA) 
in PBS and 15µg/ml Tetragonolobus purpurea in PBS. The cells were incubated for 
30min at 37°C, centrifuged at 12,000g at 0°C for 10min, washed twice in 1ml of PBS, 
and resuspended in 3ml of complete DMEM. Treatments were done as described in 
section 2.3. 
The ability of carbohydrates to inhibit the anti-inflammatory response by 
binding to receptors specific for carbohydrates on the HCT116 cell surface was 
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assayed by adding different sugars – mannose, D-galactose, D-trehalose, N-acetyl 
glucosamine, D-glucose and D-fucose at a final concentration of 10mg/ml to the 
intestinal cells. Sugars were added to the HCT116 cells for 1h incubation at 37°C in 
5% CO2 before co-culturing with bacteria (Guzman, et al. 1991). When the bacteria 
were added, extra sugar was added to the bacterial suspension to ensure that the final 
concentration remained at 10mg/ml.  
2.5.5 UV- and Heat-Killed Bacteria  
3ml of bacterial suspensions were exposed to UV light for 5min (Conner-Kerr, 
et al. 1998) to make sure at least 99% bacteria were killed.  To kill the bacteria by 
heat 3ml of bacterial suspensions were put on a heating block at 100°C for 20min. 
The killed bacteria were plated on their respective agar plates to ensure cell death. 
After killed the bacteria, treatments were performed as described in section 2.3. 
2.6 APOPTOSIS ANYLISIS 
Propidium iodide staining assay was applied to colon cancer cell line: HT-29, 
HCT116 cells and colon normal epithelial cells CRL-1790 (both floating and attached 
cells) to detect apoptotic cells after treatment with various LABs. Cells cultured with 
medium only were used as a control. In the propidium iodide (PI) staining assay, the 
supernatants and the trypsinised cells were collected in 15ml falcons’ tube and 
pelleted. The pellet was washed twice with ice cold PBS and then resuspended in 
500µl of PBS. 4.5ml of 70% ethanol was added while vortexing gently followed by 
incubation for at least 30min at −20°C. Fixed cells were washed twice and allowed to 
rehydrate in PBS. Prior to fluorescence-activated cell sorting (FACS) analysis, the 
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cells were resuspended in 500µl sample buffer (PBS containing 0.1% glucose) with 
5µl 1mg/ml propidium iodide and 10µl 100µg/ml RNaseA and incubated for 30min. 
With this method, the percentage of apoptotic cells was determined by quantification 
of the sub-G1 fraction of cells. In this assay, 20,000 fluorescent events were measured 
by a FACScalibur flow cytometer (Becton Dickinson Immunocytometry Systems; San 
Jose, CA) for each sample. 108cfu/ml bacteria only were used as a control in the flow 
cytometry analysis. Flow cytometric data were analyzed using WinMDIv2.8 software. 
2.7 GENE EXPRESSION ANALYSIS 
2.7.1    RNA Extraction 
RNA was extracted after a 6h incubation of cell culture with 1 x 107 or 
108cfu/ml of bacteria (Section 2.3), using the High Pure RNA Isolation Kit (Roche 
Applied Science, Germany). The wells were washed once with 1ml of ice cold PBS to 
remove excess bacterial cells, and resuspended in 200µl of PBS. Lysis-binding buffer 
was added to each well (400µl per well) and residual cells were scrapped off the well 
bottom before adding the cell lysate to the filter and collection tubes. The tubes were 
centrifuged at 10,000g for 15sec to remove the buffer while RNA remained bound to 
the glass fiber fleece on the filter tubes. DNase was added to each tube to digest 
contaminating DNA for 15min. The RNA was purified from salts, proteins and other 
cellular impurities using the wash buffer provided in the kit followed by 
centrifugation before elution from the glass fiber fleece. RNA was then kept at -70°C 
immediately. 
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2.7.2    RNA Quantification 
RNA extracted was diluted 200 folds in sterile diethylpyrocarbonate (DEPC; 
Sigma, USA) treated water before measuring the optical density at 260nm using 
quartz cuvettes. The RNA was quantified using the following equation: 
Amount of RNA present in sample (µg of RNA/ml) = OD260 x 40 x Dilution Factor 
In addition, optical density was also measured at 280nm to quantify any 
contaminating proteins. A ratio of OD 260: OD 280 has to be between 1.8 and 2.0 to 
exclude any protein contamination in the RNA obtained. 
The integrity and quality of RNA were determined by running formaldehyde 
gel.  In brief, to form the formaldehyde gel, 87.5ml sterile distilled water, 1.5g 
agarose, 10ml 10xMOPS, 1.6ml formaldehyde were mixed and micro-waved for 2min 
to get a clear gel solution. Before casting of the gel, the solution was added 2µl ETBR 
and mixed well. To prepare the sample, 15.5µl master mixture (2µl 10x MOPS, 3.5µl 
formaldehyde, 10µl formamide) (Appendix 6) together with 4.5µl sample were mixed 
and incubated at 65°C for 10min. The samples were then cooled on ice for another 
10min and loaded into the gel wells. To view the gel image, the gel was destained in 
deionized water for 45min and then viewed under UV light. 
2.7.3    Reverse Transcription-Polymerase Chain Reaction 
cDNA were synthesized from a template of 1µg total RNA using the 
Superscript III (Invitrogen Life Technologies, UK) according to the manufacture’s 
instruction. In brief, 1µg of RNA, 1µl of 50µM oligo(dT)20 primers were added to 1µl 
of a 10mM dNTP mix, and DEPC-treated water was used to make up a final volume 
of 10µl. The mixture was incubated at 65°C for 5min before placing on ice for at least 
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1min. A total volume of 10µl of the following cDNA synthesis mix was added to each 
reaction tube: 2µl of 10x RT buffer, 4µl of 25mM MgCl2, 2µl of 0.1M DTT, 1µl of 
40U/µl RNaseOUT™, and 1µl of 200U/µl SuperScript™ III Reverse Transcriptase 
enzyme. The cDNA synthesis reaction was carried out at 50°C for 50min, and 
terminated by heat inactivation at 85°C for 5min before chilling on ice. 1µl of E. coli 
RNase H (2U/µl) was then added and kept at 37°C for 20min, to remove the RNA 
template from the cDNA:RNA hybrid molecule after first strand synthesis, so as to 
increase the sensitivity of the subsequent PCR step.  
DNA contamination was excluded by the use of a reverse transcriptase 
negative control for each sample and performing PCR with β-actin primers. Reverse 
transcriptase enzyme positive and negative samples were also run as an internal 
experimental control. 
PCR were performed using 2µl of the cDNA as a template in a final volume of 
50µl. The standard program used was as follows: denaturation for 2min at 94°C, 35 
cycles of 30sec treatment at 94°C, 1min at 55°C or 60°C, and 1min at 72°C, followed 
by a final elongation for 7min at 72°C. 0.2 unit of Taq (Invitrogen Life Technologies, 
UK) was used for one PCR. H2O was used as a negative control and plasmids 
containing the specific gene were used as a positive control in the PCR. After 
electrophoresis in a 1.2% agarose gel containing Ethidium Bromide, PCR products 
were quantified using the Gene Tool software (Syngene, UK). The primers used and 
annealing temperature are described in Table 2.4. 
In this study, the expression of TLR1, TLR2, TLR3, TLR4, TLR5, TLR9, 
Tumor necrosis factor (TNF) receptor associated factor 6 (TRAF6) and Toll 
inhibitory protein (Tollip) were measured using RT-PCR. Cytokine gene expression 
like IL-8, IL-4, IL-10, TGF-β, TNF-α, were also detected using this method. 
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Tollip CGCGGTACCGCCACCATGGCGACCACCGTCAGC Forward 60 850 










2.7.4    Semi-Quantitative Gene Expression Analysis 
(Densitometry) 
The bands obtained after gel electrophoresis were analyzed using a 
densitometry software (Gene Tools; Syngene, UK), a semi-quantitative method to 
compare gene expression intensities. The intensities were normalized by analysis of 
expression of the gene encoding β-actin which acts a loading control between samples. 
Thereafter, the samples were compared against the control well (without bacteria 
treatment) to obtain the gene expression fold difference.  
2.8 MICROARRAY ANALYSIS 
2.8.1 RNA Extraction and Probe Labeling 
RNA was extracted according to the protocol described in section 2.7.1. First-
strand cDNA was synthesized using AmpoLabeling-LPR Kit (Superarray, USA) 
according to the manufacture’s instruction. Briefly, 1.5µg of total RNA was used for 
constructing the cDNA. RNA was mixed with 1µl RT primer and appropriate RNase 
free H2O to get a total volume of 10µl.  The contents were mixed well by gentle 
pipetting up and down 2 to 3 times followed by a brief centrifugation to collect the 
mixture at the bottom of the tube. The mixture was then incubated at 70°C for 3min 
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followed by a brief centrifugation. Tubes were placed on ice immediately and kept at 
37°C for 10min.  The cDNA Synthesis Master Mix were prepared as below (Table 
2.5): 
Table 2.5 cDNA Synthesis Master Mix 
 
cDNA Synthesis Master Mix Per Array (µl) 
RNase free H2O 4 
Buffer BN 4 
Rnase Inhibitor (RI) 1 
Reverse Transcriptase(RE) 1 
Final Volume 10 
 
The cDNA Synthesis Master Mix was mixed well and put on ice for use. For 
each array, transfer 10µl of the cDNA Synthesis Master Mix to the 10µl Annealing 
Mixture. They were mixed well but gently with a pipetting up and down 2 to 3 times 
followed by a brief centrifugation to collect the mixture at the bottom of the tube. The 
mixtures were then continued to be incubated at 37°C for 25min.  After that, they 
were heated at 85°C for 5min to hydrolyze the RNA and to inactivate the reverse 
transcriptase. The finished RT Reactions were then held on ice until the next step. 
To prepare for the LPR cocktail (Labeling reaction), the followings (Table 2.6) 
were mixed well in a sterile PCR tube per Array. 
Table 2.6 LPR Cocktail 
 
Master Mix Per Array
Buffer L 18µl 
Buffer AF (BLUE tube) 9µl 
Biotin-16-UTP from Roche 2µl 
DNA Polymerase(LE) 1µl 
Final Volume 30µl 
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For each array, add 30µl of the LPR Cocktail to each RT reaction (20µl) and 
mixed well but gently with a pipettor. Program the thermal cycle for Liner polymerase 
reaction (LPR) as follows: 
85°C 5min 
85°C 1min, 50°C 1min, 72°C 1min for 30 cycles 
72°C 5min 
Before denaturing the probes for hybridization, the incorporation efficiency of 
dUTP with probe was checked according to the manufacture’s instruction (Superarray, 
USA).  The labeled cDNA probes were then denatured by heating the tube containing 
the LPR at 94°C for 2min, and quickly chilling on ice. The cDNA probe is now ready 
for hybridization. 
2.8.2 Hybridization 
cDNA microarrays (GEArray S Series Human Immunology Signaling 
Pathways Gene Array) were obtained from Superarray (USA). A total of 406 human 
immunology signaling pathway related cDNA clones were detected in the 
experiments.  
Before pre-hybridization, membranes were pre-wet by adding roughly 5ml of 
deionized water to the hybridization tube. Warm the GEAhyb Hybridization Solution 
(in the kit) to 60°C, and then add 2ml of the GEAhyb Hybridization Solution into 
each tube. The membranes were then pre-hybridized in the oven at 60°C for 24h with 
continuous agitation at 5-10rpm. 
The hybridization step was done according to the manufacture’s instruction. 
The target hybridization solution was prepared by adding 5µg of biotin labeled cRNA 
to 1ml of prewarmed GEAhyb Hybridization solution. The solution was then mixed 
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well by pipetting and kept at 60°C till use. The pre-hybridization solution from the 
hybridization tube was discarded and the Target Hybridization Mix was added into 
the membrane in the hybridization tube. The membranes were then hybridized 
overnight at 60°C with continuous agitation (5-10rpm). After hybridization, the 
Target Hybridization Mix was poured off. The membranes were washed by Wash 
Solution 1 (2x SSC, 1%SDS) 10min twice at 60°C and Wash Solution 2 (0.1x SSC, 
0.5%SDS) 7min twice at 60°C with 20-30 rpm agitation. The signals were then 
detected using Chemiluminenscent detection Kit (Superarray, USA) according to the 
manufacture’s instruction. Image were acquired by exposing to X-ray film (Koda, 
USA), the images were then scanned using image scanner (Amersham, UK) and 
analyzed. 
2.8.3 Data Analysis 
The signals were analyzed using the web-based GEArray Expression Analysis 
Suite (Supperarray, US). Intensity of the spot equal to the signal strength of gene 
tested subtract average signal of the negative controls. All the signals were 
normalized against the average signal of positive controls i.e. GAPDH in our study. 
The genes with an up regulation or down regulation at least 1.5 folds were selected for 
the further study. In this experiment, five replicates were done for one treatment.  
Statistical significance was assessed by student t test to control the false-positive rate 
(P < 0.05 was considered significant). Scatter plot images and clustering analysis was 
generated by the software. To obtain more accurate data, GeneSpring GX 3.7.1 
software was also used to analyze the data. The signals with “absent” flag were 
excluded. Volcano plots were generated by the software with a P value available (P< 
0.05 was considered as significant regulation.). 
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2.9 SIGNALING PATHWAY VERIFICATION 
2.9.1 TaqMan Low Density Array (TLDA) 
The RNA was harvested as described in section 2.7.1. A 48-well format 
Taqman low density array was designed for a subset of genes that were differentially 
expressed in the array experiments including two endogenous controls 18S and β-
actin (Applied Biosystems, USA). Gene and ABI assay IDs are listed in Table 2.7. 
0.5µg total RNA was converted to cDNA using High-Capacity cDNA archive kit 
(Applied Biosystems, USA) and 10µg cDNA in 100µl TaqMan universal PCR master 
mix (Applied Biosystems, USA) was used for each port and run on an ABI 7900 
system (Applied Biosystems, USA). Data was analyzed using the SDS2.2 software 
where baseline and threshold settings were automatically adjusted. 
Table 2.7 Gene ID and Taqman Primers ID 
GeneBank ID Human Gene ID Gene symbol Assay ID 
NM_053056 Hs.523852 CCND1 Hs00277039_m1 
NM_000077 Hs.512599 CDKN2A Hs00233365_m1 
NM_004379 Hs.516646 CREB1 Hs00231713_m1 
NM_004417 Hs.171695 DUSP1 Hs00610256_g1 
NM_005225 Hs.96055 E2F1 Hs00153451_m1 
NM_005252 Hs.25647 FOS Hs00170630_m1 
NM_000874 Hs.549042 IFNAR2 Hs00174198_m1 
NM_001556 Hs.413513 IKBKB Hs00233284_m1 
NM_000572 Hs.193717 IL10 Hs00174086_m1 
NM_014432 Hs.445868 IL20RA Hs00205346_m1 
NM_000589 Hs.73917 IL4 Hs00174122_m1 
NM_000584 Hs.624 IL8 Hs00174103_m1 
NM_000634 Hs.194778 IL8RA Hs00174146_m1 
NM_002228 Hs.525704 JUN Hs00277190_s1 
NM_006116 Hs.507681 MAP3K7IP1 Hs00196143_m1 
NM_005204 Hs.432453 MAP3K8 Hs00178297_m1 
NM_002751 Hs.57732 MAPK11 Hs00177101_m1 
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NM_002754 Hs.178695 MAPK13 Hs00234085_m1 
NM_002749 Hs.150136 MAPK7 Hs00611114_g1 
NM_002752 Hs.484371 MAPK9 Hs00177102_m1 
NM_004759 Hs.519276 MAPKAPK2 Hs00358962_m1 
NM_002392 Hs.369849 MDM2 Hs00242813_m1 
NM_005919 Hs.153629 MEF2B Hs00232232_m1 
NM_003684 Hs.371594 MKNK1 Hs00374376_m1 
NM_005373 Hs.82906 MPL Hs00180489_m1 
NM_172390 Hs.534074 NFATC1 Hs00232342_m1 
NM_003998 Hs.431926 NFKB1 Hs00231653_m1 
NM_002502 Hs.73090 NFKB2 Hs00174517_m1 
NM_003629 Hs.170510 PIK3R3 Hs00177524_m1 
NM_006221 Hs.465849 PIN1 Hs00749260_s1 
NM_006244 Hs.75199 PPP2R5B Hs00196561_m1 
NM_005903 Hs.167700 SMAD5 Hs00195437_m1 
NM_005585 Hs.153863 SMAD6 Hs00178579_m1 
NM_005904 Hs.465087 SMAD7 Hs00178696_m1 
NM_005905 Hs.528630 SMAD9 Hs00195441_m1 
NM_138473 Hs.524461 SP1 Hs00412720_m1 
NM_003120 Hs.502511 SPI1 Hs00231368_m1 
NM_000660 Hs.1103 TGFB1 Hs99999918_m1 
NM_003264 Hs.519033 TLR2 Hs00610101_m1 
NM_003265 Hs.29499 TLR3 Hs00152933_m1 
NM_003266 Hs.174312 TLR4 Hs00152939_m1 
NM_017442 Hs.87968 TLR9 Hs00152973_m1 
NM_000594 Hs.241570 TNF Hs00174128_m1 
NM_003839 Hs.204044 TNFRSF11A Hs00187192_m1 
NM_019009  TOLLIP Hs00184085_m1 
NM_004620 Hs.444172 TRAF6 Hs00371508_m1 
NM_001101  ACTB Hs99999903_m1 
  18S Hs99999901_s1 
 
2.9.2 Western Blotting 
2.9.2.1 Protein Harvesting 
After the treatments (Section 2.3), the supernatants were removed and cells 
were washed twice with PBS. 2ml of PBS were added in to the wells. Cells were then 
scraped from the plates and transferred into a tube. Cells were pelleted down to the 
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bottom of the tube by centrifugation at 800g for 5min (Sigma, USA). PBS was 
removed thoroughly and cell pellets were resuspended in ice cold 1x cell lysis buffer 
(Cell signaling technology, USA) and transferred into a 1.5ml tube. The suspension 
was then briefly sonicated with a medium power (25W) of a sonicator (MSE Soniprep 
150, SANYO, Japan) for 3 cycles with 5sec on and 15sec rest to shear genomic DNA 
on ice. The tube was centrifuged at 14,000g (Eppendorf, Germany) for 10min at 4°C. 
Supernatants were kept for Bradford assay and pellets were discarded. 40µg of protein 
(for two pieces of gel) was aliquot and mixed with 3x SDS sample buffer (Appendix 8) 
with a final volume of 24µl. The mixture was then boiled at 95°C for 2min and stored 
at -20°C. Before use, the mixture was thawed on ice and 10µl was loaded to an SDS 
PAGE gel after a 2min boil at 95°C. The rest of the samples were kept at -20˚C for 
next time use.  
2.9.2.2 Bradford Assay 
After harvesting the protein, Bradford assay were conducted. A standard curve 
using BSA (0, 100, 200, 400, 600, 800, 1000 µg/ml) were made from a stock solution 
of 12mg/ml.  10µl of standards were added into a 96-well flat bottom plate in 
duplicate. 1µl of samples were added into the wells in duplicate. An appropriate 
dilution of the samples in distilled H2O was necessary if the protein concentration was 
too high. This is to make sure the sample concentration fell within the range of 0-
1000µg/ml. 190µl of diluted Bradford assay dye (Bio-Rad, USA) was added into each 
of the standard wells and 199 µl of diluted Bradford assay dye was added into each of 
the sample wells. The plate was kept at room temperature for 15min and the bubbles 
were removed using a needle. The plate’s bottom was wiped using a clean tissue 
paper with alcohol and the reading at the absorbance of 595nm was taken.  A standard 
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curve was obtained by using the wavelength reading at 595nm against protein 
concentration.  The sample protein concentration was determined according to the 
standard curve with a multiple of 10 (the volume of standard is 10 times of sample). 
20µg of protein was aliquot and mixed with 3x SDS buffer (Appendix 8). 
2.9.3.3 Sodium-Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) 
Sodium-dodecyle sulfate-polyacrylamide gel electrophoresis was performed 
on a 10% gel by using 20µg per lane of whole cell lysate.  Briefly, 10% separation gel 
(Appendix 8) was cast between two glass plates. The gel mixture was poured to about 
2cm below the top of the glass. Isopropanol was layered over the gel mixture to 
ensure a straight meniscus and to exclude any bubbles which inhibits gel 
polymerization reaction. The gel was allowed to polymerize for approximately 15min 
before decanting the isopropanol. Stacking gel solution (Appendix 8) was then mixed 
well and added on the top of the separation gel. A comb was quickly put in position 
after pouring the stacking gel and the gel was allowed to set for 15min. The comb was 
carefully removed after gel polymerization. The gel assembly was immersed into the 
electrophoresis chamber filled with running buffer (Appendix 8). 
The samples prepared as in 2.8.3.1 were then loaded into each well and also 
5µl of the Precision Plus Protein Kaleidoscope standards (Bio-rad, USA). 
Electrophoresis was carried out using consistent voltage of 75 volts for approximately 
one and a half hours. After electrophoresis, the gel was then transferred onto a 
0.22µm Nitrocellulose membrane (Biorad, USA) by using transfer buffer (Appendix 
8). Filter papers, nitrocellulose membrane and sponges for transferring sandwich were 
presoaked in transfer buffer for at least 15min. The separating gel was placed between 
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a wet nitrocellulose membrane and the pre-wet filter papers. One piece of sponge was 
placed outside the filter papers on each side. The transblot cell was then immersed 
into the transfer chamber filled with transfer buffer with the separating gel side 
adjacent to the negative electrode.  The transfer was carried out at 85 volts for 2h in 
cold room. 
2.9.3.4 Immunoblotting 
After transfer, the membrane was immersed in Ponceau S dye (Sigma, USA) 
for 1-2 minutes and then washed with running tap water to make sure that the transfer 
was done properly. The membrane was then blocked in Tris buffer saline-Tween 
(TBST) (Appendix 8) containing 5% skim milk for at least 1h. Primary antibodies 
(Table 2.8) were then diluted (1:500) in TBST containing 5% BSA or 5% milk 
according to the supplier’s instruction. The membrane with the primary antibody was 
incubated overnight at 4°C on an orbital shaker (Bellco, USA). 
After the incubation with primary antibody, the membrane was washed three 
times for 10min each with 10ml TBST.  Appropriate horseradish peroxidase (HRP)-
conjugated secondary antibodies (Table 2.8) diluted in TBST containing 5% skim 
milk were added into the membrane and incubated for 1 hour at 4°C on an orbital 
shaker (Bellco, USA). After that, the membrane was then washed three times for 
10min each using TBST. Visualization of the immunolabeled bands was then carried 
out using ECL Plus Western Blotting Detection Reagents or ECL Advance Western 
Blotting Detection Kit (GE Healthcare, UK) according to manufacturer’s instruction . 
The signals were exposed on X-ray film (Koda, USA) and scanned into computer for 
analysis. 
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2.10 STATISTICAL ANALYSIS 
Data were expressed as means ± SD. Significance of differences was 
determined using the Student’s T-test and analysis of variance. p values < 0.05 were 
considered to be statistically significant. 
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 3.1.1 MEASUREMENT OF CYTOKINE PRODUCTION 
IL-8 is an inflammation marker. In healthy tissues, IL-8 is barely detectable. 
However, it could be rapidly induced in response to proinflammatory cytokines, 
bacterial and virus products and cellular stress. In some cancer tissues, IL-8 is 
expressed constitutively.  It has been suggested that IL-8 generated by cancer cells 
may promote tumor progression by facilitating inflammation and tissue damage. 
To assess the effects of LAB on IL-8 secretion in IECs, Caco-2, HT-29 and 
HCT116 cells were incubated with the respective LAB strains listed in Table 2.1. 
THP1 cells were treated with EC1, EC3, EC15, EC16, L.GG and S. typhimurium only. 
The experiments were repeated 2-5 times using the method described in Material and 
Methods (section 2.3). 
3.1.1.1 IL-8 Production in Caco-2, HT-29 and HCT116 
The anti-inflammation effects of the enterococci and lactobacilli isolated from 
infants were investigated by co-culturing them with intestinal epithelial cells (Caco-2, 
HT-29 and HCT116). Supernatants were harvested for cytokine assays as described in 
Materials and Methods.  
Figure 3.1A-C showed that none of the Lactobacillus attenuated IL-8 secretion 
in Caco-2, HT-29 and HCT116 cells significantly. However, most of Enterococcus 
could suppress IL-8 production in Caco-2 and HCT116 cells (Figure 3.1A-C). 
Strikingly, only EC1, EC3, EC15 and EC16 showed the ability to suppresse IL-8 
secretion in all these three cell lines (Figure 3.1A-C). We further tested these four 
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strains together with L. rhamnosus GG (L.GG) and S. typhimurium (Salm) with a 
multiplicity of infection (MOI) of 100 or 1000 for 2h, 4h, 6h and 24hours in HCT116 
cells (Figure 3.1D).  Data showed that the regulation of IL-8 production by ECs is 
dose dependent, the higher concentration of ECs the more suppression of IL-8 
secretion (Figure 3.1D). L.GG, which is a commercial probiotics, could attenuate IL-8 
either with 24 hours incubation or a higher concentration in HCT116 cells. S. 
typhimurium, as expected, stimulated IL-8 secretion in HCT116 at both high and low 
concentrations. The reduction of IL-8 secretion by S. typhimurium with MOI of 1000 
at 24 hours might be due to the apoptosis of HCT116 cells 
From the above data, we can see that EC1, EC3, EC15, and EC16 
downregulated IL-8 secretion in all three IECs. With the treatment of other LAB 
listed in Table 2.1, most of them showed no regulation on IL-8 secretion in IECs. 
However, few strains showed the ability to inhibit IL-8 secretion. Together with EC1, 
EC3, EC15, EC16, these interesting LAB were treated with IECs for 6h with a MOI 
of 100 and 1000. Three independent experiments were done.  




































































































































































































































































Figure 3.1 IL-8 secretions in Caco-2 (A), HT-29 (B) and HCT116 (C) with the 
treatment of Lactobacillus and Enterococcus. A total number of 107 cfu/ml bacteria 
were added into the cells for 6h. (D) HCT116 cells were co-cultured with EC1, EC3, 
EC15 and EC16 and L. rhamnosus GG (L.GG) and S. typhimurium (Salm) with a 
multiplicity of infection (MOI) of 100 or 1000 for 2h, 4h, 6h and 24h. Supernatants 
were harvested for cytokine assay as described in Materials and Methods. Three 
independent experiments were compiled to produce the data shown. Error bars 
indicated as the standard deviation. 
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Figure 3.2 IL-8 secretions in Caco-2 (A), HT-29 (B) and HCT116 (C) cells treated 
with/without LAB for 6 hours. Bars represent mean cytokine production and the error 
bars represent standard deviation of mean. “Control” represents the consistent 
expression level of IL-8 without bacteria infection. 
Figure 3.2 shows the IL-8 secretion in Caco-2, HT-29 and HCT116 treated 
with LAB. Most of the LAB tested (including strains of ECs) showed no significant 
regulation of IL-8 secretion (data not shown) in Caco-2, HT-29, and HCT116 cell 
lines. Bifidobacterium, which was reported to down-regulate TNF-α and IL-8 
productions and inhibit NF-κB activation in inflamed mucosa of active ulcerative 
colitis (Bai et al., 2006), showed no effect on IL-8 secretion in all the three intestinal 
epithelial cell lines tested. However, EC1, EC3, EC15, EC16, L. delbrueckii 
bulgaricus D1 (L.bul), L. rhamnosus GG (L.GG), L. paracasei LP33 (LP33), L. 
brevis T6 (T6) and Streptococcus themophillus NCIMB10387 (10387) downregulated 
IL-8 secretion in Caco-2 cells (Figure 3.2A). In HT-29 cells, only EC1, EC3, EC15 
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and EC16 could downregulate IL-8 secretion (Figure 3.2B) among all the LAB tested. 
Whereas in HCT116 cell line, EC1, EC3, EC15, EC16, T6 and LP33 suppressed IL-8 
secretion (Figure 3.2C).  
Although all the 4 strains of ECs and other LAB inhibited the secretion of IL-8, 
it is interesting to note that different bacteria reduced IL-8 secretion to different levels 
after their exposure. ECs in general suppressed IL-8 production to a higher degree 
than other LAB. From Figure 3.2, we can see that the downregulation of IL-8 
secretion was dose dependent in Caco-2 and HCT116. The higher the concentration of 
LAB, the less secretion of IL-8. However, 108cful/ml of LAB treated HT-29 cell 
secreted more IL-8 than 107cfu/ml of LAB treated cell did. This might be due to the 
competition of the adhesion site on the cell surface by ECs. The higher concentration 
of the bacteria might not adhere as well as the low concentration of ECs. Above all, 
these results demonstrate that ECs could suppress IL-8 secretion in human cancer cell 
lines and thus suppress inflammation. In this respect, our findings extend those of Ma 
et al findings who showed that L.reuteri inhibited constitutive synthesis and secretion 
of IL-8 in human cancer cell lines (Ma et al., 2004).  
3.1.1.2 Production of Other Cytokines by Caco-2, HT-29 and HCT116 
The balance between inflammatory and regulatory cytokines is of crucial 
importance in gut immune modulation. TGF-β is an important inflammation 
regulatory cytokine. In our study, TGF-β cytokine was greatly induced by EC3 and 
EC15 (107cfu/ml) in Caco-2 cells as shown in Figure 3.3. Other LAB, however, could 
not induce TGF-β cytokine secretion above the detection level (above 62.5pg/ml) in 
Caco-2 cells. In HCT116 and HT-29 cell line, no TGF-β cytokine were detected in the 
cell cultures (data not shown). TGF-β, which plays a key role in the control of 
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differentiation, proliferation, and state of activation of immune cells, is important in 
downregulating inflammatory cytokine response. These data suggest that the increase 
of TGF-β might account for the balance of the human intestinal immune system. 
Moreover, recent studies showed that TGF-β also plays an important role during 
malignant transformation (Pinkas et al., 2006). Tumor-suppressor activities of TGF-β 
are inactivated at a later stage of colon cancer. In addition, colon cancer usually arises 
from chronic inflammation. Therefore, upregulation of TGF-β would help the immune 
system to fight against inflammation to further inhibit malignant transformation.   
In addition, IL-4 and IL-10, which are secreted by Th2 cells, are the dominant 
mediators of Th2 cell differentiation and proliferation. They have similar function in 
many anti-inflammatory and immunosuppressive activities. Both of them can inhibit 
the production of cytokines such as TNF-α, IL-1β, IL-6, IL-8 and IL-12. However, in 
our study, no IL-4 and IL-10 cytokine secretion were observed in Caco-2, HT-29 and 
HCT116 cells after all the LAB stimulation.  












































Figure 3.3 TGF-β production in Caco-2 cells treated with LAB for 6 hours. Bars 
represent mean cytokine production upon different strains treatments. The error bars 
represent standard deviation of mean. The ratio of cell: bacteria=1:100. 
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3.1.1.3 Production of IL-8 by THP1 cells 
ECs suppressed IL-8 secretion in IECs, however, its regulatory function in 
macrophage is still unknown. THP1 is human acute monocytic leukemia cell line. We 
therefore co-cultured EC1, EC3, EC15 and EC16, L. rhamnosus GG (L.GG), and S.  
thermophillus NCIMB10387 (10387) with THP1 cells for 1h, 2h, 4h, 6h, 8h and 24h 
with a MOI of 1, 10, 100 and 1000. S. typhimurium (Salm) and EC1, EC3, EC15 and 
EC16 were also coculured with THP1 cells for 30mins at a MOI of 1 and 10. 
Supernatants were harvested for ELISA test. Figure 3.4A showed that ECs, which 
suppressed inflammatory responses in IECs, activated IL-8 secretion in THP1 cells. 
The effects are time and dosage dependent. IL-8 expression peaked with a MOI of 10 
or 100 at various time points tested. Interestingly, L.GG and 10387 which are 
commercial probiotics also activated IL-8 secretion in THP1 cells (Figure 3.4A), 
suggesting that macrophage cells may not possess the ability to differentiate bacteria 
like IECs. Any bacteria in contact with macrophage would be considered as a foreign 
invader.  
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MOI=1, sonicated bacteriat MOI=100, sonicated bacteria
MOI=1, whole bacteria MOI=100, whole bacteria  
Figure 3.4 IL-8 production in THP1 cells. (A) IL-8 production in THP1 cells with the 
treatment of ECs, L.GG, Salm and 10387 for 30mins, 1h, 2h, 4h, 6h, 8h and 24h with 
a MOI of 1, 10, 100 and 1000. (B) IL-8 expression in THP1 with the treatment of LPS 
and ECs for 4 hours or LPS stimulated cells for 1h and then co-culture with ECs for 3 
hours. (C) IL-8 expression in THP1 with the treatment of sonicated bacteria and 
whole cell with a MOI of 1 or 100 for 1h. Values are the averages of results obtained 
on three independent experiments. 
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With the stimulation of LPS, IL-8 went up to a very high level (Figure 3.4B). 
Although ECs stimulated IL-8 expression in THP1 cells, they suppressed IL-8 
secretion stimulated by LPS (Figure 3.4B). More interestingly, live bacteria 
upregulated IL-8 secretion in THP1 cells, however, sonicated bacteria lost their ability 
to stimulate IL-8 expression in THP1 cells in one hour incubation (Figure 3.4C). 
From the above data, we can see that the suppression of IL-8 production by ECs is 
cell type dependent. THP1 responded to all types of bacteria tested, suggesting that 
any bacteria that enter the immune system would be a potential “pathogen”. In 
addition, THP1 cells could only recognize bacteria in general but not differentiate 
them. The dead bacteria lost their ability to trigger IL-8 responses in THP1 cells 
however still had the ability to suppress IL-8 secretion in IECs, implicating the 
efficacy of using dead bacteria in suppressing inflammatory responses. 
3.1.2 GENE EXPRESSION ANALYSIS  
3.1.2.1 Semi-Quantitative Gene Expression Analysis 
3.1.2.1.1 Cytokine Gene Expression Analysis 
Since ECs modulated human intestinal immune balance through regulating IL-
8 and TGF-β secretion, mRNA expressions of the inflammatory cytokines by the cell 
lines in response to ECs and other LAB treatments were studied. Each test was 
performed 2 times in triplicate. Data are expressed as mean value ± SD.  
Differentiated Caco-2 monolayers were exposed for 6 hours with 107 and 108 
cfu/ml EC1, EC3, EC15, EC16, L.GG, LP33, T6, 10387 and L.bul. Not consistent 
with IL-8 secretion, IL-8 mRNA expression was upregulated by 107cfu/ml EC1, EC3, 
EC15, EC16, L.GG and L.bul. Notably, T6 and L.bul could inhibit IL-8 mRNA 
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expression at 108cfu/ml (Figure 3.5), while other LAB had no effects on IL-8 gene 
expression at the concentration of 108cfu/ml (Figure 3.5).  
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Figure 3.5 Different cytokine expressions in Caco-2 cells in response to LAB. RT-
PCR analysis was used to determine IL-8, IL-4, TNF-α and TGF-β expression. (A) 
107 and 108 cfu/ml EC1, EC3, EC15, EC16, L.GG, LP33, T6, 10387, and L.bul were 
treated to differenciated Caco-2. mRNA expressions of the cytokines were analyzed 
as described in Materials and Methods. Results represent one of three independent 
experiments. (B) Quantitative densitometry was carried out on EtBr-stained gels and 
the results from three independent experiments were compiled to produce the data 
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Addition of EC1, EC3, EC15, EC16, LP33 and T6 (108cfu/ml) to HCT116 
cells strongly suppressed IL-8 mRNA expression (Figure 3.6). However, 107cfu/ml 
EC1, EC3, EC16 and LP33 enhanced IL-8 mRNA expression in HCT116 cells. TNF-
α is a primary mediator of immune stimulation and inflammatory responses. As 
shown in Figure 3.5B, TNF-α mRNA expression was stimulated by 107cfu/ml EC1, 
EC3, EC15 and L.bul in Caco-2 cells. However, TNF-α mRNA expression was 
suppressed at 108cfu/ml by EC1, EC3 and EC15. In HCT116 cells, TNF-α gene was 
expressed at a very low level with or without the treatment of LAB (data not shown). 
Interestingly, as we can see from Figure 3.6, TGF-β gene expression was greatly 
enhanced by 107cfu/ml EC1, EC3, EC15, EC16 and T6 in HCT116 cells. However, 
108cfu/ml of LAB showed no regulation of TGF-β gene expression. In general, the 
above studies demonstrate that ECs could regulate the human intestinal immune 
system at mRNA level. The upregulation of TGF-β and downregulation of IL-8 
mRNA by ECs in HCT116 cell lines might explain the suppression mechanism of the 
inflammatory responses in the human intestine. Given the evidence showing the 
downregulation of IL-8 secretion, the demonstrated ability of ECs to regulate IL-8 
mRNA synthesis in HCT116 cell lines is particularly interesting. Hence, the 
regulation of IL-8 secretion might be at both transcriptional and post-transcriptional 
levels in HCT116 cell lines at the higher concentration of LAB treatment. However, 
at the lower concentration of LAB, the regulation of IL-8 secretion might be mainly at 
the post-transcriptional levels since IL-8 mRNA were enhanced by them. Furthermore, 
the mRNA level of the proinflammatory cytokine TNF-α was downregulated by ECs. 
TNF-α could amplify inflammatory responses by activating neutrophils, mononuclear 
phagocytes, eosinophils and stimulate IL-8 secretion. Thus, downregulation of TNF-α 
gene expression may further dampen the mucosal inflammatory response.  
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Figure 3.6 IL-8 and TGF-β expression in HCT116 cells in response to LAB. HCT116 
cells were cultured for 6 hours in complete medium alone (control) or medium 
containing EC1, EC3, EC15, EC16, LP33 and T6 as described in Materials and 
Methods. (A) RT-PCR analysis was used for IL-8 and TGF-β after RNA was 
extracted. Results represent one of three independent experiments. (B) Quantitative 
densitometry was carried out on EtBr-stained gels and the results from three 
independent experiments were compiled to produce the data shown. The gel densities 
were normalized against β-actin. 
 
3.1.2.1.2 TLR Signaling Pathway Gene Expression Analysis 
Activation of signal transduction pathways by TLRs will lead to the induction 
of inflammatory cytokine and chemokine genes that function in host defenses and 
tumor progression. At least 13 TLRs have been identified in mammalian cells. They 
recognize a set of highly conserved pathogen-associated molecular patterns (PAMP). 
Among all the 13 members of TLRs, TLR3, TLR5, TLR9 are mainly expressed by 
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some findings suggest that epithelial cell derived TLR3 and TLR9 are capable of 
regulating proinflammatory cytokines. We therefore determined the expression of 
TLR1, TLR2, TLR3, TLR4, TLR5 and TLR9 in IECs upon ECs treatments in our 
study. The ability of the intestinal cell lines in response to ECs and other LAB at the 
level of TLRs mRNA expression was therefore assessed using semi-quantitative RT-
PCR. Gene encoding TLR1, TLR2, TLR3, TLR4, TLR5, TLR9, TRAF6 and Tollip 
were analyzed. 
TLR9 recognizes unmethylated CpG DNA in bacteria. Examination of the 
TLR9 gene expression showed that, 107cfu/ml EC1 and T6 downregulated TLR9 
mRNA expression in Caco-2 cells (Figure 3.7). In HCT116 cells, although TLR9 
mRNA was expressed very low, its expression was greatly inhibited by 108cfu/ml 
EC1, EC3, EC15, EC16, T6 and LP33 treatment (Figure 3.8).  
TLR4 is an essential receptor that transduces the signals of bacterial cell wall 
lipopolysaccharide (LPS). In the TLRs signaling pathways, TLR4 could activate 
numerous cytokine genes via TRAF6. 107cfu/ml T6 and 108cfu/ml EC1 suppressed 
TLR4 expression in Caco-2 cells (Figure 3.7). In HT-29 cells, EC1, EC3 and EC15 
but not EC16 (107cfu/ml) suppressed TLR4 mRNA expression (Figure 3.9). We could 
not detect TLR4 gene expression in HCT116 cells 
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Figure 3.7 TLR9, TLR4 and TRAF6 mRNA expression in Caco-2 cell line treated 
with LAB. (A) RT-PCR analysis was used to determine their mRNA expressions after 
exposed to EC1, EC3, EC15, EC16, L.GG, LP33, T6, 10387 and L.bul for 6 hours 
with the concentration of 107cfu/ml and 108cfu/ml. “C” represents control using 
culture medium only. “+” represents the positive control (plasmid containing certain 
genes) used in the analysis. (B) Quantitative densitometry was carried out on EtBr-
stained gels and the results from three independent experiments were compiled to 
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Figure 3.8 TLR3, TLR9 and TRAF6 mRNA expression in HCT116 cell line by EC1, 
EC3, EC15, EC16, T6 and LP33. (A) The above LAB were added to HCT116 cells as 
described in Materials and Methods. RT-PCR analysis was used to determine their 
mRNA expression. “C” represents control using culture medium only. “+” is positive 
control in PCR reactions using specific plasmid. (B) Quantitative densitometry was 
carried out on EtBr-stained gels and the results from three independent experiments 
were compiled to produce the data shown. The gel densities were normalized against 
β-actin. 
Compared to the control and also their 108cfu/ml treatment, TRAF6 mRNA 
expression was greatly suppressed by 107cfu/ml L.GG, LP33, T6 and 10387 in Caco-
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suppressed TRAF6 mRNA expression (Figure 3.9). This observation parallels the 
TLR4 regulation in HT-29 cells. Most interestingly, TRAF6 gene expression in 
HCT116 cells, was totally inhibited after treated with 107cfu/ml (except L.bul) and 
108cfu/ml LAB (Figure 3.8). 
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Figure 3.9 TLR4 and TRAF6 mRNA expression in HT-29 cell line with the treatment 
of EC1, EC3, EC15 and EC16. (A) The four strains were added to HT-29 cells as 
described in Materials and Methods. RT-PCR analysis was used to determine their 
mRNA expressions. Culture medium only was used as a control (“C”). (B) 
Quantitative densitometry was carried out on EtBr-stained gels and the results from 
three independent experiments were compiled to produce the data shown. The gel 
densities were normalized against β-actin. 
TLR3 recognizes the double-stranded RNA produced by most viruses during 
replication. As shown in Figure 3.8, TLR3 mRNA expression was also greatly 
inhibited by 108cfu/ml EC1, EC15, EC16, T6 and LP33 in HCT116 cells. However, 
there was no significant mRNA expression regulation in TLR3, TLR9 and Tollip after 
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did not modulate TLR2, TLR3 and Tollip mRNA expression in Caco-2 cells and 
Tollip mRNA expression in HCT116 cells (data not shown). In addition, we did not 
detect the expression of transcripts encoding TLR2 in HT-29 and HCT116 cells and 



















In this study, 56 LAB strains, which were isolated from infants, fermented 
products and also from our lab collection, were investigated on their immune 
modulation effects on human IECs (Caco-2, HT-29 and HCT116). These IECs have 
been shown to constitutively produce IL-8 in the study. IL-8 is a potent chemotactic 
and activating peptide from leukocytes, macrophages and T lymphocytes that can 
induce neutrophil accumulation and activation at the site of production. Among the 
LAB tested, none of the bifidobacteria showed any anti-inflammatory properties in 
IECs. Bifidobacteria is an important group of LAB which is usually considered as 
probiotics. They were reported to dominate in breast-fed infants (Gueimonde et al., 
2007). However they showed no suppression of IL-8 secretion in this study. This 
finding extended what others found that bificobacteria strains did not induce IL-8 in 
human IECs (Lammers et al., 2002). Thus, bifidobacteria may regulate human 
immune system through some other cytokines or pathways other than downregulation 
of IL-8 production. Interestingly, most lactobacillus, which is another major group of 
LAB usually used for food production, showed no ability to suppress inflammatory 
responses in the human intestine either. However, Lactobacillus delbrueckii 
bulgaricus D1 (L.bul) and Lactobacillus rhamnosus GG (L.GG) showed an inhibition 
of IL-8 secretion in Caco-2 cells but not in HT-29 and HCT116 cells.  Lactobacillus 
paracasei LP33 (LP33) and Lactobacillus brevis T6 (T6) suppressed IL-8 secretion 
both in Caco-2 and HCT116 cells but not HT-29 cells (Figure 3.2). These data 
showed that lactobacilli exhibited distinct ways in the regulation of immune responses 
in human. L.GG, but not other strains of lactobacilli, was reported on its anti-
Chapter 3 Screening of Lactic Acid Bacteria 
 
 97
inflammatory properties in the human intestine (Frick et al., 2007; Camilleri, 2005). 
Pathogenic S. typhimurium was also tested for its property in the regulation of 
inflammatory responses in the IECs. As expected, S. typhimurium upregulated IL-8 
secretion in the IECs (Figure 3.1D). This suggests that IECs could differentiate 
commensal bacteria from pathogenic bacteria and thus lead to different immune 
responses. 
In this study, among the 16 strains of enterococci isolated from 16 different 
infants aged 3 days and 1 month tested for their anti-inflammatory properties, four 
strains of ECs showed strong ability to suppress the inflammatory cytokine IL-8 
secretion in three IECs tested (Caco-2, HCT116 and HT-29) (Figure 3.1). Studies 
using Lactobacillus reuteri showed that this strain inhibited the constitutive synthesis 
of IL-8 and inhibited the synthesis and secretion of IL-8 induced by TNF-α in the 
human intestinal cell lines (Ma et al., 2004). Interestingly, most of LAB tested in this 
study including most strains of ECs (12 out of 16 strains isolated) did not show any 
effect on IL-8 production. However, IL-8 secretion was greatly downregulated after 
exposure to EC1, EC3, EC15, and EC16 in all the three IECs tested (Figure 3.1). This 
suggests that the immune reactions of an individual could be modulated by specific 
strains of a bacterial species. His healthy status is determined by the specific strains of 
LAB which were established during early childhood.  
Interestingly, ECs induced IL-8 secretion in THP1 which is a human acute 
monocytic leukemia cell line. L.GG and Streptococcus thermophilus which are 
commercial probiotics also activated IL-8 expression as well as the pathogenic S. 
typhimurium (Figure 3.4A). Therefore, the suppression of IL-8 production by ECs is 
cell type dependent. ECs could boost the immune response however suppress the 
inflammatory reactions in the host. THP1 responded to all bacteria tested, suggesting 
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that any bacteria that encounters macrophage could be considered as a potential 
“pathogen” and THP1 cells could not differentiate bacteria types. In addition, dead 
bacteria (low concentration) were not able to trigger IL-8 secretion in THP1 cells 
(Figure 3.4C) but were still able to suppress IL-8 secretion in IECs. These data 
implicate that the effector molecules of ECs to suppress IL-8 secretion from intestinal 
cells might reside on the bacterial cell surface. 
Paradoxically, IL-8 secretion level was not parallel with its mRNA expression 
level in the IECs in response to the LAB. IL-8 mRNA was upregulated by ECs in 
HCT116 cells and Caco-2 cells at the lower concentration treatment (Figure 3.5; 
Figure 3.6) even though they suppressed IL-8 secretion in the IECs (Figure 3.1). Upon 
the challenge of S. typhimurium, IL-8 mRNA remained unchanged but its secretion 
was upregulated in the IECs (Figure 3.1). This implies that ECs could boost the 
immune system to be ready for the challenge of pathogen. However, the inflammatory 
responses were suppressed in the absence of pathogen. On the contrary, S. 
typhimurium activated inflammatory responses without boosting the expression of 
immune genes.  Thus, the regulation of IL-8 protein secretion by ECs could involve 
post-transcriptional processes in protein synthesis and secretion (Hoffmann et al., 
2002). The upregulation of IL-8 mRNA in HCT116 cell might also be due to the 
negative feedback of IL-8 production because ECs suppressed IL-8 secretion to a very 
low level in HCT116 cells. Furthermore, the inhibition of IL-8 secretion in IECs is 
dose and time dependent. The higher concentration and longer incubation time of ECs, 
the lower concentration of IL-8 in the supernatants. 
Interestingly, TGF-β, which is important in inflammatory disease recovery, 
was upregulated significantly by EC3 and EC15 in Caco-2 cells at protein level 
(Figure 3.3) and in HCT116 at the gene level (Figure 3.6). TGF-β is a potent ligand 
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that regulates carcinoma initiation, progression and metastasis through a broad and 
complex spectrum of interdependent interactions (Bierie et al., 2006). TGF-β is also a 
key factor implicated in the regulation of intestinal barrier function and is considered 
to mediate tolerance to the indigenous microflora. Compared with Lactobacillus and 
Bifidobacterium, Enterocuccus demonstrated stronger effects on TGF-β production. A 
previous study suggested that lysed Enterococcus faecalis FK-23 (LFK) may have an 
effect on immune balance between Th1 and Th2 cells (Shimada et al., 2004). In this 
study, we observed that IL-8 cytokine production was suppressed and TGF-β was 
activated in the presence of ECs, therefore, ECs may also alter the balance among T 
cell responses leading to the prevention of inflammation in the intestinal cells.  
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4.1 RESULTS 
4.1.1 CHARACTERIZATION OF LACTIC ACID BACTERIA 
4.1.1.1 Phenotypic and Genotypic Characterization 
A total of 56 strains of lactic acid bacteria (LAB) were tested for their ability 
to regulate immune responses in intestinal epithelial cell lines (IECs). Among those 
bacterial strains, 27 strains were isolated from 3-day and 1-month old healthy infants, 
17 strains were isolated from fermented food, and 12 strains were from our lab 
collection (Table 4.1).  The bacteria are listed in Table 4.1.  
The 27 LAB were selected from infants’ feces on MRS and Slanetz/Bartley 
agar plates. All of the 27 isolates were Gram positive and rod or coccal in shape. The 
BioMerieux software, based on carbohydrate fermentation patterns, assigned 9 strains 
to Lactobacillus and 16 strains to Enterococcus.   
The partial sequence of the 16S rDNA demonstrated high identity (99%) of 13 
strains of the enterococci with 16S rDNA sequences of Enterococcus faecalis from 
GenBank, 1 strain of Enterococcus faecium and 2 strains of other Enterococcus. The 
identity of these strains is listed in Table 4.1. The sequences of these strains are listed 
in the Appendix 9. 
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Table 4.1 Identification of 27 strains isolated from infants 
 
Bacterial names Bacterial source (Infants Age) 
Strain ID obtained from 16S rDNA 
sequencing 
L1 3day Staphylococcus hominis 
L2 3day L.casei or E. faecium 
L5 3day Lactobacillus casei 
L6 3day Lactobacillus casei 
EC3 3day Enterococcus faecalis 
EC6 3day Enterococcus faecalis 
EC9 3day Enterococcus avium 
EC14 3day Enterococcus faecium 
EC15 3day Enterococcus faecalis 
EC16 3day Enterococcus faecalis 
   
L3 1month Lactobacillus casei 
L4 1 month Lactobacillus casei 
L7 1month Lactobacillus casei 
L8 1month Lactobacillus casei 
L9 1month Lactobacillus casei 
L10 1month Yeast 
L11 1month Yeast 
EC1 1month Enterococcus faecalis 
EC2 1month Enterococcus faecalis 
EC4 1month Enterococcus faecalis 
EC5 1month Enterococcus faecalis 
EC7 1month Enterococcus faecalis 
EC8 1month Enterococcus faecalis 
EC10 1month Enterococcus faecalis 
EC11 1 month Enterococcus gallinarum 
EC12 1 month Enterococcus faecalis 
EC13 1 month Enterococcus faecalis 
 
To fully characterize the E. faecalis, protease analysis and antibiotics 
resistance test were conducted.  
4.1.1.2 Protease Analysis 
In this assay, protease EF0706, EF0771, EF1590, EF1679, EF1917, EF2355, 
EF2380, EF2821, EF3027, EF3282 were tested in E. faecalis EC2, EC3, EC16 and E. 
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faecalis ATCC 29212. No protease was detected in E. faecalis EC2, EC3 and EC16. 
The positive control E. faecalis ATCC 29212 produced all the ten proteases. 
4.1.1.3 Antibiotics Resistance Test 
Antibiotics resistance test using chloramphenicol, erythromycin, methicillin, 


































Chloramphe-nicol Erythromycin Methicillin Tetracycline Neomycin Penicillin 
 
Figure 4.1 Antibiotic resistance properties of E. faecalis. 
From the above data, we can see that most of the E. faecalis strains are 
susceptible to chloramphenicol, penicillin, but resistance to neomycin and methicillin. 
Interestingly, E. faecalis EC1 and EC3 were susceptible to erythromycin and 
tetracycline, but not E. faecalis EC15 and EC16. L.GG, which is a commercial 
probiotics, is susceptible to most of the antibiotics tested but resistant to neomycin 
which did not seem to inhibit any of the bacteria tested. E. faecalis ATCC 29212 was 
resistant to methicillin and neomycin and susceptible to other antibiotics tested. Taken 
all these data together, we can see that E. faecalis contained some antibiotics resistant 
genes. These results are consistent with recent studies which suggested that E. faecalis 
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contains antibiotic resistant genes (Poeta et al., 2005). However, they are still 
susceptible to certain antibiotics. 
4.1.1.4 Gene Tree of the Bacteria 
25 strains (excluding yeast) of the bacteria were clustered according to their 
16s rDNA sequences. The resulting gene tree is shown in Figure 4.2. 
 
Figure 4.2 Gene tree of the 25 strains of bacteria isolated from new born infants. 
From the phylogenetic tree, we can see that enterococci are closely related to 
lactobacilli. The recent study on Lactobacillus supertree, combining individual 
phylogenetic trees from each of 354 core proteins, showed that Lactobacillus 
supertree had four main branches comprising L. salivarius-L. plantarum; L. sakei; E. 
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faecalis; and L. acidophilus-L. johnsonii (Canchaya et al., 2006). Interestingly, L. 
sakei is close to E. faecalis than to L. salivarius (Canchaya et al., 2006).   
4.1.2 IDENTIFICATION AND CHARACTERIZATION 
OF POSSIBLE EFFECTOR MOLECULES ON LAB 
From the above, we know that some LAB, especially E. faecalis, inhibited IL-
8 secretion in IECs. We further explored what are the possible molecules that play the 
important roles in the anti-inflammatory effects. To make the system simple, we 
chose E. faecalis EC1, EC3, EC15 and EC16 for this part’s study. The components 
from the four bacteria were co-cultured with HCT116.  IL-8 level was measured using 
ELISA method.  
4.1.2.1 Cell Wall Components and Crude Cell Extracts 
To investigate the effect of bacterial viability, bacterial cell wall structures and 
bacterial cell contents on the anti-inflammatory responses, the bacteria were sonicated 
and their cell wall components were separated from the crude cell extracts. Cell wall 
components were collected as cell debris after centrifugation at high speeds. 
According to Figure 4.3A, cell wall components from all E. faecalis strains 
demonstrated similar abilities as whole cells in reducing IL-8 levels (Figure 4.3B). 
Cell debris of the positive control, S. typhimurium, showed the expected ability in 
upregulating IL-8 levels since lipopolysaccharide (LPS) could be released by S. 
typhimurium lysis. Co-culturing with L.GG cell debris caused no change in IL-8 
concentration. 
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To study whether attenuation of IL-8 levels required bacterial cell contents, 
crude bacterial cell extract was co-cultured with HCT116 cells. In contrast to the 
results obtained using the cell debris, the crude cell extracts of all four E. faecalis 
strains showed no ability in reducing IL-8 levels when compared to the basal IL-8 
levels (Figure 4.3C). In fact, the crude cell extract of E. faecalis EC16 significantly 
increased the IL-8 concentration. Surprisingly, S. typhimurium crude cell extract did 
not activate IL-8 secretion but reduced IL-8 levels. This phenomenon suggested that 
cell wall components but not cell contents of S. typhimurium was very important in 
stimulating the inflammatory responses. Again, L.GG crude cell extract showed no 
significant change in IL-8 secretion. 
In order to confirm that only the cell debris of E. faecalis has an attenuating 
effect on IL-8 levels, both cell debris and crude cell extracts were combined and co-
cultured with HCT116. As seen in Figure 4.3D, treatment using a mixture of debris 
and crude cell extracts from all four E. faecalis strains could significantly attenuate 
the IL-8 levels to the same extent as the cell debris alone. S. typhimurium cell debris 
and crude cell extract had a similar significant ability in upregulating of IL-8 levels as 
the bacterial whole cell and cell debris. L.GG cell debris and crude cell extract 
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Figure 4.3 IL-8 concentrations obtained upon treatment of bacterial cell debris (A), 
whole bacterial cell (B), bacterial crude cell extracts (C), cell debris and crude cell 
extracts mixture(D) in HCT116 cells. Experiments were done three times. Standard 
deviations are indicated as error bars. 
4.1.2.2 Conditional Medium and Cell Inserts 
To further investigate the possible ability of E. faecalis cell wall components 
in stimulating a release of anti-inflammatory factors by the HCT116, conditional 
media using cell wall components was first obtained. Figure 4.4A demonstrates that 
the conditional media generated using cell debris was incapable of reducing IL-8 
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Figure 4.4 IL-8 secretion obtained upon the treatments of conditional medium on 
HCT116 cells. (A) Conditional media using cell wall components. (B) Conditional 
medium from crude cell extracts. (C) Conditional medium from a mixture of cell wall 
components and crude cell extracts.  (D)  E. faecalis strains co-culture with IL-8 
containing medium. (E) Cells co-culture with conditional medium from E. faecalis 
strains. (F) Conditional medium from co-culture of E. faecalis strains with cells. (G) 
Cell inserts. Experiments were done three times. Standard Deviations are indicated as 
error bars.   
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These results were confirmed with the conditional medium obtained from 
crude cell extracts or a mixture of cell wall components and crude cell extracts which 
were co-cultured with HCT116 cells. The lack of IL-8 attenuation was also observed 
(Figure 4.4 B, C).  
To determine whether reduction in IL-8 levels required the direct contact 
between HCT116 and bacteria or could be mediated by secreted products from either 
the bacteria or the intestinal epithelial cells, conditional media were made and added 
to HCT116 cells. Three experiments were designed to test this idea. In the first test 
involved, supernatants of the cell culture only were harvested and used in the 
subsequent treatment as conditional medium. E. faecalis strains were then added and 
incubated for 6h. Supernatants were tested for the IL-8 regulation.  If the effector 
molecules were released by E. faecalis strains or cells or some proteases from E. 
faecalis strains, there should be a downregulation of IL-8 level. However, the IL-8 did 
not change in this conditional medium (Figure 4.4 D). For the second test involved, E. 
faecalis strains were co-cultured with cell medium for 6h, bacteria were removed 
before adding the medium into the cell culture. If molecules from bacteria or some 
factors from bacteria stimulated cells to release the molecules, there should be a 
reduction of IL-8 level compared to the control. However, there was still no change in 
IL-8 level (Figure 4.4 E). For the third test involved, the conditional media were 
generated using whole cell bacteria co-cultured with cells as described in Material and 
Methods.  Figure 4.4 F demonstrated that the supernatants harvested from co-
culturing bacterial cells with HCT116 were incapable of reducing IL-8 levels in 
HCT116 cells. From the above data, I hypothesized that the effector molecules that 
suppress IL-8 level could not be the factors secreted by E. faecalis. 
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To further confirm the hypothesis, HCT116 cells cultures were incubated in 
the presence of bacterial strains housed in sterile plastic inserts. This ensured the 
physical separation between the HCT116 cells and bacteria while allowing secreted 
bacterial products to reach the HCT116 cells. Figure 4.4 G show that all the bacterial 
strains could not suppress IL-8 levels as well.  Taken all the data together, the effector 
molecules that inhibited IL-8 secretion in IECs are unlikely to be the factors secreted 
by E. faecalis or cells. 
4.1.2.3 Carbohydrate Oxidation and Protein Digestion of the Bacterial 
Cell Wall 
In order to study the importance of cell wall carbohydrates in attenuating IL-8 
levels, cell wall carbohydrates were oxidized using mild periodate and iodate. This m-
periodate oxidation at acid pH cleaves carbohydrate vicinal hydroxyl groups without 
changing polypeptide chain structures (Bobbitt, 1956). M-periodate was used because 
periodate oxidation analysis is one of the chemical methods for elucidation of 
carbohydrate structure. Periodate consumption and iodate formation, gives insight to 
the number of vicinal dihydroxyl groups (Honda, et al. 1989).  
The four E. faecalis strains in buffer A showed an expected large decrease in 
IL-8 levels as seen in Figure 4.5A. The Na-iodate and Na-m-periodate treatments of 
the E. faecalis however, prevented an appreciable decrease in IL-8 levels (Figure 
4.5A). Figures 4.5A also showed that Na-m-periodate treatment had no effect on 
L.GG’s abilities in changing IL-8 concentrations. These results confirm the 
importance of carbohydrates on the bacterial cell wall on the suppression of IL-8 
secretion on the IECs. 
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Figure 4.5 Regulation of IL-8 levels by carbohydrate oxidation and protein digestion 
of E. faecalis on IECs. (A) Carbohydrate oxidized by m-periodate and iodate. (B) 
Protein digested by chymotrypsin and trypsin in buffer B. (C) Protein digested by 
pepsin in buffer C. Treated bacteria were co-cultured with HCT116 cells for 6h and 
supernatants were harvested for IL-8 test using ELISA as described in Materials and 
Methods. Values are the averages of results obtained on three independent 
experiments. 
Although carbohydrate plays a very important role in the suppression of IL-8, 
we can not exclude other components’ importance especially the proteins on the 
bacterial cell wall. We therefore test their proteins in attenuating IL-8 levels. The 
proteins were digested using chymotrypsin and trypsin in buffer B and pepsin in 
buffer C as described in Materials and Methods. Figure 4.5 B show that buffer B did 
not change the abilities of the E. faecalis strains in attenuating IL-8 levels. Only E. 
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faecalis EC3 in buffer B did not show its usual reduction of IL-8. However, the drop 
in IL-8 levels is still statistically significant. Protein digestion via chymotrypsin and in 
buffer B caused no change in the abilities of the E. faecalis EC1, EC15 and EC16 in 
attenuating IL-8 levels. Chymotrypsin treated E. faecalis EC3 seemed unable to 
significantly reduce IL-8 levels as seen in Figure 4.5B.  
Protein digestion via trypsin in buffer B caused no changes in the abilities of 
the E. faecalis in attenuating IL-8 levels. S. typhimurium treated with buffer B and 
also with trypsin in buffer B showed no change in its capacity to stimulate IL-8 
secretion. However, with the treatment of chymotrypsin in buffer B, S. typhimurium 
lost its ability to stimulate IL-8 secretion (Figure 4.5 B).  L.GG in all three conditions 
did not show any changes in IL-8 regulating ability in comparison to its typical action 
seen in Figure 4.5B.  
Figure 4.5 C shows that buffer C prevented all four E. faecalis strains from 
attenuating IL-8 levels. Therefore, the effect of pepsin in buffer C in changing their 
abilities in decreasing IL-8 levels could not be determined. 
4.1.2.4 Adhesion Study 
From the cell inserts and conditional medium results, we can see that E. 
faecalis strains may need contact with cells to suppress IL-8 secretion in IECs. 
Moreover, the sonication pellets study and also the carbohydrate oxidation study 
suggested that bacterial cell wall carbohydrates played a role in the adhesion and 
further to inhibit IL-8 secretion in IECs. In order to study the importance of cell wall 
carbohydrates in adhering to HCT116 cells, carbohydrates on bacterial cell surfaces 
were oxidized using m-periodate. The results demonstrated that m-periodate treatment 
significantly reduced adhesion of all four E. faecalis strains to HCT116 cells (Figure 
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4.6 B, C). E. faecalis EC15 and EC16 were used as a representation here. Moreover, 
the secretion of IL-8 in HCT116 was greatly upregulated (Figure 4.5A). This study 
implied that carbohydrates on bacterial cell wall helped bacteria to adhere to cells and 
the carbohydrates may act as ligands to activate signaling pathways which led to the 
suppression of IL-8 secretion from IECs. The function of carbohydrates might not 
need the live bacteria since sonicated bacteria still suppressed IL-8 secretion (Figure 
4.3). L.GG also adhered to HCT116 cells (Figure 4.6 E). However, they did not 
adhere as well as E. faecalis. This could explain why L.GG did not suppress IL-8 
secretion as much as E. faecalis in my study. In addition, S. typhimurium, which is a 
pathogen, did not show a strong ability to adhere to HCT116 cells (Figure 4.6 F) 
suggesting that the adhesion ability of pathogen may not be important in the induction 
of IL-8 secretion. 
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Figure 4.6 Pictures of bacteria adhesion on monolayer of HCT116 cells observed 
using light microscopy at 1000X. (A) HCT116 cell without bacteria treatment. (B) 
HCT116 cells treated with E. faecalis EC16. (C) HCT116 cells treated with E. 
faecalis EC15. (D) HCT116 cells treated with E. faecalis EC15 which was treated 
with m-periodate. (E) HCT116 cells treated with L.GG. (F) HCT116 cells treated with 
S. typhimurium. 
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4.1.2.5 UV- and Heat- Killed Bacteria 
The need for the four E. faecalis strains to be alive to attenuate IL-8 levels was 
tested by co-culturing UV- treated and heat- killed bacteria with HCT 116 cells. The 
UV-killed E. faecalis maintained its ability to suppress IL-8 levels as shown in Figure 
4.7A. However, heat-killed E. faecalis lost its ability to reduce IL-8 secretion as seen 
in Figure 4.7B. This might due to heat inactivation (20mins boiling) of some 
components on the bacterial cell wall. This further suggested that the effector 
molecules which are very important in regulation of IL-8 secretion might be heat 
sensitive. Interestingly, S. typhimurium lost its ability to stimulate IL-8 secretion in 
HCT116 cells after they were UV-killed or heat treated. This phenomenon indicates 
that UV and heat treatment of S. typhimurium might cause them to lose the ability to 
activate IL-8 secretion in HCT116. 
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Heat killed bacteria  
Figure 4.7 IL-8 secretion in HCT116 with UV-killed bacteria (A) and heat-killed 
bactera (B). The bacteria were killed using the method described in Materials and 
Methods and treated with HCT116 cells for 6h. Supernatants were harvested for IL-8 
secretion test. Three independent experiments were compiled to produce the data 
shown.  
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4.1.2.6 Blocking of Specific Carbohydrate Receptors on Bacterial Cell 
Wall 
From the above study, we know the importance of carbohydrates in the 
inhibition of IL-8 secretion in HCT116 cells. In order to find out which specific 
carbohydrates are important in reducing IL-8 levels, E. faecalis was treated with three 
different lectins (Succinyl-ConA, ConA and Tetragonolobus purpureas). These 
lectins would bind specifically to these residues and possibly change the overall 
carbohydrate structures, potentially affecting their roles in attenuating IL-8 secretion. 
Figure 4.8A showed that incubation of the E. faecalis in PBS did not have an effect on 
its ability to suppress IL-8 secretion. Figure 4.8A showed that the three lectins used 
also had no effect on depressing IL-8 secretion. Interestingly, with the employment of 
lectins, the ability to activate IL-8 by S. typhimurium was inhibited. This might imply 
that lectins may act on LPS or some other carbohydrates on S. typhimurium to 
eliminate its stimulation on IL-8 secretion.   
In order to identify monosaccharides on the effector molecules, sugar 
inhibition studies were employed. Exogenous sugars seemed to be incapable of 
inhibiting all four E. faecalis strains from reducing IL-8 levels. Fucose, glucose, 
trehalose, N-acetyl-glucosamine, galactose and mannose incubated with the HCT116 
cells prior to addition of bacteria did not prevent the attenuation of IL-8 by the four E. 
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Figure 4.8 IL-8 secretion in HCT116 cells with three Lectins (A) and various sugar 
treatments (B). They were treated as described in Materials and Methods. Three 
independent experiments were compiled to produce the data shown.  
4.1.3 APOPTOSIS ANALYSIS 
From the above observations, LAB especially E. faecalis could inhibit the 
proinflammatory cytokine expression and secretion. We therefore examined the 
apoptosis feature that might be induced by LAB in IECs to see whether the 
suppressive effects of the bacteria are due to the cell death. In our study, flow 
cytometry method was used to quantify the apoptosis induced by LAB. The data 
showed that the LAB could not induce apoptosis at a concentration of 107cfu/ml in 
HCT116 with 6h incubation (data not shown). In HT-29 cells, 107cfu/ml EC3, EC15 
and T6 could slightly induce apoptosis after 6 hours incubation (Figure 4.9). However, 
other LAB like EC1, EC16, L.GG, 10387, L.bul, and Lp33 did not induce any 
apoptosis (data not shown). Most interestingly, S. typhimurium, which is a pathogen, 
did not show any property to induce apoptosis (Figure 4.9). CRL-1790, which is a 
normal colon cell line, was used as the control in this study. There were no obvious 
apoptotic responses detected in CRL-1790 with the treatments of the LAB (data not 
shown).  
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Figure 4.9 Apoptosis assay induced by 107cfu/ml LAB and S. typhimurium in HT-29 
cells. HT-29 cells were cultured and treated with LAB as described in Materials and 
Methods. Cells were then harvested and assayed by flow cytometry. For each sample, 
20,000 cells were measured. Flow cytometric data were analyzed using WinMDIv2.8 
software. (A) The pictures showed represent one in three independent experiments. (B) 













Among the 56 strains of LAB, 25 strains were isolated from 16 different 
infants aged 3 days and 1 month. Based on the carbohydrate fermentation profile and 
16S rDNA sequencing, we assigned 9 strains to Lactobacillus and 16 strains to 
Enterococcus. Moreover, most of the lactobacilli are Lactobacillus casei with a 
homology of 99% and the enterococci are Enterococcus faecalis with a homology of 
99% (Table 4.1). From the phylogenetic tree, we can see that the enterococci are 
closely related to lactobacilli (Figure 4.2). The recent study on Lactobacillus supertree, 
combining individual phylogenetic trees from each of 354 core proteins, showed that 
L. sakei branch was found phylogenetically closer to E. faecalis branch than to L. 
salivarius (Carlos et al., 2006). Moreover, they clustered E. faecalis as a branch of 
lactobacilli family. This further suggests that E. faecalis may be safer for human 
consumption than we imagined since it also belongs to lactobacilli. To further identify 
the properties of E. faecalis strains isolated from the infants, we tested their anti-
antibiotics properties. It is known that E. faecalis has natural antibiotic resistance 
property and is the leading cause of hospital-acquired secondary infections. In our test, 
most of E. faecalis strains were susceptible to chloramphenicol and penicillin, but 
resistance to neomycin and methicillin (Figure 4.1). Interestingly, E. faecalis EC1 and 
EC3 were susceptible to erythromycin and tetracycline, while E. faecalis EC15 and 
EC16 were not. Thus, chloramphenicol and penicillin are the effective antibiotics for 
E. faecalis tested in the study. L.GG, which is a commercial probiotics also 
demonstrated resistance to some antibiotics tested. Therefore, these E. faecalis strains 
are potentially safe due to their susceptibility to most clinically relevant antibiotics. 
However, the safety of E. faecalis for human uses needs to be further verified. 
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We further characterize the effector molecules of E. faecalis that modulate 
inflammatory responses in IECs. When bacterial cell wall fragments were applied to 
the intestinal cells after sonication, there was a dramatic suppression of IL-8 secretion 
in HCT116 cells (Figure 4.3). In addition, the remaining supernatant, the crude cell 
extract containing bacterial cytoplasm, ribosomes, small membrane vesicles, and large 
membrane structures, did not suppress IL-8 secretion. The use of conditional medium 
showed that the effector molecules were not secreted by cells or bacteria or molecules 
activated after co-culturing the cells and bacteria. This finding was further confirmed 
by using cell inserts. No IL-8 downregulation was observed when the cells and 
bacteria were separated by cell inserts (Figure 4.4). Moreover, we tested 10 proteases 
that might be secreted by E. faecalis. It was demonstrated that none of the E. faecalis 
tested possessed these proteases, suggesting that it might not be due to the protease 
secreted by E. faecalis that downregulated IL-8 level in the IECs. Therefore, the 
effector molecules that suppressed IL-8 secretion from the IECs were not inside the 
bacteria or secreted by them but on the surface of bacterial cell walls. In addition, 
only bacterial cell walls could inhibit IL-8 secretion, which implies that the inhibition 
does not involve bacterial metabolites but some specific molecules present on the 
bacterial cell surface.  
Results from oxidation of carbohydrate moieties of the whole cell surfaces of 
E. faecalis showed that the four E. faecalis strains lost their ability to depress IL-8 
secretion (Figure 4.5 A). Thus, carbohydrates could be the main effector molecules on 
E. faecalis cell surface. This mild periodate oxidation at acid pH cleaves carbohydrate 
vicinal hydroxyl groups without changing polypeptide chain structures (Bobbitt, 
1996), suggesting that vicinal dihydroxyl groups on E. faecalis cell surface possibly 
play a role in suppression of inflammation (Honda et al., 1989). Chymotrypsin-
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mediated protein digestion of the effector molecules on E. faecalis EC3’s cell surface 
stripped them of their ability to attenuate IL-8 levels (Figure 4.5 B). Thus, E. faecalis 
EC3’s effector molecule probably has protein structure(s) necessary for suppressing 
IL-8 secretion.  Similar chymotrypsin-mediated protein digestion of the three other E. 
faecalis strains and trypsin-mediated protein digestion on all four E. faecalis strains 
failed to alter their ability in reducing IL-8 levels (Figure 4.5 B and C), suggesting 
that proteins might not be the major components from the bacterial cell wall in 
suppressing IL-8 secretion.   
The adhesion study of E. faecalis strains demonstrated that they adhered very 
well to the mucosal layer of epithelial cells (Figure 4.6). Oxidation of the 
carbohydrate moieties on the bacterial cell surface caused a decrease in their adhesive 
abilities and also a drop in the ability to suppress IL-8 secretion. This suggests that the 
cell surface carbohydrates are necessary for the adhesion of four E. faecalis strains to 
IECs. In addition, this is in congruence with Guzmàn et al who previously observed 
that enterococcal surface carbohydrate adhesins were necessary for binding of E. 
faecalis to Girardi heart human cells and urinary tract epithelial cells (Guzman et al., 
1991). Another studies by Shorrock and Lambert also demonstrated that carbohydrate 
oxidation reduced binding abilities of E. faecalis, suggesting that surface adhesin with 
carbohydrate component is necessary for adhesion (Lsolauri et al., 2002). Since the 
same oxidation of carbohydrate moieties also stripped these E. faecalis strains of their 
IL-8 secretion suppressing abilities, adhesion of these bacteria via carbohydrate 
moieties could play a vital role in suppressing inflammation in IECs by E. faecalis.  
Another study using UV-killed bacteria confirmed that the killed bacteria 
retained the ability to suppress IL-8 secretion in HCT116 (Figure 4.7).  However, the 
heat-inactivated bacteria lost their ability to suppress IL-8 production in HCT116. 
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This might be due to heat decomposition of the carbohydrate structure on the bacterial 
cell surface (20mins at 100°C). Therefore, these results showed that live E. faecalis is 
not required to induce its IL-8 inhibitory effects and the carbohydrate structure which 
is important in IL-8 suppression might be heat sensitive. Taken all the data together, 
we can deduce that some structures of carbohydrate on the E. faecalis cell surface 
play the key role in the inhibition of IL-8 secretion in the host.  
The specific carbohydrate monosaccharides involved in IL-8 level attenuation 
could not be determined from the sugar inhibition and lectin studies because sugar 
inhibition and lectin binding had no effects on the IL-8 regulation with the treatment 
of E. faecalis. Con A has an affinity for terminal α-D-glucosyl and α-D-mannosyl 
residues. Succinyl ConA has an affinity for mannose and glucose residues 
agglutination activity (Gunther et al., 1973). Tetragonolobus purpureas has an 
affinity for α-L-fucosyl residues and a high affinity for α-L-fucose residues on type II 
chain blood group oligosaccharides. These lectins can bind to their respective target 
monosaccharide and alter the overall carbohydrate structure of the effector molecules. 
E. faecalis pre-treated with ConA, succinyl ConA and Tetragonolobus purpurea, 
however, were unable to strip the E. faecalis strains of their inflammation suppressing 
ability. Therefore, Lectin studies suggest that α-L-fucosyl, α-L-fucose, D-mannosyl 
and D-glucosyl residues are probably not vital or possibly absent from the effector 
molecules. However they may be important in upregulating IL-8 secretion in S. 
typhimurium since blockage of carbohydrate residues by lectins on S. typhimurium 
cell surface stripped its ability to induce IL-8 secretion (Figure 4.8). In order to 
identify monosaccharide on the effector molecules, sugar inhibition studies were 
employed. Sugar inhibition studies showed that the blocking of potential receptors on 
the intestinal epithelia with the following sugars - fucose, mannose, glucose, N-acetyl-
Chapter 4 Characterization of LAB and Their Effector Molecules 
 
 123
glucosamine, galactose, and trehalose - did not prevent the four E. faecalis strains 
from suppressing inflammation (Figure 4.8). This suggests that these 
monosaccharides might not be associated with the E. faecalis effector molecules. 
Moreover, we further tested the possibility of E. faecalis to induce apoptosis leading 
to the reduction of IL-8 secretion. The results showed that E. faecalis did not induce 
apoptosis in human IECs at a MOI of 100 (Figure 4.9) suggesting that the suppression 
ability of E. faecalis in IL-8 secretion is not because of the apoptosis. Furthermore, 
IL-8 is stable at a pH of 2-9 (Mukaida et al., 2003). Therefore, the downregualtion of 
IL-8 level in the supernatant is not due to the degradation of IL-8 by the production of 
lactic acid by the E. faecalis.  
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5.1.1 MICROARRAY ANALYSIS 
The four strains of E. faecalis attenuated IL-8 cytokine secretion in the human 
intestinal cell lines. Their regulation on immune gene expression was tested using 
cDNA microarray and confirmed by Taqman low density array (TLDA) and Western 
blotting.  
Microarray technology simultaneously providing information on expression 
levels of hundreds of genes has revealed new potential signaling pathways and 
molecular targets that E. faecalis regulated.  In our experimental design, cDNA 
microarrays (GEArray S Series Human Immunology Signaling Pathways Gene Array) 
were obtained from Superarray (USA). A total of 406 human immunology signaling 
pathway related cDNA clones were detected in the experiments.  The regulation of 
these genes’ expression by E. faecalis (EC1, EC3, EC15 and EC16), L.GG, S. 
typhimurium, T6 and S. typhimurium coculture with EC16 were tested in Caco-2 cells 
at a MOI of 100 for 6h. Acquired data were initially scanned into computer to obtain 
the image (Figure 5.1). Each of the bellow images is one representation of five 
independent experiments. The signals were then analyzed using the web-based 
GEArray Expression Analysis Suite provided by the supplier. Scatter plots were 
generated automatically by the software with a p value available (Figure 5.2). From 
the scatter plot, we can see the numbers and names of genes upregulated or 
downregulated by the bacteria. In addition, the clustergrams gave hints on the gene 
expression level and regulation pattern (Figure 5.3). To get more accurate data, 
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GeneSpring GX 7.3.1 (Agilent technologies, US) was further used to analyze the data, 
genes were accompanied by “absent” or “bad” flags were excluded. The regulated 
genes were in part listed in Table 5.1 and Table 5.2.  
Chapter 5 Characterization of Signaling Pathways 
 
 127
Control                                       EC1                                          EC3 
              
EC 15                                       EC 16                                        L.GG 
               
T6                                              Salm                                         Salm+EC16 
             
 
Figure 5.1 Original images of different treatments. Caco-2 was treated with E. 
faecalis (EC1, EC3, EC15 and EC16), L.GG, S. typhimurium, T6 and S. typhimurium 
coculture with EC16 at a MOI of 100 for 6h. RNA was harvested and gene expression 
was tested using the method described in Materials and Methods. The image above 
showed one representation of five independent experiments. 
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In the original images of the treatments, GAPDH, which is the positive control 
used in this study, were expressed consistent in each treatments. Blank wells (Figure 
5.1 control) detected nothing. Using the web-based GEArray Expression Analysis 
Suite provided by the supplier, gene regulation (>1.5 folds or < 0.67 folds) was 
expressed in scatter plots (Figure 5.2). Here are the labeling: Group1: Control; 
Group2: EC15; Group3: EC16; Group4: EC1; Group5: EC3; Group6: L.GG; Group7: 
Salm; Group8: T6; Group9: Salm+EC16.  
 
EC1 vs Control                                                         EC3 vs Control 
 
EC15 vs Control                                                      EC16 vs Control 
 
L.GG vs Control                                                   Salm vs Control 





T6 vs Control                                                        Salm+EC16 vs Control 
 
 
Salm+EC16 vs Salm                                            Salm+EC16 vs EC16 
 
 
Figure 5.2 Scatter plot of different treatments. Red dots are those upregulated genes 
(>1.5 folds) and green dots are those downregulated genes (<1.5 folds). Black dots are 
those non-regulated genes (1-1.5 folds). Five individual experiments were conducted 
and analyzed. 
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From the scatter plots, some interesting genes are listed in the Table 5.1. The 
number in a bracket before the genes in each column is the number of genes regulated 
by the bacteria. These data were obtained according to the average of image density.  
Table 5.1 Gene regulation in Caco-2 cells detected using cDNA microarray 
 
 Upregulation Downregulation 










(59) CDKN2B, FOS, 
IKBKB, IL8RA, SMAD9, 
MAP3K8, MAPK11, 





































































































NFKB2, PIN1, PPP3CB, 









(48) CCNE2, CTLA4, 
DLK1, G1P3, MAPK7, 
MEF2B, NFKB2, PIN1, 










(40) IL1R2, IL20RA, 
IL2RG, JUN, MAPK7, 
NFKB2, NFKBIA, TLR9, 















(37) CDKN2B, CREB1, 
CTLA4, JUN and etc. CCNE2, DLK1,
Note: EC1, EC3, EC15 and EC16: E. faecalis; L.GG: L.rhamnosus GG; Salm: S. typhimurium; 
SEC16: Salm+ EC16; 
 
From the raw data of microarray, several common signaling pathways were 
found to be involved in the anti-inflammatory effects of E. faecalis. MAPK family 
members (e.g. MAP3K8 and MAPK7) were greatly downregulated with the treatment 
of E. faecalis. DUSP1, which is known as MAPK phosphatase 1 that can inactivate 
MAPK signaling pathway, was greatly upregulated with the treatment of E. faecalis 
but not L.GG and S. typhimurium. NF-κB members (e.g. NF-κB1, NF-κB2 and 
IKBKB), which are the master regulator of proinflammatory responses, were 
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downregulated upon E. faecalis treatments too. Interestingly, some cytokine receptors 
(e.g. TNFRSF11A, IL-20RA and IL-8RA), were also suppressed by the E. faecalis.  
In addition, some genes, which are involved in cell proliferation and tumor genesis 
such as PIN1, gene transcriptions such as MEF2B and MKNK1, were greatly 
downregulated too. 
 
To be continued 






            
Figure 5.3 Clustergram of all the treatments obtained using GEArray Expression 
Analysis Suite. The inner small graph (a) demonstrated the consistency of same group 
and also the consistency of the positive control used. 
 
Figure 5.3 demonstrated the genes regulation with the treatments of the 
bacteria in a clustergram form. The red color means the higher expression of the 
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genes and the green color means the lower expression of genes. These pictures gave 
us a direct impression of the regulation of the genes. Together with the results from 
Table 5.1, we can see that with the coculture of E. faecalis and S. typhimurium in 
Caco-2 cells, DUSP1 was greatly upregulated, however cytokine receptors (IL1R2, 
IL20RA, IL2RG, and TNFRSF11A) and MAPK/NF-κB family members (MAPK7, 
NFKB2 and NFKBIA) were suppressed (Table 5.1) implicating E. faecalis might 
suppress the inflammatory signals activated by pathogenic S. typhimurium. 
Moreover, we used GeneSpring GX to analyze the data. The significantly 
differentially expressed genes were filtered with the Volcano Plot built by comparing 
“Treatments” with “Control”. Using the Genes in the “Flags are present” gene list, 
genes were differentially expressed was defined by fold difference of 1.5 and a p-
value cut-off of 0.05.  
Table 5.2 significantly regulated gene (P<0.05) in Caco-2 cells treated with E. 
faecalis strains for 6h measured by cDNA microarray. 
 
Functional category Gene population 
Response protein GBP1; SLC2A4, NPPB, 
Receptors EGFR; IL8RA, TNFRSF11A, P2RX7 
Transcription factors 
MLLT7, EGR1, ETS1; 
MAPKAPK2, MAPKAPK3, MAX, MEF2B, MKNK1, 
SP1 
AKT& PI3K family PIK3R3, TCL1A, TCL1B 
MAKP famlily MAPK13; MAPK7, MAP4K1 
Adaptor TNFAIP3, MDM2; 
Nuclear factors NCOA1, SPI1 
Signal transduction 
kinases IKBKB, MAP3K7IP1, PRKCA 
Rel/NF-kb NFKB1, NFKBIL2, NFKB2 
Others SMAD4, SMAD1, BCL2; NFATC2, NCK2, PPP3CB, PPP3CC, CTLA4, SMAD6.
Note: Bold italic labeled genes are those upregulated. The rest are downregulated genes. 
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The genes demonstrated in Table 5.2 were those significantly regulated by E. 
faecalis strains. From those data, we can see that MAPK and NF-κB are two main 
families that involve in the immune regulation of E. faecalis. Cytokine receptors are 
also important in the regulation. Interestingly, 10 transcription factors were modulated 
by E. faecalis in Caco-2 cells suggesting that E. faecalis regulates immune responses 
in the human intestine might through modulating all kinds of transcription factors. 
Moreover, cytokine gene expression such as ICAM-1 did not change significantly. 
JAK/ STAT family members which are involved in the signaling of cytokines did not 
change significantly either.  
 To further investigate the signaling pathways that E. faecalis regulated in 
IECs. We chose 46 genes for further study using TLDA. A 48-well format TLDA was 
designed for a subset of genes that were differentially expressed in the array 
experiments including two endogenous controls 18S and β-actin. 
5.1.2 SIGNALING PATHWAY ANALYSIS 
5.1.2.1 TaqMan Low Density Array Results 
In this part, RNAs from HCT116 and Caco-2 with the treatment of E. faecalis 
(EC1, EC3, EC15 and EC16), L.GG and S. typhimurium for 6h at a MOI of 100 were 
harvested. cDNA was made using 0.5µg total RNA and further tested on TLDA cards. 
Data were analyzed using the SDS2.2 software where baseline and threshold settings 
were automatically adjusted. In this part, each test was done with four biological 
replicates. The gene expression in HCT116 with the treatment of EC16 was done with 
two technical replicates including the four biological replicates. Student T-test were 
applied to the results and p<0.05 were considered significant. 
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5.1.2.1.1 Results in HCT116 cells 
The gene ID tested in the TLDA cards are listed in Table 3.7. In HCT116 cells, 
the four E. faecalis (EC1, EC3, EC15 and EC16) strains demonstrated a similar 
regulation pattern on the genes. We therefore use EC16 as an example to illustrate the 
results. Figure 5.4A showed the genes regulated by EC16 significantly in HCT116 
cells. 
Figure 5.4A shows that CCND1 (cyclin D1), IKBKB (Inhibitor of nuclear 
factor kappa B kinase beta subunit), MAP3K7IP1 (Mitogen-activated protein kinase 
kinase kinase 7 interacting protein 1), MDM2 (transformed 3T3 cell double minute 2, 
p53 binding protein) , MKNK1 (MAP kinase-interacting serine/threonine kinase 1), 
NF-κB1, PIK3R3 (Phosphoinositide-3-kinase, regulatory subunit 3 (p55, gamma)), 
SMAD7 (SMAD family member 7) , TNFRSF11A (Tumor necrosis factor receptor 
superfamily, member 11a, NFKB activator) and TRAF6 (TNF receptor-associated 
factor 6) were suppressed with the treatment of E. faecalis EC16 in HCT116, however 
DUSP1 (Dual specificity phosphatase 1) , IL-8 and JUN were upregulated. 












































Figure 5.4 Gene expression in HCT116 with the treatment of EC16. (A) All the genes 
listed in this figure were regulated significantly. (B) The gene expression were not 
regulated significantly (except JUN) in HCT116 but with a fold change above 1.5. 
Experiments were done on 4 biological replicates and 2 technical replicates using 
10µg cDNA. Folds changes > 1.5 and T-test with a P < 0.05 were considered 
significant. 
 
There are also other interesting genes regulated by E. faecalis in HCT116 cells. 
MDM2, which is a target gene of the transcription factor tumor protein p53, is a 
nuclear phosphoprotein that binds part of an autoregulatory negative feedback loop. It 
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was greatly suppressed with the treatment of E. faecalis in our study (Figure 5.4A). 
Overexpression of this gene can result in excessive inactivation of tumor protein p53, 
diminishing its tumor suppressor function. MDM2 also has E3 ubiquitin ligase 
activity, which targets tumor protein p53 for proteasomal degradation. This protein 
also affects the cell cycle, apoptosis, and tumorigenesis through interactions with 
other proteins, including Rb1 (retinoblastoma 1). Another interesting gene is SMAD7, 
which is SMAD superfamily. SMAD7 was also suppressed by E. faecalis in our study 
(Figure 5.4A). It induces tumorigenicity by blocking TGF-β induced growth 
inhibition and apoptosis. However, SMAD7 has no effect on TGF-β induced 
activation of p38 and ERK. It blocks the phosphorylation of Akt by TGF-β and 
enhances TGF-β induced phosphorylation of c-JUN. Therefore, suppression of these 
proteins may suppress the tumor progression in colon cancer cell lines. 
Figure 5.4B showed the trends of the gene regulation in HCT116 with the 
treatment of E. faecalis EC16. Cytokine receptors like IL-20RA, IL-8RA were 
suppressed.  Unexpectedly, FOS and JUN, which can dimerize and form the 
transcription factor complex AP-1, were upregulated. However, CREB1 (cAMP 
responsive element binding protein 1), which is also an important transcription factor, 
was suppressed, suggesting a complex regulation system of the gene transcriptions in 
the host at the presence of E. faecalis strains. Conflicting with the upregulation of IL-
8 gene expression, TNF was suppressed in HCT116 (Figure 5.4B) which hints the 
regulation of IL-8 protein production may involve a post-transcription regulation. 
Furthermore, PIN1 (Protein (peptidylprolyl cis/trans isomerase) NIMA-interacting 1), 
a conserved enzyme involved in diverse biological processes and pathological 
conditions, has profound effects on phosphorylation signaling pathways. It was found 
overexpressed in many human cancers (Gerburg et al., 2005). However, it was 
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suppressed with the treatment of E. faecalis in human colon cancer cell lines. PIN1 is 
also a target gene of E2F1 in response to growth factors and other stimulating 
conditions (Ryo et al., 2002), and PIN1 in turn positively regulates cyclin D1 function 
at the transcriptional level and also through post-transcriptional stabilization. 
Moreover, PIN1 also inhibits negative feedback of MAPK signaling (Dougherty et al., 
2005). This further suggests the inhibition of the overexpression of PIN1 in human 
colon cancer cell lines may put a brake on multiple oncogenic signal pathways at 
multiple levels. Interestingly, in our study, PIN1, cyclin D1 and E2F1 were all 
suppressed in the presence of E. faecalis in HCT116 cells (Figure 5.4), suggesting an 
overwhelming function of E. faecalis in the regulation of host response. In summary, 
the genes regulated by all bacteria tested were listed in Figure 5.5. 
From Figure 5.5, we can see the regulation of all the 40 genes detected using 
TLDA cards. The gene expression of IL-4, IL-10, SPI1, TLR2, TLR4 and TLR9 were 
either not expressed or expressed in minute quantities in HCT116. S. typhimurium and 
L.GG did not regulate most of the genes tested.   E. faecalis EC1 which was isolated 
from one month old infant exhibit some different regulation pattern compared with 
other E. faecalis isolated from three day old infants.  EC1 did not inhibit NF-κB, 
MKNK1, MAP3K7IP and cyclin D1 expression as other E. faecalis suggesting a 



















































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 5.5 Gene expression in HCT116 with the treatment of E. faecalis (EC1, EC3, 
EC15 and EC16), L.GG and S. typhimurium. Experiments were done on 4 biological 
replicates using 10µg cDNA as described in Materials and Methods. Values are the 
averages of results obtained on four independent experiments. 
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5.1.2.1.2 Results in Caco-2 cells 
To find out the common signaling pathways in the immune responses that E. 
faecalis regulates in the host, we tested the gene expression in Caco-2 cells as well. 
Figure 5.6 showed the results with the changes exceeding 1.5 folds compared with 
control in at least one treatment. 
Consistent with the observations in HCT116 cells, NF-κB1, MAP3KPIP, 
MKNK1 as well as E2F1 and MDM2 were suppressed. DUSP1 was also upregulated 
in Caco-2 cells (Figure 5.6). This further suggested the importance of NF-κB and 
MAPK signaling pathways in the regulation of immune responses upon the treatment 
of E. faecalis. Interestingly, IL-8 was not upregulated significantly as we observed in 
HCT116 cells suggesting a multiple regulatory pathway of IL-8 protein production.  
TLRs are important in the regulation of immune responses including 
modulating the cytokine production. TLR3 could not be detected or expressed low in 
Caco-2 but TLR2, TLR4 and TLR9 were expressed in Caco-2 cells. Taken the results 
from HCT116, in which, TLR2, TLR4 and TLR9 were not detected, we can see that 
TLRs might not play a key role in the regulation of immune responses in IECs in 
responses to E. faecalis since there were no common TLRs regulated in these two 
IECs.  In addition, transcription factors like CREB1, FOS, E2F1 and MKNK1 were 
inhibited with the treatment of E. faecalis. The inhibition of these transcription factors 
might inhibit the gene transcription and also translation thus to inhibit the 
proinflammatory protein production. However, JUN was still upregulated by E. 
faecalis in the gene level. The different regulation pattern of transcription factors by E. 
faecalis again suggested the complex regulation mechanism of it in the host. 












































































































Control EC1 EC15 EC16 EC3 LGG Salmonella
RQ














































































Control EC1 EC15 EC16 EC3 LGG Salmonella
RQ
 
Figure 5.6 Gene regulation in Caco-2 cells with the treatment of E. faecalis (EC1, 
EC3, EC15 and EC16), L.GG and S. typhimurium for 6h. Experiments were done on 4 
biological replicates using 10µg cDNA. Values are the averages of results obtained on 
four independent experiments. 
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5.1.2.1.3 Results in THP1 cells 
For simplicity, in this part, E. faecalis EC3 was used to treat with THP1 cells 
for 1 hour with a MOI of 1 and 6 hours with a MOI of 100.  Experiments were 
repeated three times. All the data showed below are fold changes >1.5 with a P value< 
0.05. All controls were set to 1.  
E. faecalis stimulated IL-8 secretion in THP1 cell even at a low concentration 
(MOI=1) and short incubation time (1h) (Figure 3.4). The immune genes regulated by 
E. faecalis in THP1 cell were therefore investigated using TLDA cards. Figure 5.7A 
showed that TNF, IL-8, DUSP1 and JUN were quickly upregulated even with 1h 
incubation at a MOI of 1. The upregulation of DUSP1 might imply the negative 
feedback mechanism of MAPK signaling pathway which play a critical role in the 
inflammatory responses. JUN, however, was activated in both IECs and THP1 cells, 
suggesting that it is an important transcription factor in the inflammatory responses 
(Figure 5.4A and Figure 5.7A, B).  
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Figure 5.7 Gene regulation in THP1 cells with the treatment of E. faecalis EC3 for 1h 
at a MOI of 1 (A) and for 6h at a MOI of 100 (B, C). Experiments were done on 3 
biological replicates using 10µg cDNA. Values are the averages of results obtained on 
three independent experiments. 
More interestingly, with stronger stimulation of E. faecalis to THP1 cells, 15 
genes were greatly upregulated and 17 genes were suppressed. Compared with the 
data obtained from HCT116 and Caco-2 with the treatment of E. faecalis, the results 
show that TLR3, TLR4 and TLR9 were all suppressed in the IECs and THP1 cells 
although not all of them were expressed in both Caco-2 and HCT116 cells. In our 
study, TLRs were merely detectable in HCT116 cells whereas TLR2, TLR4 and 
TLR9 were found expressed in Caco-2 cells. Only TLR3 were detected in HCT116 
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cells (Figure 5.4; Figure 5.5; Figure 5.6). Therefore, there are no common TLRs 
expressed by both HCT116 and Caco-2 cells. The low expression of TLRs in IECs 
implicated the mechanism of tolerance to the commensal bacteria in the intestine. In 
addition, IL-8 was suppressed in IECs but stimulated in THP1 cells. It is logical to 
reason that TLRs may not be involved in the regulation of IL-8 production or even 
inflammatory responses modulated by E. faecalis in intestinal epithelial cells. 
However, the upregulation of IL-8 secretion in THP1 cell might through TLR2 but 
not TLR3, TLR4 and TLR9.  
Consistent with our cDNA microarray results, TLDA results showed that E. 
faecalis suppressed some cytokine receptors on the cell surface including IL-8RA and 
TNFRSF11A in IECs (Figure 5.4). Furthermore, using Western blotting, it showed 
that E. faecalis suppressed IL-8RA protein production in HCT116 cells (Figure 5.8). 
However, IL-8RA and TNFRSF11A were greatly upregulated in THP1 cells with the 
elevated level of IL-8 secretion (Figure 5.7B). Taken the data together, E. faecalis 
could regulate immune responses in the host through cytokine receptors like 
TNFRSF11A and IL-8RA. TLRs although are important in the innate immunity might 
not be the vital receptors on IL-8 regulation or inflammation suppression regulated by 
E. faecalis. In addition, NFKB1 and NFKB2 were greatly upregulated in THP1 cells 
suggesting their important roles in the inflammatory responses in macrophage. Other 
genes regulated in THP1 are listed in Figure 5.7. Several SMAD family members 
(SMAD5, 6, 9) were suppressed in THP1 by E. faecalis whereas SMAD7 was 
upregulated (Figure 5.7 B, C). Moreover, some of the MAPK family members 
(MAPK9, MAP3K7IP1 and MAPKAPK2) were also suppressed by E. faecalis in 
THP1 cells whereas MAPK8 was upregulated suggesting that E. faecalis regulates the 
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immune responses in the host in a very distinct way in both intestinal cells and 
immune cells (Figure 5.7 B, C). 
5.1.2.2 Immunobloting Analysis 
In response to E. faecalis, genes such as DUSP1, PIN1, E2F1, cylin D1 and 
IL8RA were regulated in HCT116 cells (Figure 5.4). To test protein expression 
encoded by these genes, we co-cultured E. faecalis (EC1, EC3, EC15 and EC16), 
L.GG and S. typhimurium with HCT116 cells for 6h with a MOI of 100 and analyzed 
the protein production using Western blotting as described in Materials and Methods.  
Consistent with the gene expression in HCT116 cells, PIN1, cyclin D1 and 
E2F1 protein production were suppressed by E. faecalis (EC1, EC3, EC15 and EC16) 
but not L.GG and S. typhimurium (Figure 5.8). PIN1 has been shown to catalytically 
induce conformational changes in proteins following phosphorylation, thereby having 
profound effects on their catalytic activity, dephosphorylation, protein-protein 
interactions, subcellular location and/or turn over (Hsu et al., 2001; Liou et al., 2002; 
Lu et al., 1999; Ryo et al., 2001, 2002; Shen et al., 1998; Stukenberg et al., 2001; 
Wulf et al., 2001; Yaffe et al., 1997; Zhou et al., 2000). Thus, PIN1 is critical in 
phosphorylation signaling (Lu et al., 2002). Upregulation of PIN1 has been shown to 
elevate cyclin D1 gene expression by activating c-JUN, β-catenin and E2F1 
transcription factors (Ryo et al., 2001; Wulf et al., 2001). Cyclin D1 has been shown 
to play a pivotal role in the development of cancer. Overexpression of cyclin D1 is 
found in many cancers (Bartkova et al., 1994; Gillett et al., 1994; Elsheikh et al., 
2007). In contrast, inhibition of cyclin D1 expression causes growth arrest in tumor 
cells. Thus, PIN1 is an E2F1 target gene that is essential for transformation of 
mammary epithelial cells through activation of cyclin D1. In our study, the 
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suppression of PIN1, E2F1, cyclin D1 by E. faecalis at the same time implies the 
multiple control of tumor cell growth by the bacteria. This control might be mediated 
through inflammatory responses to E. faecalis in IECs, as tumor growth and 
metastasis are results of inflammation (Lu et al., 2006). However, results obtained 
from coculturing THP1 cells with E. faecalis demonstrated that even with a high 
secretion of IL-8, E2F1 protein production did not change (data not shown), 
suggesting the indirect regulation of E2F1 to IL-8 gene transcription and protein 
production. 
  
Figure 5.8 Protein expression in HCT116. E. faecalis (EC1, EC3, EC15 and EC16), 
L.GG and S. typhimurium (Salm) were treated with HCT116 cells for 6h with a MOI 
of 100. Total protein was harvested and protein production of PIN1, E2F1, cyclin D1, 
IL-8RA and DUSP1 were analyzed using Western blotting as described in Materials 
and Methods. 
Recent study also showed that transcription factors like E2F1 are linked with 
central signaling pathways like MAPK (Tzippi, 2006). In addition, MAPK regulates 
cytokine production in response to a variety of stimuli. We therefore measured the 
phosphorylation of MAPK in IECs exposed to E. faecalis (EC1, EC3, EC15 and 
EC16), L.GG and S. typhimurium for 6h at a MOI of 100. In our study, DUSP1 
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protein was greatly stimulated upon the treatment of E. faecalis (EC1, EC15 and 
EC16). However, L.GG and S. typhimurium did not show any significant change on 
its expression (Figure 5.8).  DUSP1, which dephosphorylates and inactivates MAPKs, 
is required for the inhibition of proinflammatory signaling pathways in mouse model 
(Sonya et al., 2006). As shown in Figure 5.9, phosphorylated ERK were suppressed 
by E. faecalis EC1, EC3 and EC15. E. faecalis EC16 seems have no effect on 
phosphorylated ERK production compared with other E. faecalis tested. Interestingly, 
phosphorylated p38 and JNK were not highly expressed with or without the bacteria 
stimulation. E. faecalis suppressed phosphorylated p38 and JNK1 at 6h incubation. 
L.GG and S. typhimurium surprisingly suppressed the phosphorylated p38 and JNK1 
at 6h incubation too. The suppression of phosphorylated p38 and JNK by E. faecalis 
might due to upregulation of DUSP1, on the other hand, the suppression of 
phosphorylated p38 and JNK by L.GG and S. typhimurium might due to the negative 
feed back in the MAPK signaling pathway.  
 
Figure 5.9 Protein expression in HCT116. E. faecalis (EC1, EC3, EC15 and EC16), 
L.GG and S. typhimurium (Salm) were administrated to HCT116 cells for 6h with a 
MOI of 100. Total protein was harvested and protein production of p38, JNK and 
ERK were analyzed using Western blotting as described in Materials and Methods. 
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Other protein tested such as p65, p105/p50 did not change significantly (data 
not shown) in HCT116 cells and in Caco-2 cells (Figure 5.10). Almost the same 
results were observed in Caco-2 cells as in HCT116 cells on the protein expression, 





Figure 5.10 Protein expression in Caco-2. (A) p50 and p65 expression in Caco-2 cells 
with the treatment of E. faecalis (EC1, EC3, EC15 and EC16), L.GG and S. 
typhimurium (Salm) for 6h with a MOI of 100. (B) p50 and p65 expression in Caco-2 
cells with the treatment of 2ng/ml of IL-1β, 200ng/ml of TNF-α, the coculture of 
2ng/ml of IL-1β and 200ng/ml of TNF-α with E. faecalis EC1, EC16 respectively, 
and E. faecalis EC1, EC16 at a MOI of 100.  Total protein was harvested and protein 
production was analyzed using Western blotting as described in Materials and 
Methods. 
The data above show that E. faecalis did not change the expression of 
p105/p50 and p65 significantly even with the stimulation of IL-1β and TNF-α, 
implying the suppression of inflammatory responses in IECs by E. faecalis might 
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bypass NF-κB signaling pathway. However, L.GG and S. typhimurium seemed to 
upregulate p50 and p65 expression (Figure 5.10A). Furthermore, the results from 
EMSA experiment showed that E. faecalis did not activate NF-κB binding activities 
(data not shown), further suggested that E. faecalis regulates inflammatory responses 
might bypass NF-κB signaling pathways at first 6h tested.  
Taken the results from HCT116 and Caco-2 cells, we can see that MAPK 
signaling pathway might be the main regulatory pathway involve in the inflammatory 
suppression by E. faecalis in IECs. More interestingly, other proteins (e.g. E2F1 and 
PIN1) might also be involved indirectly in the immune modulation by E. faecalis.  
5.1.2.3 TNF-α, IL-1β and S. typhimurium Induced Cytokine Secretion 
and Protein Production 
The above data showed that E. faecalis suppressed inflammatory responses in 
IECs by inhibition of IL-8 production. To investigate the effects of E. faecalis on 
inflammatory responses stimulated by proinflammatory cytokines and pathogen, we 
cocultured IECs (HCT116 and Caco-2) with 2ng/ml of IL-1β, 200ng/ml of TNF-α and 
S. typhimurium with or without the presence of E. faecalis EC16 at a MOI of 100 for 
30mins, 1h, 2h, 4h and 6h as described in Materials and Methods. Supernatants were 
harvested for ELISA and cytokine assays. Proteins were harvested for Western 
blotting analysis. IL-8 concentrations inside cells were determined using ELISA 
method. 
5.1.2.3.1 Cytokine Production 
The results showed that IL-8 secretion by HCT116 cells increased from 
30mins to 6 hours with IL-1β and S. typhimurium stimulation (Figure 5.11A).  In 
contrast, IL-8 secretion into the supernatant remained suppressed with the 
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administration of EC16 to IL-1β and S. typhimurium stimulated culture and thereafter 
rapidly decreased from 4h to 6h. As shown in Figure 5.11A, E. faecalis EC2 and E. 
faecalis ATCC 29212 did not show any effects on IL-8 secretion in HCT116 cells 
suggesting that only few strains of E. faecalis possessed the ability to suppress 
inflammatory responses in the host.  
To further investigate how E. faecalis regulates IL-8 production, we examined 
the IL-8 protein expression inside the cells upon the stimulation with IL-1β and S. 
typhimurium with or without the presence of EC16. As shown in Figure 5.11B, IL-1β 
and S. typhimurium stimulated IL-8 production inside the cells from 30mins or even 
earlier. The attenuation of IL-8 inside HCT116 by EC16 was observed from 4h to 6h. 
Compared with the IL-8 production in IL-1β and S. typhimurium stimulated culture, 
EC16 suppressed the IL-8 activation from 30mins.  As expected, E. faecalis EC2 and 
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Figure 5.11 IL-8 expression in HCT116 with the stimulation of 2ng/ml of IL-1β, 
E.faecalis EC16, EC16 in the presence of 2ng/ml IL-1β, S. typhimurium, S. 
typhimurium coculture with EC16, E. faecalis EC2 and E. faecalis ATCC 29212 at a 
MOI of 100 for 30mins, 1h, 2h, 4h and 6h. Control was added with culture medium 
only. (A) Supernatants were harvested and IL-8 secretion was tested using ELISA 
method as described in Materials and Methods. (B) Proteins were harvested and IL-8 
expression was tested using ELISA with a 50 times dilution. Three independent 
experiments were compiled to produce the data shown.  
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Figure 5.12 IL-8 expression in HCT116 with the stimulation of 200ng/ml of TNF-α, 
E.faecalis EC16, and EC16 in the presence of 200ng/ml TNF-α for 30min, 1h, 2h, 4h 
and 6h. Control was added with culture medium only. (A) Supernatants were 
harvested and IL-8 secretion was tested using ELISA method as described in 
Materials and Methods. (B) Proteins were harvested and IL-8 expression was tested 
using ELISA with a 50 times dilution. Three independent experiments were compiled 
to produce the data shown.  
The same phenomena were also observed with the stimulation of TNF-α in 
HCT116 cells (Figure 5.12). IL-8 secretion was activated by TNF-α from 1h. 
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However, in the presence of EC16, the effects of TNF-α on inflammatory reaction 
was eliminated. Not surprisingly, EC16 also attenuated IL-8 stimulation by TNF-α 
inside HCT116 cells (Figure 5.12 B).  
In the studies described above, we focused on IL-8 regulation by E. faecalis in 
IECs. However, the IL-8 attenuation effects may be only one of many important 
events regulated by E. faecalis. Therefore, we examined other cytokines and 
inflammation related molecules production (ICAM-1, IL-18, IL-2, IL-5, IL-17, IFN-γ 
and TNF-α) modulated by E. faecalis in IECs using cytokine assays. IL-12(P70), IL-6, 
IL-4, IL-10 and TGF-β expression were tested using ELISA. 
Including numerous receptors, IECs also express adhesion molecules and 
proinflammatory mediators that allow IECs to communicate with the immune system. 
It is well established that activated endothelial cells in inflamed colonic tissue express 
intercellular adhesion molecule-1 (ICAM-1) (Vainer et al., 2000; 2002; 2006), 
however the function and expression pattern in IECs have not been fully illustrated. 
From Figure 5.13 A, we can see that ICAM-1, which is important in immune 
responses by mediating the arrest and further migration of neutrophils, was expressed 
in HCT116 cells. More interestingly, IL-1β upregulated ICAM-1 expression from 4h 
and S. typhimurium stimulate its expression from 6h. E. faecalis EC16 suppressed the 
ICAM-1 expression stimulated by IL-1β and S. typhimurium (Figure 5.13 A).  
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Figure 5.13 ICAM-1, TNF-α and IL-18 secretion in HCT116 with the stimulation of 
2ng/ml of IL-1β, E.faecalis EC16, EC16 in the presence of IL-1β, S. typhimurium, S. 
typhimurium coculture with EC16, E. faecalis EC2 and E. faecalis ATCC 29212 at a 
MOI of 100 for 30min,1h, 2h, 4h and 6h. Control was added with culture medium 
only. Supernatants were harvested for cytokine assay as described in Materials and 
Methods. (A) ICAM-1 secretion in HCT116. (B) TNF-α secretion in HCT116. (C) IL-
18 secretion in HCT116. Three independent experiments were compiled to produce 
the data shown.  
Chapter 5 Characterization of Signaling Pathways 
 
 160
Another important regulator of epithelial function during inflammation is 
TNF-α. Its levels are elevated in both human inflammatory bowel diseases and animal 
models of intestinal inflammation. Therefore, therapies that target TNF-α may 
provide promising new alternative for the treatment of intestinal inflammation (Jijon 
et al., 2002). TNF-α, the important proinflammatory cytokine, was expressed at a very 
low level in HCT116 cells (Figure 5.13B). However, with the stimulation of IL-1β, 
TNF-α was enhanced to a higher level compared with control suggesting a positive 
feed back loop on the inflammatory responses in HCT116 cells upon proinflammatory 
cytokine stimulation. E. faecalis EC16, again, suppressed TNF-α secretion stimulated 
by IL-1β.  S. typhimurium, however, had no significant effect on TNF-α secretion. 
As we can see from Figure 5.13C, E. faecalis activated IL-18 secretion in 
HCT116 from 1 hour. IL-18 is a member of the IL-1 family. IL-1β and IL-18 are 
related closely, and both require the intracellular cysteine protease caspase-1 for 
biological activity. IL-18 is a proinflammatory cytokine. It plays an important role in 
immune and inflammatory reactions, and is notably present in several autoimmune 
disorders. It seems to exert its functions not by itself but rather in concert with other 
factor, promoting many of the biologic activities associated with these other cytokines. 
Different with most of the other cytokines, IL-18 is abundant in non-immune tissues 
including the gut and the skin and it likely provides an important role in the defense 
against mucosal and commensal organisms.  Studies showed that activation of 
caspase-1 could release IL-18 from the cells (Li et al., 2007). However, the 
mechanism for processing and secretion of IL-18 remains somewhat of a mystery. 
The activation of caspase-1 occurs independently of gene expression.  IL-18 may also 
be processed by stimuli other than caspase-1. Interestingly, administration of IL-18 to 
mice infected with a lethal dose of virulent strain of S. typhimurium reduced the 
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bacteria number in the tissues, rescuing them from death. On the other hand, 
macrophage infected with S. typhimurium exhibited reduced expression of IL-18, 
suggesting the ability of this pathogen to suppress production of IL-18 (Elhofy and 
Bost, 1999; John et al., 2002). A more recent study showed that IL-18 has an effective 
antitumor effect by developing a long-lasting protective immunity including both 
innate and adaptive immunity in the host (Xu et al., 2007). In our study, 
proinflammatory cytokine IL-1β and S. typhimurium could not activate IL-18 
secretion in HCT116. However, E. faecalis, which suppressed several inflammatory 
cytokines production, activated IL-18 secretion in HCT116 even in the presence of S. 
typhimurium. Furthermore, IFN-γ, which was reported to increase in the presence of 
IL-18 in several cell lines (Bombardieri et al., 2007), was not detected in our system. 
Therefore, E. faecalis activated IL-18 expression in HCT116 may help in the 
suppression of inflammatory responses other than activation.  
Other cytokines like, IL-4, IL-10, TGF-β, IL-12 (P70), IL-6, IL-2, IL-5, IL-17 
and IFN-γ were not detected in HCT116 cells. 
To confirm the regulatory effect of E. faecalis on IECs, Caco-2 was treated 
with 2ng/ml of IL-1β, E. faecalis EC16, EC16 in the presence of IL-1β, S. 
typhimurium, S. typhimurium co-culture with EC16, E. faecalis EC2 and E. faecalis 
ATCC 29212 at a MOI of 100 for 30min, 1h, 2h, 4h and 6h. IL-8 secretion in the 
supernatants and its expression inside the cells were tested using ELISA as described 
in Materials and Methods. Other cytokines and adhesion molecules expression 
(ICAM-1, IL-18, IL-2, IL-5, IL-17, IFN-γ and TNF-α) were detected using cytokine 
assay at 30mins, 2h and 6h of the treatments.  
Consistent with what we found in HCT116 cells, IL-1β and S. typhimurium 
triggered IL-8 secretion and also its expression inside the Caco-2 cells from 1h or 
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even earlier (Figure 5.14). When E. faecalis EC16 was added into the media, IL-8 
activation by IL-1β and S. typhimurium was eliminated. In addition, E. faecalis EC16 
suppressed IL-8 secretion in Caco-2 from 4h. However, they did not downregulate IL-
8 expression inside the cells. As expected, E. faecalis EC2 and E. faecalis ATCC 
29212 had no effect on IL-8 production in Caco-2 (Figure 5.14). 
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B 















Control IL-1b EC16 EC16+IL-1b
Salm Salm+EC16 EC2 29212  
Figure 5.14 IL-8 expression in Caco-2 with the stimulation of 2ng/ml of IL-1β, 
E.faecalis EC16, EC16 in the presence of IL-1β, S. typhimurium, S. typhimurium 
coculture with EC16, E. faecalis EC2 and E. faecalis ATCC 29212 at a MOI of 100 
for 30mins, 1h, 2h, 4h and 6h. Control was added with culture medium only. (A) 
Supernatants were harvested and IL-8 secretion was tested using ELISA method as 
described in Materials and Methods. (B) Proteins were harvested and IL-8 expression 
was tested using ELISA with a 50 times dilution. Three independent experiments 
were compiled to produce the data shown. 
We further tested other cytokines production in Caco-2 cells. As shown in 
Figure 5.15, ICAM-1 was stimulated by IL-1β at 6h however was suppressed by 
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adding E. faecalis EC16. S. typhimurium, surprisingly did not activate ICAM1 at 6h 
in Caco-2 cells (Figure 5.15A). TNF-α was stimulated by IL-1β and S. typhimurium at 
6h. Its secretion activated by S. typhimurium was attenuated by E. faecalis EC16.  
However E. faecalis EC16 did not inhibit TNF-α secretion with the stimulation of IL-
1β suggesting the different mechanisms regulated by proinflammatory cytokines and 
pathogenic bacteria. As expected, E. faecalis EC2 and E. faecalis ATCC 29212 did 
not regulate ICAM-1 and TNF-α expression in Caco-2 cells (Figure 5.15 B).  
Cytokine action is contextual (Sporn and Roberts, 1998). As it was reported, 
IL-1β can activate IL-2, IL-6 and chemokines in various types of cells. IL-2 and IFN-
γ can augment IL-1, TNF and IL-6 production. IL-2 can stimulate IFN-γ (Torres et al., 
1982). In our study using Caco-2 cells, IL-2 was greatly augmented with the presence 
of IL-1β and S. typhimurium at 6 hours. E. faecalis EC16 suppressed IL-2 activation 
in Caco-2 cells (Figure 5.15 C). Confusingly, E. faecalis did not reduce IL-2 level 
stimulated by IL-1β. E. faecalis EC2 and E. faecalis ATCC 29212 activated IL-2 
secretion at 6h. The same phenomena were observed in the regulation of IL-5, IL-17 
and IFN-γ secretion in Caco-2 with the treatment of E. faecalis, IL-1β and S. 
typhimurium.  
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Control IL-1b EC16 EC16+IL-1b Salm Salm+EC16 EC2 29212
 
Figure 5.15 ICAM-1(A), TNF-α (B) and IL-2 (C), IL-5 (D), IL-17 (E) and IFN-γ (F) 
secretion in Caco-2 cells with the stimulation of 2ng/ml of IL-1β, E. faecalis EC16, 
EC16 in the presence of 2ng/ml IL-1β, S. typhimurium, S. typhimurium coculture with 
EC16, E. faecalis EC2 and E. faecalis ATCC 29212 at a MOI of 100 for 30min, 2h 
and 6h. Control was added with culture medium only. Supernatants were harvested 
for cytokine assay as described in Materials and Methods. All experiments were done 
once. 
IL-5 is a Th2 cytokine which promote humoral immune responses, especially 
IgE production leading to allergy. IL-17 is characterized as cytokine-inducing 
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cytokine that exhibits pleiotropic biologic activities on various cell types. It can 
activate IL-8 in IECs. In addition to inducing cytokines and chemokines, IL-17 
enhances surface expression of ICAM-1 in human fibroblasts. Also, in human 
keratinocytes, IL-17 specifically and dose-dependently expression augmented IFN-γ 
induced ICAM-1 expression and the induction of IL-8 (Teunissen et al., 1998; 
Albanesi et al., 1999). IL-17, in addition to inducing NF-κB and AP-1 DNA binding 
activities, also regulates the activities of MAP kinases in IECs and therefore could be 
involved in enteric disorders (Andoh et al., 2001). In our study, IL-5, IFN-γ and IL-17 
were induced by IL-1β and S. typhimurium but suppressed by E. faecalis with the 
stimulation of S. typhimurium (Figure 5.15 D, E, F).  
From the above results, we can see that together with reduced production of 
inflammatory cytokine IL-8, E. faecalis EC16 inhibited several other 
proinflammatory cytokines production in IECs. This inhibition may contribute to 
human innate and adaptive immune homeostasis in response to infection and 
overexpression of proinflammatory cytokines in the intestine.  
IL-4, IL-10, IL-6, IL-12 (P70), IL-18 and TGF-β could not be detected in 
Caco-2 with the treatments stated above. 
5.1.2.3.2 Immunoblotting study 
So far, we tested cytokine production in the IECs and also the gene expression 
of some interesting genes. We further examine the protein expression in IECs. In this 
part, Caco-2 and HCT116 were treated with 2ng/ml of IL-1β, E. faecalis EC16, EC16 
in the presence of 2ng/ml IL-1β, S. typhimurium, S. typhimurium co-culture with 
EC16, E. faecalis EC2 and E. faecalis ATCC 29212 at a MOI of 100 for 30min, 1h, 
2h, 4h and 6h respectively. Proteins were harvested as described in Materials and 
Methods and their expression were determined using Western blotting.  
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From the microarray and TLDA data, we can see that MAPKs signaling 
pathways were regulated by E. faecalis. In addition, a consequence of IL-1β or 
pathogen stimulation in IECs is the activation of mitogen activated protein kinases 
(MAKPs). At least three groups of MAPKs have been identified including the 
extracellular signal-regulated kinases (ERKs), the c-JUN NH2-terminal kinases (JNKs) 
and p38. Of these, ERKs are responsible for growth and differentiation. JNKs and p-
38 family members are generally implicated in responses to cellular stress, 
inflammation and apoptosis (Jijon et al., 2002; Cobb, 1999). C-JUN is a major 
component of the AP-1 transcription factor which regulates various aspects of cell 
proliferation and differentiation. In our study, activation of these kinases was assayed 
by using antibodies specific for the phosphorylated, active forms of these kinases by 
Western blotting. As shown in Figure 5.16 A and D, phosphorylated JNK was greatly 
activated by IL-1β and S. typhimurium at 30mins. Interestingly, E. faecalis suppressed 
the activated phosphorylated JNK in Caco-2 and HCT116 cells (Figure 5.16 A and D). 
phosphorylated JNK level activated by IL-1β and S. typhimurium then went down 
from 1 hour (Figure 5.16 B and E). p38, which was reported to stabilize IL-8 mRNA 
(Hoffman et al., 2002), was greatly upregulated by IL-1β and S. typhimurium at 1h, 
2h and 4h incubation (Figure 5.16 D, E and F). Interestingly, E. faecalis EC 16 itself 
not only inactivate p38 expression but also suppress the activation stimulated by IL-
1β and S. typhimurium (Figure 5.16 D, E and F) at first several hours incubation. 
However co-culture of E. faecalis EC16 in the presence of IL-1β or S. 
typhimurium activated phosphorylated JNK (Figure 5.16 B, E, G, and H) even though 
there was no activation of IL-8 production from 1h (Figure 5.14). Unexpectedly, E. 
faecalis EC16 itself activated phosphorylated JNK expression from 2h and peaked at 
4h incubation in Caco-2 cells (Figure 5.16 F, G and H) with the suppression of IL-8 
Chapter 5 Characterization of Signaling Pathways 
 
 168
secretion (Figure 5.14A).  The same was observed with phosphorylated p38 
expression from 4h (Figure 5.16 G and H). These data conflicted with what we 
observed in HCT116 at 6h incubation with E. faecalis (Figure 5.9) suggesting that the 
immune regulation by E. faecalis may be cell line dependent.  The different regulation 
pattern in JNK and p38 by E. faecalis in Caco-2 and HCT116 might explain the 
different modulation ability of E. faecalis in the inflammatory cytokines production 
(Figure 5.12; Figure 5.13; Figure 5.14; Figure 5.15).  
From Figure 5.16 (B, C, E and F), we can see that c-JUN activated by IL-1β 
and S. typhimurium but suppressed by the co-culture of E. faecalis EC16 at 1h and 2h 
in both Caco-2 and HCT116 cells.  Interestingly, E. faecalis EC2 and 29212 also 
activated c-JUN in Caco-2 cells (Figure 5.16E and F), which might explain the 
upregulation of IL-2 in Caco-2 with the treatment of E. faecalis EC2 and 29212 
(Figure 5.15 C).  C-JUN expression could not be detected in either HCT116 or Caco-2 
cells with the treatments after 2h. Recent studies also showed that AP-1 especially c-
JUN are important in regulation of IL-8 expression (Matsumoto, 2007; Choi, 2007). 
Moreover, we found that ERKs in IECs did not change upon the treatment of IL-1β, S. 
typhimurium and E. faecalis from 30min to 6h (Figure 5.16 H), suggesting that ERKs 
are not involved in the regulation of inflammatory responses in IECs upon E. faecalis 
treatment.  Taking all the data together, we can see that E. faecalis suppresses 
inflammatory responses through suppression of JNK and p38 signaling pathway and 
further suppress AP-1. JNK and p38 might have negative feedback mechanisms since 
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Figure 5.16 Protein expression in HCT116 and Caco-2 cells with the stimulation of 
2ng/ml of IL-1β, E. faecalis EC16, EC16 in the presence of 2ng/ml IL-1β, S. 
typhimurium, IL-1β  and S. typhimurium coculture with EC16, E. faecalis EC2 and E. 
faecalis ATCC 29212 at a MOI of 100 for 30min, 1h, 2h, 4h and 6h. Control was 
added with culture medium only. Protein expression was detected using Western 
blotting method as described in Materials and Methods. Only the interested proteins 
expressions were listed above. (A) JNK expression in HCT116 cells at 30min with the 
treatments. (B) JNK and c-JUN expression in HCT116 cells at 1h with the treatments. 
(C) c-JUN expression in HCT116 cells at 2h with the treatments. (D) p38 and JNK 
expression in Caco-2 cell at 30min with the treatments. (E) p38, JNK and c-JUN 
expression in Caco-2 cell at 1h with the treatments. (F) p38, JNK and c-JUN 
expression in Caco-2 cell at 2h with the treatments. (G) p38, JNK and IL-8RA 
expression in Caco-2 cell at 4h with the treatments. (H) p38, JNK, ERK and IL-8RA 
expression in Caco-2 cell at 6h with the treatments. 
IL-8RA expression was also detected using Western blotting. From Figure 
5.16 G and H, we can see that IL-8RA expression was enhanced with the treatment of 
IL-1β and S. typhimurium at 6h, and suppressed with the administration of E. faecalis 
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EC16. However, there is no change in IL-8RA expression detected before 4h (data not 
shown). These data implied the importance of the IL-8RA in the inflammatory 
responses and its regulation might be at late phase compared with MAPK signaling 
pathway. 
From Figure 5.13, we found that IL-18 was activated by E. faecalis in 
HCT116 cells. Caspase-1, which could release IL-18 from cells, is an important 
enzyme in inflammatory responses. We therefore tested its active form (p20) 
expression in HCT116 cells using Western blotting.  
 
Figure 5.17 Caspase-1(p20) expression in HCT116 cells with the stimulation of 
2ng/ml of IL-1β, E.faecalis EC16, S. typhimurium, EC16 in the presence of S. 
typhimurium and 2ng/ml IL-1β, E. faecalis EC2 and E. faecalis ATCC 29212 at a 
MOI of 100 for 30min, 1h, 2h, 4h and 6h. Control was added with culture medium 
only. Caspase-1 expression was detected using Western blotting method as described 
in Materials and Methods. 
Figure 5.17 showed that E. faecalis suppressed the active form of caspase-1 
from 1h. Interestingly, IL-1β and S. typhimurium activated p20 at 6h incubation. 
However, E. faecalis suppressed its enhanced expression activated by IL-1β and S. 
typhimurium. Together with the data that E. faecalis activated IL-18 expression, we 
Caspase-1 (P20) 
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can see that the activation of IL-18 might be independent of caspase-1 in HCT116 in 
response to E. faecalis.  
5.1.2.4 Protein Inhibitors Study 
The above results showed that E. faecalis suppressed inflammatory responses 
in IECs by suppression of JNK and p38 signaling pathways. To mimic the 
suppression function of E. faecalis in IECs on these pathways, we therefore used p38 
inhibitor (SB203580 iodo), JNK inhibitor (SP600125) and DUSP1 inhibitor 
(Triptolide) to treat the cells. SB203580 is a specific p38 inhibitor that inhibits the 
catalytic activity of p38 MAPK by competitive binding in the ATP pocket. This 
compound has been shown to inhibit p38 in vivo in a variety of animal models of 
inflammatory diseases (Kumar et al., 2003). SP600125, which is a reversible ATP-
competitive inhibitor, preferentially inhibits JNK in vitro (Ki 0.19µM) and at 
concentrations above 5 µM in vivo. However, at higher concentrations (50 µM), it also 
inhibited p38 MAPK (Bennett et al., 2001). In our study, a final concentration of 
7.5µM of p38 inhibitor (SB), JNK inhibitor (SP) was employed to the cells. For 
Triptolide (TRI), we used a final concentration of 1µM. Caco-2 cells were tested on 
SB, SP and TRI incubations. Supernatants were harvested for ELISA test and total 
proteins were harvested for Western blotting analysis and also IL-8 expression inside 
the cells. 
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Figure 5.18 Protein expression in Caco-2 cells with the treatment of p38, JNK and 
DUSP1 inhibitors. A final concentration of 7.5µM of p38 inhibitor (SB), JNK 
inhibitor (SP) and 1µM of DUSP1 inhibitor, Triptolide (TRI) was employed to Caco-
2 cell and incubated for 30min, 1h, 2h, 4h and 6h. (A) Western blotting results on 6h 
incubation. (B) IL-8 secretion in Caco-2 cells. (C) IL-8 secretion inside Caco-2 cells. 
Experiments were done three times independently. Error bars indicated as the 
standard deviation (B, C). 
From Figure 5.18A, we can see that these three inhibitors had their effects at 
6h incubation. With the inhibition of phosphorylated p38, E2F1, c-JUN and 
phosphorylated JNK expression were increased. However, p50, and phosphorylated 
ERK did not change significantly. Almost the same results were observed with the 
inhibition of phosphorylated JNK, E2F1, and phosphorylated p38 expressions were 
enhanced, suggesting the interplay between phosphorylated JNK and p38 
suppression/activation in Caco-2 cells. In addition, with the inhibition of DUSP1, 
phosphorylated p38 production was upregulated (Figure 5.18A), which is consistent 
with previous suggestion that DUSP1 is the phosphatase of p38.  
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Surprisingly, with the inhibition of p38 or JNK, consistent IL-8 secretion in 
Caco-2 was not suppressed as expected (Figure 5.18B). The IL-8 production inside 
the cells tested using ELISA showed that IL-8 producing level was inhibited although 
not that much (Figure 5.18C). Unexpectedly, with the inhibition of DUSP1, IL-8 
secretion was not upregulated (Figure 5.18B and C). The phenomenon observed 
above may be due to the interplay of JNK and p38 signaling pathways. When one of 
them was inhibited, the other was activated. In addition, other proteins like E2F1 and 
c-JUN may also be activated to “balance” the system. NF-κB and ERK seemed not to 
be involved in the regulation since they were not changed upon JNK and p38 
inhibitors. However, JNK, p38, c-JUN, and E2F1 were suppressed in IECs with the 
treatment of E. faecalis (Figure 5.8; Figure 5.16). We therefore deduce that E. faecalis 
could put the brake at multiple levels of the inflammatory responses and inhibit the 
phosphorylation of JNK and p38 and even some other inflammation related proteins 
at the same time.  
To confirm our hypothesis, we used the combination of p38 and JNK 
inhibitors to treat the cells. A final concentration of 7.5µM of phosphorylated p38 
inhibitor (SB) and phosphorylated JNK inhibitor (SP) was employed. HCT116 cells 
were cultured with the respective inhibitors or a combination of SB and SP for 30mins, 
1h, 2h, and 6h with or without the presence of 2ng/ml IL-1β. 
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Figure 5.19 IL-8 production in HCT116 after incubating with p38 inhibitor (SB), 
JNK inhibitor (SP), p38 inhibitor combined with JNK inhibitor (SB+SP), 2ng/ml IL-
1β, IL-1β with SB, IL-1β with SP, IL-1β with SB+SP for 30mins, 1h, 2h and 6h. (A) 
IL-8 secretion in the supernatants. (B) IL-8 expression inside the cells. Three 
independent experiments were done. Error bars indicated as the standard deviation. 
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  From Figure 5.19 A, we can see that SB (p38 inhibitor) and SP (JNK inhibitor) 
inhibited IL-1β activated IL-8 secretion from 2h. The combination of these two 
inhibitors had a stronger effect in the suppression. Compared with the SB, SP did not 
exhibit the same ability to suppress IL-8 secretion in HCT116 cells. Interestingly, IL-
8 expression inside the cells was inhibited by the inhibitors from 1h. Moreover, the 
IL-8 expression level peaked at 2h inside the cells (Figure 5.19 B). Taken the above 
data together, we can see that the combination of the two inhibitors had a much 
stronger suppression effects on IL-8 production.  
Immunoblotting assay was then performed to check for the expression of JNK, 
p-38 and c-JUN protein (Figure 5.20). Total protein from 30min incubation subjected 
to Western blotting revealed a suppression of phosphorylated JNK expression 
activated by IL-1β with JNK inhibitor. However, phosphorylated JNK appeared to be 
activated with the application of p38 inhibitor (Figure 5.20 A) which is consistent 
with what we had observed using p38 inhibitors in Caco-2 cells (Figure 5.18). With 
the combination of these two inhibitors, phosphorylated JNK was also activated 
which further suggested the interplay between p38 and JNK.  
c-JUN is a main target protein of JNK. It can be greatly upregulated with the 
treatment of IL-1β in HCT116 cells. However, c-JUN expression was suppressed with 
the administration of JNK inhibitor but not p38 inhibitor (Figure 5.20 A).  






















Figure 5.20 Protein expression in HCT116 after incubating with p38 inhibitor (SB), 
JNK inhibitor (SP), p38 inhibitor combine with JNK inhibitor (SB+SP), 2ng/ml IL-1β, 
IL-1β with SB, IL-1β with SP, IL-1β with SB+SP for 30min, 1h, 2h and 6h. (A) JNK 
and c-JUN expression in HCT116 cells at 30min treatment. (B) JNK, p38 and c-JUN 
expression in HCT116 cells at 1h treatment. (C) JNK, p38 and c-JUN expression in 
HCT116 cells at 2h treatment. (D) JNK, p38 and c-JUN expression in HCT116 cells 
at 6h treatment. 
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Almost the same results were observed in 30min, 1h and 2h treatment in 
HCT116 cells with the inhibitors (Figure 5.20 A, B, C). The combination of the two 
inhibitors suppressed the phosphorylated c-JUN and also total c-JUN expression 
activated by IL-1β (Figure 5.20 B, C). At 6h incubation with treatments described 
above, phosphorylated p38 and phosphorylated JNK was inhibited with their 
inhibitors respectively. As expected, when phosphorylated p38 was inhibited, 
phosphorylated JNK expression was greatly upregulated and vice versa (Figure 5.20 
D). In addition, with the application of p38 inhibitor, phosphorylated and total c-JUN 
was increased which might be due to the upregulation of phosphorylated JNK treated 
with the p38 inhibitor (Figure 5.20 D). With the combination of p38 and JNK 
inhibitors at 6h, phosphorylated JNK was inhibited. Furthermore, c-JUN was also 
suppressed compared with the treatment with phosphorylated p38 inhibitor only 
(Figure 5.20 D).  
Taking together all these results, the regulation of p38 and JNK appears to be 
linked. The suppression of them might reduce the stimulated IL-8 production but not 
consistent IL-8 production in IECs. With a combination of these two inhibitors, a 
stronger IL-8 suppression was observed. However, even with the combination of 
these two inhibitors, the suppression effects were not as strong as observed with E. 
faecalis. This suggests a complicated signaling pathway in the regulation of IL-8 
production by E. faecalis and also the complex mechanism of communication of 









Using human Immunology Signaling Pathway cDNA Microarray assay, we 
detected the regulation of immune genes modulated by E. faecalis. It showed that 
several common signaling pathways may be involved in the anti-inflammatory effects 
of E. faecalis. MAPK and NF-κB are two main families that are involved in the 
regulation by E. faecalis. MAPK7, MAP4K1 and MAP3K7IP1 (Mitogen-activated 
protein kinase kinase kinase 7 interacting protein 1) were suppressed by E. faecalis 
(Table 5.2). In addition, NFKB1, NFKBIL2 (Nuclear factor of kappa light 
polypeptide gene enhancer in B-cells inhibitor-like 2), NFKB2 and IKBKB (Inhibitor 
of nuclear factor kappa B kinase beta subunit) were greatly suppressed by E. faecalis 
(Table 5.2). MAPK and NF-κB family are important in innate and adaptive immune 
responses in the host. The activation of these two signaling pathways would cause 
inflammatory responses in the host. Suppression of the gene expression of these two 
families by E. faecalis may further inhibit inflammatory responses. Furthermore, 
microarray data also showed that cytokine receptors are important in the regulation. E. 
faecalis suppressed cytokine receptors expression in IECs (Table 5.1; Table 5.2; 
Figure 5.3). Moreover, quite a number of transcription factors were also regulated by 
E. faecalis (Table 5.2) which might indicate that they regulate immune responses in 
the host mainly through regulating gene transcription and translation.  
To verify the signaling pathways regulated by E. faecalis in the host, we 
further confirmed the gene expression using Taqman low density array (TLDA) and 
their protein expression using Western blotting method. 48-well TLDA cards were 
designed according to the data we obtained from microarray assay. The results from 
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TLDA demonstrated that a similar regulation pattern of different E. faecalis in two 
different cell lines (Caco-2 and HCT116) (Figure 5.4; Figure 5.5; Figure 5.6). 
Consistent with what we found in microarray assay, MAPK and NF-κB families are 
still the main genes regulated by E. faecalis (Figure 5.4).  DUSP1 (Dual specificity 
phosphatase 1), the important phosphatase of MAPK family, was greatly upregulated 
by E. faecalis however other MAPK members such as MAP3K7IP1 and MKNK1 
(MAP kinase-interacting serine/threonine kinase 1) were suppressed (Figure 5.4).  
NF-κB1 and IKBKB were also inhibited in IECs with the treatment of E. faecalis. 
The regulation of MAPK signaling pathway was confirmed using Western blotting by 
detection of p38, JNK and ERK expression. It showed that E. faecalis suppressed 
JNK and p38 expression but not ERK (Figure 5.9) in HCT116 cells. These results 
implicated the importance of suppression of MAPK in the inhibitory effects of 
inflammation by E. faecalis and also the different functions of the individual MAPK 
members. Interestingly, other genes that are involved in cell proliferation such as 
CCND1 (cyclin D1), PIN1 (Protein (peptidylprolyl cis/trans isomerase) NIMA-
interacting 1), E2F1 and MDM2 (transformed 3T3 cell double minute 2) were also 
inhibited by E. faecalis (Figure 5.8) in the host suggesting an overwhelming function 
of E. faecalis in the regulation of host responses.  
CyclinD1 (CCND1) belongs to the highly conserved cyclin family, which 
function as regulators of CDK kinases. Cyclin D1 forms a complex with and functions 
as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle 
G1/S transition. Moreover, mutations, amplification and overexpression of this gene 
are observed frequently in a variety of tumors and may contribute to tumorigenesis. 
Hence, suppression of cyclin D1 in cancer cell lines might suppress the tumor 
proliferation or even tumorigensis. 
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Cyclin D1 can be regulated by MAPK family members which are critical to 
the immune responses. MAPK are negatively regulated via their dephospohrylation 
by DUSP1. The bacterially expressed and purified DUSP1 protein has intrinsic 
phosphatase activity, and specifically inactivates mitogen-activated protein (MAP) 
kinase in vitro by the concomitant dephosphorylation of both its phosphothreonine 
and phosphotyrosine residues.  Furthermore, it suppresses the activities of MAP 
kinase to regulate both pro- and anti- inflammatory cytokines (Chi et al., 2006).  Thus, 
the upregulation of DUSP1 (Figure 5.4A) may play an important role in the human 
cellular response to environmental stress as well as in the regulation of human 
immunity through regulation of MAPK signaling pathways. 
MAP3K7IP was identified as a regulator of the MAP kinase kinase kinase 
MAP3K7/TAK1, which is known to mediate various intracellular signaling pathways, 
such as those activated by TGF-β, IL-1 and WNT-1. This protein interacts and thus 
activates MAP3K7. Also, it can interact with and activate MAPK14/p38alpha 
(Mitogen-activated protein kinase 14), and thus represents an alternative activation 
pathway. Attenuation of MAP3K7IP may suppress the activation of the MAPKK 
pathways, which contributes to the biological responses of MAPK14 to various 
stimuli. Interestingly, MKNK1 (MAP kinase-interacting serine/threonine kinase 1), a 
down stream of MAPK protein which phosphorylates human eukaryotic translation 
initiation factor 4G (eIF4G) thus to regulate protein translation in human, was 
suppressed in HCT116.  Studies using MKNK1 inhibitors showed that TNF-α 
production is inhibited in a concentration-dependent manner by CGP57380 (MKNK1 
inhibitor). The inhibition targets posttranscriptional regulation and is paralleled by 
inhibition of the phosphorylation of eukaryotic initiation factor 4E (eIF4E) 
(Andersson et al., 2006). Moreover, MKNK1 inhibitor blocked soluble IL-1β and IL-
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8 production in THP1 cells, suggesting that the regulation of cytokine expression in 
part through activation of MAPK cascades, activation of MNK1, and phosphorylation 
of eIF4E (Cherla et al., 2006). Taken together, E. faecalis suppressed the 
inflammatory responses through attenuating MAPK signaling pathways. 
Besides MAPK signaling pathway, NF-κB is another important signaling 
pathway in the regulation of immune responses in the host. NF-κB is a transcription 
factor which plays an evolutionarily conserved and critical role in the triggering and 
coordination of both innate and adaptive immune responses.  NF-κB1 (p-50/p-105) or 
NF-κB2 (p49/p100) is bound to REL, RELA (p-65), or RELB to form the NF-κB 
complex. The NF-κB complex is inhibited by IκB proteins, which inactivate NF-κB 
by trapping it in the cytoplasm. Phosphorylation of serine residues on IκB proteins by 
IKBKA or IKBKB marks them for destruction via the ubiquitination pathway, thereby 
allowing activation of the NF-κB complex. Activated NF-κB complex translocates 
into the nucleus and binds DNA at NF-κB-binding motifs thus activating 
inflammatory gene transcription. In our study, NF-κB1, and IKBKB were suppressed 
with the application of E. faecalis to HCT116 cells (Figure 5.4A), suggesting that E. 
faecalis might inhibit NF-κB signaling pathway through inhibition of IκB kinase and 
also the attenuation NF-κB family members’ genes expression.  
More interestingly, NF-κB can be activated through cytokine receptors such as 
TNF-receptor superfamily (Papa et al., 2006). TNFRSF11A, which belongs to tumor 
necrosis factor receptor superfamily, interacts with various TNF receptor associated 
factor (TRAF) family proteins, through which this receptor induces the activation of 
NF-κB and MAPK8/JNK and thus the inflammatory responses in the host (Papa et al., 
2006). TRAF6, which is a member of the TRAF protein family, is associated with, 
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and mediates signal transduction from members of the TNF receptor superfamily. 
This protein mediates the signaling not only from the members of the TNF receptor 
superfamily, but also from the members of the Toll/IL-1 family. Signals from 
receptors such as TNFRSF11 and IL-1 have been shown to be mediated by this 
protein. TRAF6 also interacts with various protein kinases including IRAK1/IRAK 
and SRC, which provides a link between distinct signaling pathways. In the NF-κB 
signaling pathway, it functions as a signal transducer that activates IκB kinase (IKK) 
in response to proinflammatory cytokines. In the study using E. faecalis co-culture 
with HCT116, the TNFRSF11A, TRAF6 as well as NF-κB family members were 
suppressed (Figure 5.4A) suggesting a strong inhibition mechanism by E. faecalis on 
inflammatory responses in HCT116 cells. 
From the above results and discussion, we can see that some strains of E. 
faecalis have the distinct properties to suppress IL-8 secretion in IECs in a dose- and 
strain- dependent manner. The inhibitory effects of E. faecalis could be conducted 
through the carbohydrates on the cell surface. Furthermore, E. faecalis may act 
through MAPK and NF-κB signaling pathways to suppress the inflammatory 
responses in the host.  However, E. faecalis induced IL-8 production in THP1 cells 
(Figure 3.4). We thus tested the genes regulation in THP1 cells upon E. faecalis 
treatment. Opposite to what we observed in IECs, E. faecalis upregulated IL-8 and 
TNF gene expression to a very high level (Figure 5.7) suggesting a multiple 
regulation mechanisms of IL-8 production by E. faecalis in different cell lines. 
Furthermore, MAPK (MAP3K8), NF-κB (NFKB1 and NFKB2) and cytokine 
receptors (TNFRSF11A and IL-8RA) family members were greatly upregulated 
(Figure 5.7B). Interestingly, most of the Toll-like receptors (TLRs) were suppressed 
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irrespective of the activation of IL-8 secretion by E. faecalis. The results suggested 
that MAPK and NF-κB are the most possible signaling pathways regulated by E. 
faecalis to the immune responses in the host. TLRs and cytokine receptors might also 
be important in the suppression of inflammatory responses upon E. faecalis exposure. 
Some other proteins like cyclin D1, PIN1 and E2F1 may be involved in the regulation 
indirectly. However, to fully illustrate the signaling pathways, co-culture of E. 
faecalis with other well known inflammation activators is important. We further 
confirm these ideas through co-culture of E. faecalis with pathogenic S. typhimurium 
and the proinflammatory cytokines TNF-α and IL-1β. Their protein productions were 
tested by Western blotting and their cytokine productions were measured using 
ELISA and cytokine assays.  
Results showed that these four E. faecalis strains inhibited the synthesis and 
secretion of IL-8 protein triggered by TNF-α, IL-1β and pathogenic S. typhimurium. 
TNF-α, IL-1β and pathogenic S. typhimurium greatly stimulated IL-8 secretion in 
IECs from 1h (Figure 5.11; Figure 5.12; Figure 5.14). In addition, they activated 
accumulation of IL-8 inside the cells even earlier. E. faecalis inhibited TNF-α, IL-1β 
and pathogenic S. typhimurium induced IL-8 protein production both inside and 
outside of the cells (Figure 5.11; Figure 5.12; Figure 5.14). Considering the crucial 
role of IL-8 in inflammatory processes and implication of the IBD, the findings that E. 
faecalis attenuated IL-8 production at baseline and also in the response to 
proinflammatory cytokines and pathogenic bacteria in IECs are particularly 
interesting. E. faecalis could be a potential therapeutic agent to treat inflammation 
diseases such as IBD in the human intestine and also in the suppression of 
inflammatory responses activated by pathogen and other components in infants’ 
intestine. 
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Beside IL-8, other cytokines or factors such as IL-4, IL-10, TNF-α, IL-2, IL-5, 
IL-6, IL-12 (P70), IL-17, IL-18, ICAM-1 and IFN-γ are also important in the 
regulation of immune responses in human. Among these cytokines, IL-4 and IL-10 
have been implicated in the inhibition of IL-8 formation (Kasama et al., 1994; Meda 
et al., 1994; Wertheim et al., 1993). However, these cytokines were not detected in 
the supernatants of IECs in the study. Therefore, the inhibitory role for these agonists 
could be excluded from the current experimental system. IL-2 and IFN-γ can augment 
IL-1, TNF, IL-6 production. Moreover, IL-2 can stimulate IFN-γ (Torres et al., 1982) 
and IL-8 secretion (Wei et al., 1994). IL-12 induces IFN-γ production in T and NK 
cells and appears to be a major regulator of IFN-γ production in the intact organism 
(Trinchieri, 1995). IL-17 is characterized as cytokine-inducing cytokine that exhibits 
pleiotropic biologic activities on various cell types. It can activate IL-8 in IECs. In 
addition to inducing cytokines and chemokines, IL-17 presents itself with certain 
other unique functions. It enhances surface expression of ICAM-1 in human 
fibroblasts. Also, in human keratinocytes, IL-17 specifically and dose-dependently 
augmented IFN-γ induced ICAM-1 expression and the induction of IL-8 (Teunissen et 
al., 1998; Albanesi et al., 1999). However, IL-12 and IL-6 was not detected in IECs in 
this study. Other proinflammatory cytokines like TNF-α, IL-2, IL-5, IL-17 and IFN-γ 
were suppressed by E. faecalis in Caco-2 cells even with the stimulation of 
pathogenic S. typhimurium (Figure 5.15 B, C, D, E and F). TNF-α was also 
suppressed by E. faecalis in HCT116 cells (Figure 5.13B). Therefore, E. faecalis 
exhibits its distinct anti-inflammatory ability to suppresse multiple inflammatory 
cytokines and further to inhibit inflammatory responses. 
ICAM-1, which is found in inflamed colonic tissues, mediates the arrest and 
further migration of neutrophils. Clinical studies also showed that a sustained increase 
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in ICAM-1 occurs during acute stress in children which may contribute to morbidity 
in patients with traumatic brain injury (Briassoulis et al., 2007). In the study, E. 
faecalis was found to suppress IL-1β and S. typhimurium induced ICAM-1 expression 
in IECs (Caco-2 and HCT116) (Figure 5.13A; Figure 5.15A). Therefore, the 
suppression of ICAM-1 by E. faecalis may inhibit inflammatory responses in infants 
activated by Gram negative bacteria or other stimuli. 
E. faecalis induced IL-18 secretion in HCT116 was unexpected (Figure 5.13C). 
IL-18 is a member of the IL-1 family, which plays a role in immune and inflammatory 
reactions, and is notably present in several autoimmune disorders. Different with most 
of the other cytokines, IL-18 is abundant in non-immune tissues including the gut and 
the skin and may involve in the defense against mucosal organisms. Interestingly, 
administration of IL-18 to mice infected with a lethal dose of virulent strain of S. 
typhimurium reduced the bacteria number in the tissues and rescued them from death. 
On the other hand, macrophage infected with S. typhimurium exhibited reduced 
expression of IL-18, suggesting the ability of this pathogen to suppress production of 
IL-18 to facilitate its survival in the host (Elhofy and bost, 1999; John et al., 2002). A 
more recent study showed that IL-18 has an effective antitumor effect (Xu et al., 
2007). In the study, E. faecalis, which suppressed several inflammatory cytokines 
production, activated IL-18 secretion in HCT116 even with the presence of S. 
typhimurium. Therefore, E. faecalis induction of IL-18 expression in HCT116 without 
corresponding production of other proinflammatory cytokines may serve to enhance 
removal of pathogens without the involvement of inflammatory responses. In addition, 
studies showed that the release of IL-18 from the cells could be activated by caspase-1 
(Li et al., 2007). In the study, caspase-1 was not activated by E. faecalis but 
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suppressed (Figure 5.17). Therefore, the activation of IL-18 by E. faecalis in HCT116 
cells involved in a caspase-1 independent pathway.  
E. faecalis regulated inflammatory responses through the network of cytokines. 
Studies using commensal bacteria suggested that there are a variety of pathways 
involved in the anti-inflammatory effects of these bacteria, not all of which depend on 
signaling by TLRs (Rachmilewitz et al., 2004). TLRs are important in regulating 
inflammatory responses and Th1/Th2 immunities in the host. In the study, most of 
TLRs were suppressed in both IECs and THP1 by E. faecalis irrespective of the 
production of IL-8 (Figure 5.4; Figure 5.5; Figure 5.6; Figure 5.7). No TLRs except 
TLR3 were detected in HCT116 cells. TLR2, TLR4 and TLR9 were found expressed 
in Caco-2 cells but not in HCT116 cells. Expression of TLR3, TLR4 and TLR9 were 
suppressed in THP1 cells upon E. faecalis treatment even though a super high IL-8 
and TNF expression were detected (Figure 5.7). Recent studies suggest that TLR3 and 
TLR9 signaling could be used for therapeutic treatment of inflammatory diseases 
including cancer, asthma and allergy (Salaun et al., 2006; Bhattacharjee et al., 2006). 
In addition, a link was found between TLR4 signaling, inflammation and tumor 
growth (Kelly et al., 2006). TLR4 was usually lowly expressed in healthy intestine 
resulting in tolerance of the large quantities of luminal LPS (Nomura et al., 2000). 
Moreover, we found that tumor necrosis factor (TNF) receptor associated factor 6 
(TRAF6) mRNA was suppressed by L.GG, LP33, T6 and 10387 in Caco-2 cells 
(Figure 3.7), E. faecalis (EC1, EC3 and EC15) in HT-29 cells (Figure 3.9), E. faecalis 
(EC1, EC3, EC15, EC16), T6, L.bul in HCT116 (Figure 3.8; Figure 5.4). TRAF6 is 
an adaptor in TLRs signaling pathway. It is also involved in cytokine signaling 
pathways through MAPK. TRAF6 could bind TAB1, TAK1 and TAB2 to form a 
complex leading to the activation of IKK, thus the activation of NF-κB. Activation of 
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TAK1 also results in the activation of MAP kinases (Akira and Sato, 2003). Moreover, 
we have observed that TLR2 was expressed by Caco-2 cells and Tollip was expressed 
by all the intestinal cells. Both TLR2 and Tollip were not affected significantly by 
LAB (Figure 5.5) even at a high concentration at a MOI of 1000 (data not shown). 
From this we can deduce that TLR2 and Tollip might not be involved in the 
inflammation modulation by LAB. Interestingly, cytokine receptors such as IL-8RA 
and TNFRSF11A were greatly inhibited on their expression upon the treatment of E. 
faecalis in IECs with the suppression of multiple proinflammatory cytokines 
production (Figure 5.4; Figure 5.5). However, they were greatly upregulated in THP1 
cells with a high induction of IL-8 secretion (Figure 5.7). In addition, IL-8RA protein 
expression was upregulated by IL-1β and S. typhimurium treatment but suppressed in 
the presence of E. faecalis (Figure 5.16 D).  Taken these data together, the inhibitory 
effects of E. faecalis appear to mediate through cytokine receptors instead of TLRs. 
The low expression of TLRs in intestinal epithelial cells has important implication in 
the mechanism of tolerance to the commensal bacteria in intestine. The regulation of 
inflammatory response by E. faecalis may not be mediated through TLRs but 
cytokine receptors. However, the modulation of intestinal immunity by E. faecalis 
may involve TRAF6. 
NF-κB is another important pathway which regulates inflammation reaction in 
the human. Inhibition of NF-κB pathway can block specific gene expression such as 
IL-8 (Hoffmann et al., 2002). However, Lawrence et al suggested that the NF-κB 
pathway may also be an important anti-inflammatory pathway in the resolution of 
inflammation (Lawerence et al., 2001). In the study, we showed that NF-κB1, NF-
κB2 and IKKB gene expression were suppressed by E. faecalis in IECs (Table 5.2; 
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Figure 5.4; Figure 5.6). However, their protein productions did not change 
significantly (Figure 5.10). Furthermore, EMSA experiments on the NF-κB DNA 
binding analysis showed that E. faecalis did not inhibit its DNA binding activity, 
suggesting that E. faecalis uses a different anti-inflammatory signaling pathway other 
than inhibiting NF-κB protein expression or their DNA binding activities. However, 
NF-κB may be involved in late regulation mechanisms since their gene expression 
were suppressed by E. faecalis. The mechanisms utilized may vary between different 
commensal species since Kelly et al demonstrated that the anti-inflammatory activity 
of the commensal gut bacterium Bacteroides thetaiotaomicron does not involve 
inhibition of IκB degradation but selectively antagonizes NF-κB via a new 
mechanism (Kelly et al., 2004).  
Activation of mitogen-activated protein kinase (MAPK) is important in the 
regulation of cytokines production and inflammation. Inhibition of MAPK would 
cause widespread suppression of cytokine network in vivo (Sheryanna et al., 2007). E. 
faecalis inhibited IL-1β and S. typhimurium activated phosphorylated JNK and p38 
but not ERK during the first two hours of incubation (Figure 5.16 A, B, C, D, E and 
F). The transcriptional regulator AP-1 is downstream of MAPKs signaling pathway. It 
is a homo- or hetero-dimer composed of c-JUN, JUN D, JUN B, ATF-2, c-FOS, 
FRA-1, FRA-2 and other family members. It is important to note that JNK are the 
only c-JUN kinases identified to date. The gene expression of c-JUN was upregulated 
by E. faecalis. However the phosphorylated form of c-JUN was suppressed by E. 
faecalis (Figure 5.16 B, C, E and F). These data suggest the importance of c-JUN in 
the regulation of IL-8 production. Moreover, JNK was enhanced by E. faecalis but not 
IL-1β and S. typhimurium after 2h of incubation (Figure 5.16 G and H) in Caco-2 
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cells. This might explain the upregulation of c-JUN gene expression but not protein 
production. Furthermore, JNK1 and JNK2 have different function in the regulation of 
inflammatory responses. Thus the upregulation of JNK expression might be involved 
in a new mechanism of E. faecalis in the suppression of inflammatory responses 
which needs further verifications.  Using inhibitors of JNK and p-38, the roles of JNK 
and p38 in the modulation of stimulated IL-8 expression were further confirmed. JNK 
and p38 inhibitors suppressed the IL-1β stimulated IL-8 production inside and outside 
of HCT116 cells (Figure 5.19). The combination of these two inhibitors showed 
stronger suppression ability compared to single inhibitor (Figure 5.19). The 
suppression of JNK by specific JNK inhibitor activated p38 expression and the 
suppression of p38 by specific p38 inhibitor activate JNK expression (Figure 5.18A; 
Figure 5.20) suggesting the interplay between JNK and p38 signaling pathways. This 
result extended the finding of Krause et al which suggested that the specific inhibition 
of JNK did not affect p38 activation (Krause et al., 1998). Unexpectedly, inhibitors 
did not affect significantly on the constitutive expression of IL-8 in IECs (Figure 5.18 
B, C; Figure 5.19 A, B). Therefore, inhibition of MAPK signaling pathway by 
inhibitors could be effective in the suppression of stimulated IL-8 secretion but not 
constitutive expression of IL-8. A previous study showed that inhibitors of JNK had 
no effect on IL-8 expression in LPS stimulated human monocytes (Hoffmann et al., 
2002). Studies also showed that treatment with p38 MAPK inhibitor did not suppress 
renal levels of IL-1β or IL-6 in vivo (Sheryanna et al., 2007).  In addition, the 
activation of p38 and JNK protein expression during the late hours of incubation with 
E. faecalis might be one of the unknown mechanisms of the suppression of 
inflammation or the negative feed back of this signaling pathway. Further studies 
need to be carried out to prove this.  








































































Figure 5.221 Signaling pathways that E. faecalis may be involved in regulating anti-
inflammatory responses in the human intestine. The red colors labeled are those 
regulated by E. faecalis at protein levels, and purples color labeled are those regulated 
at gene levels. “T” means the suppression of the proteins/genes by E. faecalis. In brief, 
E. faecalis inhibited cytokine receptors like TNFRSF11A and IL-8RA on the cell 
surface, further inhibited JNK and p38 by suppressing their protein phosphorylation 
and upregulating DUSP1, and thus inhibiting c-JUN gene transcription and translation. 
PIN1 and E2F1 were also suppressed. NK-κB family members were suppressed on 
gene levels but not protein level.  
Overall, E. faecalis isolated from infants demonstrated strong anti-
inflammation properties in the human IECs by inhibiting several proinflammatory 
cytokines especially IL-8. In addition, the study has demonstrated for the first time 
that E. faecalis is the major human intestinal LAB in modulating expression of host 
immune genes that participate in inflammation. The immune regulatory mechanism 
may involve the adhesion of E. faecalis on intestinal cells and suppression of several 
inflammation related signaling pathways via carbohydrates mediated adhesion-
receptor interaction. Infant intestine usually undergo acute inflammation when they 
are exposed to Gram negative bacteria. The presence of E. faecalis would help the 
Chapter 5 Characterization of Signaling Pathways 
 
 195
intestine to maintain the immune balance by suppressing the inflammation activated 
by Gram negative bacteria thus enhanced the removal of pathogens and maintain 
immune homeostasis. IL-8 synthesis and secretion could be regulated by multiple 
signaling pathways as JNK, c-JUN, PIN1 and E2F1 expression was suppressed by E. 
faecalis (Figure 5.21). JNK and p38 appear to be important in the suppression of IL-8 
production since blockade of these pathways at early inflammatory stage significantly 
suppressed IL-8 secretion. The signaling pathways involved in the suppression of 
inflammatory responses by E. faecalis are illustrated in Figure 5.21. 
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6.1 Conclusions 
The immunomodulation effects of lactic acid bacteria (LAB) on human 
intestine and the possible mechanisms of how E. faecalis regulates human intestinal 
inflammatory responses were investigated in the thesis. The results demonstrated for 
the first time that specific strains of human intestinal E. faecalis suppressed 
inflammatory responses in the human intestinal epithelial cell lines (IECs).  
Commensal bacteria are key regulators of mucosal immune responses, which 
are determined by the host genetic background. Lactic acid bacteria (LAB) are a very 
important group in human gut bacteria population. They help in gut immune 
homeostasis. Studies derived from different experimental model systems showed that 
Enterococcus is a critical component in regulation of chronic intestinal inflammation 
and gastrointestinal dysfunction. However, little is known about the molecular 
mechanisms of bacteria-specific crosstalk and the host cells with respect to 
inflammatory or protective immune responses. 
It becomes apparent that various pathogenic bacteria or other stimuli trigger an 
innate immune response in the intestine that is tightly controlled in the normal host. A 
failure to terminate these responses may lead to persistent inflammation and 
potentially chronic inflammation in a susceptible host. In infants, because the gut 
microflora population is very unstable in early neonatal life, it is often difficult for 
their gut to maintain the delicate balance between harmful and beneficial bacteria, 
thus reducing the ability of the immune system to function normally. Therefore, the 
presence of the bacteria with anti-inflammation properties in the infants is crucial for 
them to maintain the balance of the gut. In the study, we found four E. faecalis strains, 
which are from healthy newborn infants’ stool, among 56 strains of LAB of all kinds 
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of sources. They demonstrated a very strong ability to suppress inflammatory 
responses in the human intestinal epithelial cells. These E. faecalis strains inhibited 
several proinflammatory cytokines and factors such as IL-8, ICAM-1 and TNF-α at 
the basal level and also the level activated by IL-1β and pathogenic S. typhimurium 
(Figure 6.1). Among the four interesting E. faecalis strains, three were from 3 day old 
infants and 1 was from 1 month old infants, suggesting that the wellness of the infants 
could be determined by the composition of their gut bacteria. 
 
 
Figure 6.1 The cartoon demonstrated how E. faecalis suppressed inflammatory 
responses in the host with the stimulation of proinflammatory cytokines like IL-1β 
and pathogenic bacteria such as S. typhimurium. E. faecalis adheres to the cell surface 
very well and thus blocks the receptors to be accessed by proinflammtory cytokines 
and pathogens. It further inhibits the signaling pathways like p38, JNK and AP-1, and 
block the translation and possible transcription of IL-8, TNF-α and also ICAM-1.  The 
reduced production of IL-8 and other proinflammatory cytokines lower the response 
of immune cells like neutrophils thus inhibit the inflammatory responses in the 
intestine. 
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In the study, we also demonstrated the importance of the adhesion ability of E. 
faecalis and its cell surface carbohydrates in the regulation of anti-inflammatory 
responses. It suppressed MAPK signaling pathway, through downregulation of JNK 
and p38 expression leading to inhibition of c-JUN and its downstream signals thus 
inhibit inflammatory responses in the host (Figure 6.1). Moreover, E. faecalis could 
regulate multiple cellular signaling pathways including cell proliferation, and even 
oncogenic signal pathways through the inhibition of PIN1 and E2F1 protein 
expression (Figure 5.21). Furthermore, E. faecalis may modulate the immune 
responses through cytokine receptors rather than TLRs. Its regulation could bypass 
NF-κB in the regulation of inflammatory responses in the host. Therefore, E. faecalis 
exhibits its unique but broad regulation pattern on multiple biological evens in the 
host. These unique properties could contribute to immune homeostasis both in the 
early childhood and possibly also in adult. The understanding of signal transduction 
mechanisms by E. faecalis in the IECs will help to develop new strategies to 
terminate immunopathology of intestinal inflammation. Exploitation of such findings 
may lead to the development of new therapeutics for human IBD and other 
inflammatory conditions.  
6.2 Future Work 
Because of the complexity of the human immune system, further studies might 
include the investigation of the receptors on the cell surface. The involvement of 
TLRs in response to E. faecalis needs to be further confirmed. TLRs play a key role in 
the host innate immune system. They were regulated by E. faecalis at the gene levels. 
Further studies using TLRs mutants in the IECs could investigate the role of TLRs in 
Chapter 6 Conclusions 
 200
response to E. faecalis and other commensal bacteria. In addition, other new signaling 
pathways might also be involved in the regulation of inflammatory responses by E. 
faecalis since IL-18 which was reported as a proinflammatory cytokine was greatly 
upregulated but other proinflammatory cytokines were greatly suppressed.  
New technologies such as proteomics (expression, functional and structural), 
genomics and bioinformatics will likely contribute to the discovery of the components 
involved in the interaction of bacteria with the host under normal and pathological 
conditions of inflammation. Isolation and identification of specific components can 
lead to the isolation of these compounds for therapy in gut inflammatory conditions.   
For in vivo studies, a novel colitis related mouse model initiated with 
azoxymethane (AOM) or dextran sodium sulfate (DSS) could be used. The incidence 
and syndrome ponderance of colitis induced by AOM/DSS in mice treat with or 
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CONVERSION FACTORS OF BACTERIA 
Lactic Acid Bacteria (LAB) 
Conversion Equations (Y=OD 
reading at 600nm; X= CFU/ml 
bacteria) 
Bifidobacterium adolescentis ATCC15703 y = 1E-10x + 0.2475 
Bifidobacterium. brevi ATCC15700 y = 2E-10x + 0.1559 
B. dentium scardori & crociani ATCC27534 y = 2E-07x + 0.0043 
Bifidobacterium. longum ATCC15707 y = 5E-08x - 0.0063 
Enterococcus faecalis EC1 y = 7E-09x + 0.04 
Enterococcus faecalis EC2 y = 2E-10x + 0.0983 
Enterococcus faecalis EC3 y = 1E-08x - 0.019 
Enterococcus faecalis EC5 y = 6E-11x + 0.0047 
Enterococcus faecalis EC7 y = 5E-11x + 0.1456 
Enterococcus faecalis EC15 y = 1E-08x + 0.0062 
Enterococcus faecalis EC16 y = 1E-08x - 0.0797 
Lactobacillus acidophilus ATCC4356 y = 1E-08x + 0.1408 
L. brevis K7 y = 6E-09x + 0.0479 
L. brevis T1 y = 5E-09x + 0.2843 
L. brevis T6 y = 4E-06x - 0.0089 
L. casei ATCC11578 y = 6E-10x + 0.5116 
L. casei IS7257 y = 1E-10x + 0.3184 
L. casei subsp. casei NCIMB11970 y = 5E-11x + 0.542 
L. casei Shirota y = 3E-09x + 0.2131 
L. delbrueckii subsp. bulgaricus 
NCIMB11778 y = 8E-09x - 0.3748 
L. delbrueckii bulgaricus D1 y = 1E-11x + 0.4361 
L. lactis subsp. lactis B4 y = 4E-08x - 3E-06 
L. lactis subsp. lactis B9 y = 8E-08x - 1E-05 
L. lactis subsp. lactis B12 y = 8E-07x + 0.0685 
L. lactis subsp. lactis K5 y = 3E-09x + 0.3222 
L. lactis subsp. lactis K6 y = 7E-06x + 0.0407 
L. lactis subsp. lactis K7 y = 6E-09x + 0.0479 
L. paracasei LP33 y = 8E-10x + 0.2244 
Lactobacillus paracasei Chamyto y = 6E-09x + 0.1245 
L. paracasei subsp. paracasei ATCC11974 y = 3E-09x + 0.4289 
L. paracasei subsp. paracasei NCIMB8001 y = 2E-10x + 0.2283 
L. rhamnusus NCIMB6375 y = 6E-10x + 0.369 
L.rhamnosus GG y = 2E-11x + 0.7368 
L. rhamnosus NCIMB 8690 y = 4E-07x - 0.0682 
Leuconostoc mesentroides K13 y = 2E-10x + 0.3348 
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Streptococcus thermophilus NCIMB10387 y = 3E-08x - 0.0184 
S. typhimurium 14028  y = 4E-10x + 0.169 
L. plantarum 1 y = 7E-09x + 0.1965 
L. plantarum 2 y = 4E-09x + 0.4011 
L. plantarum 3 y = 2E-10x + 0.3886 
L.casei 705 y = 1E-08x - 0.1479 
L. Indenesia y = 1E-10x + 0.3149 
L. casei I2775 y = 3E-09x + 0.1987 
 
The following four graphs are the conversion factor curve for E. faecalis EC1, EC3, 
EC15 and EC16. 
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MATERIAL FOR BACTERIA CULTURE 
 
1. Saline 
Add 0.85g NaCL (Merck, Germany) in 100ml Nano water and autoclave at 121°C for 
15min (Hirayama, Japan), store at room temperature or 4°C. 
2. de Man, Rogosa and Sharpe (MRS) broth/agar  
MRS Broth  
52.2g of MRS broth powder (Merck, USA) were added into 1L distilled water. The 
solution was autoclaved at 121°C for 15min (Hirayama, Japan) and store at room 
temperature or 4°C. 
MRS Agar  
68.2g of MRS Agar powder (Merck, USA) were added into 1L distilled water. The 
solution was autoclaved at 121°C for 15min (Hirayama, Japan) and cooled to 60°C 
before pouring plates, stored at 4°C.  
3. Reinforced Clostridial Medium (RCM) broth/agar 
RCM Broth 
33g of RCM broth powder (Merck, USA) were added into 1L distilled water. The 
solution was autoclaved at 121°C for 15min (Hirayama, Japan) and store at room 




52.5g of RCM Agar powder (Oxoid, UK) were added into 1L distilled water. The 
solution was autoclaved at 121°C for 15min (Hirayama, Japan) and cooled to 60°C 
before pouring plates, stored at 4°C.  
4. Luria-Bertani (LB) broth/agar 
Luria-Bertani (LB) Broth, PH 7.0 
 
Items Amount Source 
Bacto-tryptone 10g BD biosciences, USA 
Bacto-yeast extract 5g BD biosciences, USA 
NaCL 10g Merck, Germany 
 
The above components were dissolved in 1 liter of distilled water. The solution was 
autoclaved at 121°C for 15min (Hirayama, Japan) and store at room temperature or 
4°C.  
Luria-Bertani (LB) Agar 
Items Amount Source 
Bacto-tryptone 10g BD biosciences, USA 
Bacto-yeast extract 5g BD biosciences, USA 
NaCL 10g Merck, Germany 
Agarose 15g Oxoid, UK 
 
The above components were dissolved in 1 liter of distilled water. The solution was 
autoclaved at 121°C for 15min (Hirayama, Japan) and cooled to 60°C before pouring 
plates, stored at 4°C.  
5. M17 broth/agar 
M17 Broth 
37.25g M17 broth powder (Oxoid, UK) were added into 950ml distilled water. The 
solution was autoclaved at 121°C for 15min (Hirayama, Japan) and cooled to 50°C 




37.25g M17 broth powder (Oxoid, UK) and 15g Agarose (Oxoid, UK) were added 
into 950ml distilled water. The solution was autoclaved at 121°C for 15min 
(Hirayama, Japan) and cooled to 50°C before adding 50ml 10% (W/V) Lactose 
solution. Pouring plates after adding lactose then store at 4°C. 
10% Lactose (L70) 
10g Lactose (L70) was added into 100ml distilled water autoclaved at 121°C for 
15min (Hirayama, Japan) or filter sterile for use. 
6. Tryptone Soy (TS) broth/agar 
TS Broth 
30g of TS broth powder (Merck, USA) were added into 1L distilled water. The 
solution was autoclaved at 121°C for 15min (Hirayama, Japan) and store at room 
temperature or 4°C. 
TS Agar 
30g of TS broth powder (Merck, USA) and 15g Argrose (Oxoid, UK) were added into 
1L distilled water. The solution was autoclaved at 121°C for 15min (Hirayama, Japan) 
and cooled to 60°C before pouring plates, stored at 4°C.  
7. TE buffer 
The final concentration of TE buffer is 10 mM Tris–HCl and 1 mM EDTA; 





MATERIALS FOR CELL CULTURE 
 
All materials prepared for cell culture were either sterile or sterilized. Nano water 
(Corning, USA) was used for all dilutions. 
1. Phosphate Buffered Saline (PBS) 
 
Items Amount (g) Source 
KH2PO4 0.24 Merck, Germany 
Na2HPO4 1.44 Merck, Germany 
NaCL 8 Merck, Germany 
KCL 0.2 Merck, Germany 
The materials were dissolved in 1 liter of Nano water. The pH was adjusted to 7.4 
using either 1M HCL or 1M NaOH. The solution was aliquoted and sterilized using 
autoclave machine (Hirayama, Japan) for 15min at 121°C. Store at 4°C. 
2.  Trypsin-EDTA 
10 ml 10X Trypsin-EDTA (GIBCO) was dilluted in 90ml PBS buffer. Filter 
sterilization and store at 4°C. 
3. 0.5% Trypan Blue Solution  
Items Amount  Source 
Trypan Blue 0.5g Merck, Germany 
PBS 100ml Appendix 3 
 The solution was autoclaved (Hirayama, Japan) at 121°C for 15min and filtered 
before use.  
4. 200mM L-glutamate 




5.  0.1M Na-pyrurate 
1.1g of Na-pyrurate was disolved in 100ml Nano water and store at 4°C for use. 
6.  7.5% Sodium bicarbonate 
18.75g of NaHCO3 was disolved in 250ml Nano water and store at 4°C for use. 
7. MEM medium for Caco-2 
9.39g MEM (Minimal Essential Medium) powder (Giboco, USA) was dissolved in 
750ml of Nano water and autoclaved (Hirayama, Japan) at 121°C for 15min before 
use.  
Items Amount (ml) Source 
MEM 750 Appendix 3 
Fetal Bovine Serum 200 Bioclot, Germany 
7.5% Sodium bicarbonate 20 Appendix 3 
0.1M Na-pyrurate 10 Appendix 3 
200mM L-glutamate 10 Appendix 3 
10mM Non-essential amino acid 10 GIBCO, USA 
Penicillin/Streptomycin 1 GIBCO, USA 
The above solutions were then filter sterilized and store at 4°C. 
8. DMEM medium for HT-29 and HCT116 
One package of DMEM powder (GIBCO, USA) was dissolved in 900ml Nano-water.  
Items Amount (ml) Source 
DMEM 900 Appendix 3 
7.5% Sodium bicarbonate 20 Appendix 3 
Fetal Bovine Serum 100 Bioclot, Germany 
Penicillin/Streptomycin 1 GIBCO, USA 
The above solutions were then filter sterilized and store at 4°C. 
9. RPMI 1640 for THP1 
One package of RPMI1640 powder (GIBCO, USA) and 1.5 sodium biocarbonate and 




Items Amount (ml) Source 
RPMI1640 880 Appendix 3 
0.1M Na-pyrurate 10 Appendix 3 
200mM L-glutamate 10 Appendix 3 
Fetal Bovine Serum 100 Bioclot, Germany 
Penicillin/Streptomycin 1 GIBCO, USA 




MATERIAL FOR CYTOKINE ASSAY 
1. Coating buffer (0.1m Sodium Carbonate, pH 9.5) 
Items Amount (g) Source 
NaHCO3 8.40 Merck, Germany 
Na2CO3 3.56 Merck, Germany 
The materials were dissolved in 1 liter of Nano water. The pH was adjusted to 9.5 
using either 1M HCL or 1M NaOH. The solution was freshly prepared or use within 7 
days of preparation, stored at 2-8°C. 
2. PBS* for ELISA 
Items Amount (g) Source 
KH2PO4 0.2 Merck, Germany 
Na2HPO4 1.16 Merck, Germany 
NaCL 8 Merck, Germany 
KCL 0.2 Merck, Germany 
The materials were dissolved in 1 liter of Nano water. The pH was adjusted to 7.0 
using either 1M HCL or 1M NaOH. The solution was aliquoted and sterilized using 
autoclave machine (Hirayama, Japan) for 15min at 121°C. Store at 4°C. 
3. Assay Dilluent 
PBS*(Appendix 4) with 10% FBS (Bioclot, Germany), pH was adjusted to7.0. 
Freshly prepared or use within 3 days of preparation and stored at 2-8°C. 
 
4. Washing buffer 
PBS* (Appendix 4) with 0.05% Tween-20 (Merck, Germany), freshly prepare or use 




Tetramethylbenzidine (TMB) and Hydrogen Peroxide. We bought from the BD 
Pharmingen™ TMB Substrate Reagent Set (Cat.No. 555214). Mix them at the equal 
volume before use. 
6. Stop buffer  (1M H3PO4) 




MATERIAL FOR APOPTOSIS ANALYSIS 
1. Sample buffer 
1g Glucose was added into 1L PBS buffer (Appendix 3). 
2. 10mM Tris-HCL buffer 
1.576g Tris-HCL and 0.877g NaCL were dissolved in 1L distilled water and adjusted 
pH to 7.5. 
3. 1000U/ml RNAse 
0.012g of RNase A were dissolved in 1 ml 10mM Tris-HCL buffer and read to use. 
4. Propidium Iodide 
1mg of Propidium Iodide was dissolved in 1ml of PBS buffer (Appendix 3). Keep in 




MATERIAL FOR RNA/DNA PREPARATION 
For RNA 
1. Diethyl pyrocarbonate (DEPC) treated water 
0.5ml of DEPC (Sigma, USA) was added into 1L autoclaved Nano water and mixed 
overnight, then autoclave 15min (Hirayama, Japan) to destroy DEPC by causing 
hydrolysis of DEPC. 
2. Formadehy gel 
Items Amount  Source 
Formaldehyde 1.6ml Sigma, USA 
10xMOPS 10ml Appendix 6 
Agarose 1.5g Merck, Germany 
Ethidium Bromide 2 ul  Sigma, USA 
H2O 87.5ml Corning, USA 
3. 10x MOPS (1L) 
MOPS 41.8 g 
DEPC water 700ml 
Adjust PH 7.0 
20ml 1M sodium acetate 
20ml 0.5 M EDTA (PH 8.0) 
Make 1 L then filter 
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4. Gel loading buffer/dye (RNA) 
50% glycerol                          25ml 
1mM EDTA (PH 8.0) 
0.25% bromophenol blue 
0.25% xylene cyanol FF 
DEPC water                           25ml 
Total                                       50ml 
 
For DNA 
5. 1.2% agarose gel 
Items Amount  Source 
Agarose 0.3g Seakem, USA 
10x TBE 25ml Prepared 
Ethidium Bromide 2µl Sigma, USA 
 
6. DNA loading buffer 
Items Amount  Source 
Bromophenol Blue 25mg Sigma, USA 
Sucrose 4g Merck, Germany 






MATERIALS FOR MICROARRAY 
 
1. 20x SSC 
Dissolve 175.3 g NaCl and 88.2 g sodium citrate dihydrate into 900 ml H2O. Adjust 
pH to 7.0 with 1M HCl. Dilute to 1 L with H2O. Autoclave for 15mins (Hirayama, 
Japan) and store at room temperature for up to 2 months.  
2. 20% SDS 
Dissolve 200 g sodium dodecyl sulfate in 1 L H2O. Heat to 65 °C if necessary to 
dissolve. Store at room temperature.  
3. Wash Solution 1& 2  
Wash Buffer: 20X SSC (ml) 20% SDS dH2O Total Volume 
1. 2X SSC, 1% SDS 10 5 85 100 






MATERIAL FOR WESTERN BLOTTING 
1. Stacking gel (5%) 
Items Amount  Source 
Water 2.7ml Nano water (Corning, USA) 
30% acrylamide 0.67ml BioRad, 
1.0M Tris-base (pH6.8) 0.5ml  Merck, Germany 
10% SDS 0.04ml Merck, Germany 
10% ammonium persulphate* 0.04ml Merck, Germany 
TEMED 0.004ml BioRad, 
*prepare fresh 
2. Running gel (10%), 2 gels. 
Items Amount  Source 
Water 5.3ml Nano water (Corning, USA) 
30% acrylamide 2.0ml BioRad, 
1.5M Tris-base (pH8.8) 2.5ml    Merck, Germany 
10% SDS 0.1ml Merck, Germany 
10% ammonium persulphate* 0.1ml Merck, Germany 
TEMED 0.008ml BioRad, 
*prepare fresh 
Pour isopropanol over the running gel (let gel solidify for ~20min). Decant away the 
isopropanol just before adding the stacking gel. 
3. Running buffer (10x) 
Items Amount  Source 
Tris base 30.2g Merck, Germany 
Glycine 188g Merck, Germany 
10% SDS 100ml BioRad, USA 









4. Transfer buffer (Prepare fresh ) 
Items Amount  Source 
Tris base 3.03g Merck, Germany 
Glycine 14.4g Merck, Germany 
Methanol 200ml Merck, Germany 
Water Top up to 1L  
5. Ponceau S dye 
Items Amount  Source 
Ponceau S dye 0.5g Sigma, USA 
Acetic acid  25ml Merck, Germany 
Water 475ml Corning, USA 
 
6. Tris buffer saline-Tween (TBST), pH 7.6 
Items Amount  Source 
5M NaCl 27ml Appendix 8 
1M Tris-HCl pH 7.4 12ml Appendix 8 
Tween-20 900ul Merck, Germany 
Water 900ml Corning, USA 
 
pH was adjusted to 7.6 and then top up to 1 liter. The solution was then autoclaved at 
121°C for 15min (Hirayama, Japan) and store at room temperature.  
5M NaCl : 292.2g NaCl (Merck, Germany) was dissolved in 1 liter Nano water for 
use.  
1M Tris-HCl pH 7.4: 157.6g Tris-HCl (Merck, Germany) was dissolved in 1 liter 
Nano water and pH was adjusted to 7.4 for use. 
7. 5% skim milk 
5g of skim milk (Diploma, singapore) was dissolved in 100ml TBST (Appendix 8). 
Mix well and ready for use. 
8. 3X SDS Sample Buffer 
187.5 mM Tris-HCl (pH 6.8 at 25°C), 6% (w/v) SDS, 30% glycerol and 0.03% (w/v) 




9. 30X Reducing Agent 
1.25 M dithiothreitol (DTT) (Store at –20°C.) Add 30X DTT at 1:10 to 3X SDS 
sample buffer 
10. 1X Cell Lysis buffer 
20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% 
Triton, 2.5 mM sodium pyrophosphate, 1 mM beta-glycerophosphate, 1 mM 
Na3VO4, 1 µg/ml leupeptin. Add 1 mM PMSF (Sigma, USA) immediately 




The sequence of the strains 
 
The ID of the strains can be obtained in the gene bank 





         1 ctgcgcgtgc tatacatgca gtcgaacgct tctttcctcc cgagtgcttg cactcaattg  
       61 gaaagaggag tggcggacgg gtgagtaaca cgtgggtaac ctacccatca gagggggata  
      121 acacttggaa acaggtgcta ataccgcata acagtttatg ccgcatggca taagagtgaa  
      181 aggcgctttc gggtgtcgct gatggatgga cccgcggtgc attagctagt tggtgaggta  
      241 acggctcacc aaggccacga tgcatagccg acctgagagg gtgatcggcc acactgggac  
      301 tgagacacgg cccagactcc tacgggaggc agcagtaggg aatcttcggc aatggacgaa  
      361 agtctgaccg agcaacgccg cgtgagtgaa gaaggttttc ggatcgtaaa actctgttgt  
      421 tagagaagaa caaggacgtt agtaactgaa cgtcccctga cggtatctaa ccagaaagcc  
      481 acggctaact acgtgccagc agccgcggta atacgtaggt ggcaagcgtt gtccggattt  
      541 attgggcgta aagcgagcgc aggcggtttc ttaagtctga tgtgaaagcc cccggctcaa  
      601 ccggggaggg tcattggaaa ctgggagact tgagtgcaga agaggagagt ggaattccat  
      661 gtgtagcggt gaaatgcgta gatatatgga ggaacaccag tggcgaaggc ggctctctgg  
      721 tctgtaactg acgctgaggc tcgaaagcgt ggggagcaaa caggattaga taccctggta  
      781 gtccacgccg taaacgatga gtgctaagtg ttggagggtt tccgcccttc agtgctgcag  
      841 caaacgcatt aagcactccg cctggggagt acgaccgcaa ggttgaaact caaaggaatt  
      901 gacgggggcc cgcacaagcg gtggagcatg tggtttaatt cgaagcaacg cgaagaacct  
      961 taccaggtct tgacatcctt tgaccactct agagatagag ctttcccttc ggggacaaag  
     1021 tgacaggtgg tgcatggttg tcgtcagctc gtgtcgtgag atgttgggtt aagtcccgca  
     1081 acgagcgcaa cccttattgt tagttgccat catttagttg ggcactctag cgagactgcc  
     1141 ggtgacaaac cggagagaag gtggggatga cgtcaaatca tcatgcccct tatgacctgg  
     1201 gctacacacg tgctacaatg ggaagtacaa cgagtcgcta gaccgcgagg tcatgcaaat  
     1261 ctcttaaagc ttctctcagt tcggattgca ggctgcaact cgcctgcatg aagccggaat  
     1 3 2 1  c g c t a g t a a t  c g c g g a t c a g  c a c g c c g c g t  a t g c g a c 
 
EC2:  
         1 ctgcgcgtgc tatacatgca gtcgaacgct tctttcctcc cgagtgcttg cactcaattg  
       61 gaaagaggag tggcggacgg gtgagtaaca cgtgggtaac ctacccatca gagggggata  
      121 acacttggaa acaggtgcta ataccgcata acagtttatg ccgcatggca taagagtgaa  
      181 aggcgctttc gggtgtcgct gatggatgga cccgcggtgc attagctagt tggtgaggta  
      241 acggctcacc aaggccacga tgcatagccg acctgagagg gtgatcggcc acactgggac  
      301 tgagacacgg cccagactcc tacgggaggc agcagtaggg aatcttcggc aatggacgaa  
      361 agtctgaccg agcaacgccg cgtgagtgaa gaaggttttc ggatcgtaaa actctgttgt  
      421 tagagaagaa caaggacgtt agtaactgaa cgtcccctga cggtatctaa ccagaaagcc  
      481 acggctaact acgtgccagc agccgcggta atacgtaggt ggcaagcgtt gtccggattt  
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      541 attgggcgta aagcgagcgc aggcggtttc ttaagtctga tgtgaaagcc cccggctcaa  
      601 ccggggaggg tcattggaaa ctgggagact tgagtgcaga agaggagagt ggaattccat  
      661 gtgtagcggt gaaatgcgta gatatatgga ggaacaccag tggcgaaggc ggctctctgg  
      721 tctgtaactg acgctgaggc tcgaaagcgt ggggagcaaa caggattaga taccctggta  
      781 gtccacgccg taaacgatga gtgctaagtg ttggagggtt tccgcccttc agtgctgcag  
      841 caaacgcatt aagcactccg cctggggagt acgaccgcaa ggttgaaact caaaggaatt  
      901 gacgggggcc cgcacaagcg gtggagcatg tggtttaatt cgaagcaacg cgaagaacct  
      961 taccaggtct tgacatcctt tgaccactct agagatagag ctttcccttc ggggacaaag  
     1021 tgacaggtgg tgcatggttg tcgtcagctc gtgtcgtgag atgttgggtt aagtcccgca  
     1081 acgagcgcaa cccttattgt tagttgccat catttagttg ggcactctag cgagactgcc  
     1141 ggtgacaaac cggaggaagg tggggatgac gtcaaatcat catgcccctt atgacctggg  
     1201 ctacacacgt gctacaatgg gaagtacaac gagtcgctag accgcgaggt catgcaaatc  
     1261 tcttaaagct tctctcagtt cggattgcag gctgcaactc gcctgcatga agccggaatc  
     1 3 2 1  g c t a g t a a t c  g c g g a t c a g c  a c g c c g c g t a  t g c g a c 
 
EC3: 
        1 gctggcgcgt gctatacatg cagtcgaacg cttctttcct cccgagtgct tgcactcaat  
       61 tggaaagagg agtggcggac gggtgagtaa cacgtgggta acctacccat cagaggggga  
      121 taacacttgg aaacaggtgc taataccgca taacagttta tgccgcatgg cataagagtg  
      181 aaaggcgctt tcgggtgtcg ctgatggatg gacccgcggt gcattagcta gttggtgagg  
      241 taacggctca ccaaggccac gatgcatagc cgacctgaga gggtgatcgg ccacactggg  
      301 actgagacac ggcccagact cctacgggag gcagcagtag ggaatcttcg gcaatggacg  
      361 aaagtctgac cgagcaacgc cgcgtgagtg aagaaggttt tcggatcgta aaactctgtt  
      421 gttagagaag aacaaggacg ttagtaactg aacgtcccct gacggtatct aaccagaaag  
      481 ccacggctaa ctacgtgcca gcagccgcgg taatacgtag gtggcaagcg ttgtccggat  
      541 ttattgggcg taaagcgagc gcaggcggtt tcttaagtct gatgtgaaag cccccggctc  
      601 aaccggggag ggtcattgga aactgggaga cttgagtgca gaagaggaga gtggaattcc  
      661 atgtgtagcg gtgaaatgcg tagatatatg gaggaacacc agtggcgaag gcggctctct  
      721 ggtctgtaac tgacgctgag gctcgaaagc gtggggagca aacaggatta gataccctgg  
      781 tagtccacgc cgtaaacgat gagtgctagt gttggagggt ttccgccctt cagtgctgca  
      841 gcaaacgcat taagcactcc gcctggggag tacgaccgca aggttgaaac tcaaaggaat  
      901 tgacgggggc ccgcacaagc ggtggagcat gtggtttaat tcgtagcaac gcgaagaacc  
      961 ttaccaggtc ttgacatcct ttgaccactc tagagataga gctttccctt cggggacaaa  
     1021 gtgacaggtg gtgcatggtt gtcgtcagct gcgtgtcgtg agatgttggg ttaagtcccg  
     1081 caacgagcgc aacccttatt gttagttgcc atcatttagt tgggcactct agcgagactg  
     1141 ccggtgacaa accggaggaa ggtggggatg acgtcaaatc atcatgcccc ttatgacctg  
     1201 ggctacacac gtgctacaat gggaagtaca acgagtcgct agaccgcgag gtcatgcaaa  
     1261 tctcttaaag cttctctcag ttcggattgc aggctgcaac tcgcctgcat gaagccggaa  
     1 3 2 1  t c g c t a g t a a  t c g c g g a t c a  g c a c g c c g c g  t a a t g c g c 
 
EC4: 
        1 ggcggcgcgt gctatacatg cagtcgaacg cttctttcct cccgagtgct tgcactcaat  
       61 tggaaagagg agtggcggac gggtgagtaa cacgtgggta acctacccat cagaggggga  
      121 taacacttgg aaacaggtgc taataccgca taacagttta tgccgcatgg cataagagtg  
      181 aaaggcgctt tcgggtgtcg ctgatggatg gacccgcggt gcattagcta gttggtgagg  
      241 taacggctca ccaaggccac gatgcatagc cgacctgaga gggtgatcgg ccacactggg  
      301 actgagacac ggcccagact cctacgggag gcagcagtag ggaatcttcg gcaatggacg  
      361 aaagtctgac cgagcaacgc cgcgtgagtg aagaaggttt tcggatcgta aaactctgtt  
      421 gttagagaag aacaaggacg ttagtaactg aacgtcccct gacggtatct aaccagaaag  
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      481 ccacggctaa ctacgtgcca gcagccgcgg taatacgtag gtggcaagcg ttgtccggat  
      541 ttattgggcg taaagcgagc gcaggcggtt tcttaagtct gatgtgaaag cccccggctc  
      601 aaccggggag ggtcattgga aactgggaga cttgagtgca gaagaggaga gtggaattcc  
      661 atgtgtagcg gtgaaatgcg tagatatatg gaggaacacc agtggcgaag gcggctctct  
      721 ggtctgtaac tgacgctgag gctcgaaagc gtggggagca aacaggatta gataccctgg  
      781 tagtccacgc cgtaaacgat gagtgctaag tgtttggagg gtttccgccc ttcagtgctg  
      841 cagcaaacgc attaagcact ccgcctgggg agtacgaccg caaggttgaa actcaaagga  
      901 attgacgggg gcccgcacaa gcggtggagc atggggttta attcgaagca acgcgaaaac  
      961 cttaccaggt cttgacatcc tttgaccact ctagagatag agctttccct tcggggacaa  
     1021 agtgacaggt ggtgcatggt tgtcgtcagc tcgtgtcgtg agatgttggg ttaagtcccg  
     1081 caacgagcgc aacccttatt gttagttgcc atcatttagt tgggcactct agcgagactg  
     1141 ccggtgacaa accggaggaa ggtggggatg acgtcaaatc atcatgcccc ttatgacctg  
     1201 ggctacacac gtgctacaat gggaagtaca acgagtccct agaccgcgag gtcatgcaaa  
     1261 tctcttaaag cttctctcag ttcggattgc aggctgcaac tcgcctgcat gaagccggaa  
     1 3 2 1  t c g c t a g t a a  t c g c g g a t c a  g c a c g c c g c g  t a a t g c c a c 
 
EC5: 
        1 ggctgcggcg tgctatacat gcaagtcgaa cgcttctttc ctcccgagtg cttgcactca  
       61 attggaaaga ggagtggcgg acgggtgagt aacacgtggg taacctaccc atcagagggg  
      121 gataacactt ggaaacaggt gctaataccg cataacagtt tatgccgcat ggcataagag  
      181 tgaaaggcgc tttcgggtgt cgctgatgga tggacccgcg gtgcattagc tagttggtga  
      241 ggtaacggct caccaaggcc acgatgcata gccgacctga gagggtgatc ggccacactg  
      301 ggactgagac acggcccaga ctcctacggg aggcagcagt agggaatctt cggcaatgga  
      361 cgaaagtctg accgagcaac gccgcgtgag tgaagaaggt tttcggatcg taaaactctg  
      421 ttgttagaga agaacaagga cgttagtaac tgaacgtccc ctgacggtat ctaaccagaa  
      481 agccacggct aactacgtgc cagcagccgc ggtaatacgt aggtggcaag cgttgtccgg  
      541 atttattggg cgtaaagcga gcgcaggcgg tttcttaagt ctgatgtgaa agcccccggc  
      601 tcaaccgggg agggtcattg gaaactggga gacttgagtg cagaagagga gagtggaatt  
      661 ccatgtgtag cggtgaaatg cgtagatata tggaggaaca ccagtggcga aggcggctct  
      721 ctggtctgta actgacgctg aggctcgaaa gcgtggggag caaacaggat tagataccct  
      781 ggtagtccac gccgtaaacg atgagtgcta agtgttggag ggtttccgcc cttcagtgct  
      841 gcagcaaacg cattaagcac tccgcctggg gagtacgacc gcaaggttga aactcaaagg  
      901 aattgacggg ggcccgcaca agcggtggag catgtggttt aattcgaagc aacgcgaaga  
      961 accttaccag gtcttgacat cctttgacca ctctagagat agagctttcc cttcggggac  
     1021 aaagtgacag gtggtgcatg gttgtcgtca gctcgtgtcg tgagatgttg ggttaagtcc  
     1081 cgcaacgagc gcaaccctta ttgttagttg ccatcattta gttgggcact ctagcgagac  
     1141 tgccggtgac aaaccggagg aaggtgggga tgacgtcaaa tcatcatgcc ccttatgacc  
     1201 tgggctacac acgtgctaca atgggaagta caacgagtcg ctagaccgcg aggtcatgca  
     1261 aatctcttaa agcttctctc agttcggatt gcaggctgca actcgcctgc atgaagccgg  
     1 3 2 1  a a t c g c t a g t  a a t c g c g g a t  c a g c a c g c c g  c g t a t g c g t a 
 
EC6: 
        1 gtgatgcggc gtgctataat gcaagtcgaa cgcttctttc ctcccgagtg cttgcactca  
       61 attggaaaga ggagtggcgg acgggtgagt aacacgtggg taacctaccc atcagagggg  
      121 gataacactt ggaaacaggt gctaataccg cataacagtt tatgccgcat ggcataagag  
      181 tgaaaggcgc tttcgggtgt cgctgatgga tggacccgcg gtgcattagc tagttggtga  
      241 ggtaacggct caccaaggcc acgatgcata gccgacctga gagggtgatc ggccaccact  
      301 gggactgaga cacggcccag actcctacgg gaggcagcag tagggaatct tcggcaatgg  
      361 acgaaagtct gaccgagcaa cgccgcgtga gtgaagaagg ttttcggatc gtaaaactct  
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      421 gttgttagag aagaacaagg acgttagtaa ctgaacgtcc cctgacggta tctaaccaga  
      481 aagccacggc taactacgtg ccagcagccg cggtaatacg taggtggcaa gcgttgtccg  
      541 gatttattgg gcgtaaagcg agcgcaggcg gtttcttaag tctgatgtga aagcccccgg  
      601 ctcaaccggg gagggtcatt ggaaactggg agacttgagt gcagaagagg agagtggaat  
      661 tccatgtgta gcggtgaaat gcgtatatat atggaggaac accaatggcg aaggcgggct  
      721 ctctggtctg ttactgacgc tgaggctcga aagcgtgggg agcaaacagg attagatacc  
      781 ctggtagtcc acgccgtaaa cgatgagtgc taagtgttgg agggtttccg cccttcagtg  
      841 ctgcagcaaa cgcattaagc actccgcctg gggagtacga ccgcaaggtt gaaactcaaa  
      901 ggaattgacg ggggcccgca caagcggtgg agcatgtggt ttaattcgaa gcaacgcgaa  
      961 gaaccttacc aggtcttgac atcctttgac cactctagag atagagcttt cccttcgggg  
     1021 acaaagtgac aggtggtgca tggttgtcgt cagctcgtgt cgtgagatgt tgggttaagt  
     1081 cccgcaacga gcgcaaccct tattgttagt tgccatcatt tagttgggca ctctagcgag  
     1141 actgccggtg acaaaccgga ggaaggtggg gatgacgtca aatcatcatg ccccttatga  
     1201 cctgggctac acacgtgcta caatgggaag tacaacgagt cgctagaccg cgaggtcatg  
     1261 caaatctctt aaagcttctc tcagttcgga ttgcaggctg caactcgcct gcatgaagcc  
     1 3 2 1  g g a a t c g c t a  g t a a t c g c g g  a t c a g c a c g c  c g c g t a t g c g  t c 
 
EC7: 
        1 gctgcgcgtg ctatacatgc aagtcgaacg cttctttcct cccgagtgct tgcactcatt  
       61 tggaaagagg agtggcggac gggtgagtaa cacgtgggta acctacccat cagaggggga  
      121 taacacttgg aaacaggtgc taataccgca taacagttta tgccgcatgg cataagagtg  
      181 aaaggcgctt tcgggtgtca ctgatggatg gacccgcggt gcattagcta gttggtgagg  
      241 taacggctca ccaaggccac gatgcatagc cgacctgaga gggtgatcgg ccacactggg  
      301 actgagacac ggcccagact cctacgggag gcagcagtag ggaatcttcg gcaatggacg  
      361 aaagtctgac cgagcaacgc cgcgtgagtg aagaaggttt tcggatcgta aaactctgtt  
      421 gttagagaag aacaaggacg ttagtaactg aacgtcccct gacggtatct aaccagaaag  
      481 ccacggctaa ctacgtgcca gcagccgcgg taatacgtag gtggcaagcg ttgtccggat  
      541 ttattgggcg taaagcgagc gcaggcggtt tcttaagtct gatgtgaaag cccccggctc  
      601 aaccggggag ggtcattgga aactgggaga cttgagtgca gaagaggaga gtggaattcc  
      661 atgtgtagcg gtgaaatgcg tagatatatg gaggaacacc agtggcgaag gcggctctct  
      721 ggtctgtaac tgacgctgag gctcgaaagc gtggggagca aacaggatta gataccctgg  
      781 tagtccacgc cgtaaacgat gagtgctaag tgttggaggg tttccgccct tcagtgctgc  
      841 agcaaacgca ttaagcactc cgcctgggga gtacgaccgc aaggttgaaa ctcaaaggaa  
      901 ttgacggggg cccgcacaag cggtggagca tgtggtttaa ttcgaagcaa cgcgaagaac  
      961 cttaccaggt cttgacatcc tttgaccact ctagagatag agctttccct tcggggacaa  
     1021 agtgacaggt ggtgcatggt tgtcgtcagc tcgtgtcgtg agatgttggg ttaagtcccg  
     1081 caacgagcgc aacccttatt gttagttgcc atcatttagt tgggcactct agcgagactg  
     1141 ccggtgacaa accggaggaa ggtggggatg acgtcaaatc atcatgcccc ttatgacctg  
     1201 ggctacacac gtgctacaat gggaagtaca acgagtcgct agaccgcgag gtcatgcaaa  
     1261 tctcttaaag cttctctcag ttcggattgc aggctgcaac tcgcctgcat gaagccggaa  
     1 3 2 1  t c g c t a g t a a  t c g c g g a t c a  g c a c g c c g c g  t a t g c g t c 
 
EC8: 
        1 ggctgcgggt gctatacatg cagtcgaacg cttctttcct cccgagtgct tgcactcaat  
       61 tggaaagagg agtggcggac gggtgagtaa cacgtgggta acctacccat cagaggggga  
      121 taacacttgg aaacaggtgc taataccgca taacagttta tgccgcatgg cataagagtg  
      181 aaaggcgctt tcgggtgtcg ctgatggatg gacccgcggt gcattagcta gttggtgagg  
      241 taacggctca ccaaggccac gatgcatagc cgacctgaga gggtgatcgg ccacactggg  
      301 actgagacac ggcccagact cctacgggag gcagcagtag ggaatcttcg gcaatggacg  
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      361 aaagtctgac cgagcaacgc cgcgtgagtg aagaaggttt tcggatcgta aaactctgtt  
      421 gttagagaag aacaaggacg ttagtaactg aacgtcccct gacggtatct aaccagaaag  
      481 ccacggctaa ctacgtgcca gcagccgcgg taatacgtag gtggcaagcg ttgtccggat  
      541 ttattgggcg taaagcgagc gcaggcggtt tcttaagtct gatgtgaaag cccccggctc  
      601 aaccggggag ggtcattgga aactgggaga cttgagtgca gaagaggaga gtggaattcc  
      661 atgtgtagcg gtgaaatgcg tagatatatg gaggaacacc agtggcgaag gcggctctct  
      721 ggtctgtaac tgacgctgag gctcgaaagc gtggggagca aacaggatta gataccctgg  
      781 tagtccacgc cgtaaacgat gagtgctaag tgttggaggg tttccgccct tcagtgctgc  
      841 agcaaacgca ttaagcactc cgcctgggga gtacgaccgc aaggttgaaa ctcaaaggaa  
      901 ttgacggggg cccgcacaag cggtggagca tgtggtttaa ttcgaagcaa cgcgaagaac  
      961 cttaccaggt cttgacatcc tttgaccact ctagagatag agctttccct tcggggacaa  
     1021 agtgacaggt ggtgcatggt tgtcgtcagc tcgtgtcgtg agatgttggg ttaagtcccg  
     1081 caacgagcgc aacccttatt gttagttgcc atcatttagt tgggcactct agcgagactg  
     1141 ccggtgacaa accggaggaa ggtggggatg acgtcaaatc atcatgcccc ttatgacctg  
     1201 ggctacacac gtgctacaat gggaagtaca acgagtcgct agaccgcgag gtcatgcaaa  
     1261 tctcttaaag cttctctcag ttcggattgc aggctgcaac tcgcctgcat gaagccggaa  
     1 3 2 1  t c g c t a g t a a  t c g c g g a t c a  g c a c g c c g c g  t a a t g c g t c 
 
EC9: 
        1 gctgcgggtg ctatacatgc agtcgaacgc tttttctttc accggagctt gctccaccga  
       61 aagaaaagga gtggcgaacg ggtgagtaac acgtgggtaa cctgcccatc agaaggggat  
      121 aacacttgga aacaggtgct aataccgtat aacaatcgaa accgcatggt ttcggtttga  
      181 aaggcgcttt tgcgtcactg atggatggac ccgcggtgca ttagctagtt ggtgaggtaa  
      241 cggctcacca aggcaacgat gcatagccga cctgagaggg tgatcggcca cattgggact  
      301 gagacacggc ccaaactcct acgggaggca gcagtaggga atcttcggca atggacgcaa  
      361 gtctgaccga gcaacgccgc gtgagtgaag aaggttttcg gatcgtaaaa ctctgttgtt  
      421 agagaagaac aaggatgaga gtaaaatgtt catcccttga cggtatctaa ccagaaagcc  
      481 acggctaact acgtgccagc agccgcggta atacgtaggt ggcaagcgtt gtccggattt  
      541 attgggcgta aagcgagcgc aggcggtttc ttaagtctga tgtgaaagcc cccggctcaa  
      601 ccggggaggg tcattggaaa ctgggaaact tgagtgcaga agaggagagt ggaattccat  
      661 gtgtagcggt gaaatgcgta gatatatgga ggaacaccag tggcgaaggc ggctctctgg  
      721 tctgtaactg acgctgaggc tcgaaagcgt ggggagcaaa caggattaga taccctggta  
      781 gtccacgccg taaacgatga gtgctaagtg ttggagggtt tccgcccttc agtgctgcag  
      841 ctaacgcatt aagcactccg cctggggagt acgaccgcaa ggttgaaact caaaggaatt  
      901 gacgggggcc cgcacaagcg gtggagcatg tggtttaatt cgaagcaacg cgaagaacct  
      961 taccaggtct tgacatcctt tgaccactct agagatagag cttccccttc gggggcaaag  
     1021 tgacaggtgg tgcatggttg tcgtcagctc gtgtcgtgag atgttgggtt aagtcccgca  
     1081 acgagcgcaa cccttattgt tagttgccat catttagttg ggcactctag cgagactgcc  
     1141 ggtgacaaac cggaggaagg tggggatgac gtcaaatcat catgcccctt atgacctggg  
     1201 ctacacacgt gctacaatgg gaagtacaac gagtcgcgaa gtcgcgaggc taagctaatc  
     1261 tcttaaagct tctctcagtt cggattgtag gctgcaactc gcctacatga agccggaatc  
     1 3 2 1  g c t a g t a a t c  g c g g a t c a g c  a c g c c g c g t a  a t g c t c 
 
EC10: 
        1 ggctgcgggt gctatacatg caagtcgaac gcttctttcc tcccgagtgc ttgcactcaa  
       61 ttggaaagag gagtggcgga cgggtgagta acacgtgggt aacctaccca tcagaggggg  
      121 ataacacttg gaaacaggtg ctaataccgc ataacagttt atgccgcatg gcataagagt  
      181 gaaaggcgct ttcgggtgtc gctgatggat ggacccgcgg tgcattagct agttggtgag  
      241 gtaacggctc accaaggcca cgatgcatag ccgacctgag agggtgatcg gccacactgg  
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      301 gactgagaca cggcccagac tcctacggga ggcagcagta gggaatcttc ggcaatggac  
      361 gaaagtctga ccgagcaacg ccgcgtgagt gaagaaggtt ttcggatcgt aaaactctgt  
      421 tgttagagaa gaacaaggac gttagtaact gaacgtcccc tgacggtatc taaccagaaa  
      481 gccacggcta actacgtgcc agcagccgcg gtaatacgta ggtggcaagc gttgtccgga  
      541 tttattgggc gtaaagcgag cgcaggcggt ttcttaagtc tgatgtgaaa gcccccggct  
      601 caaccgggga gggtcattgg aaactgggag acttgagtgc agaagaggag agtggaattc  
      661 catgtgtagc ggtgaaatgc gtagatatat ggaggaacac cagtggcgaa ggcggctctc  
      721 tggtctgtaa ctgacgctga ggctcgaaag cgtggggagc aaacaggatt agataccctg  
      781 gtagtccacg ccgtaaacga tgagtgctaa gtgttggagg gtttccgccc ttcagtgctg  
      841 cagcaaacgc attaagcact ccgcctgggg agtacgaccg caaggttgaa actcaaagga  
      901 attgacgggg gcccgcacca gcggtggagc atgtggttta attctaagca acgcgaagaa  
      961 ccttaccagg tcttgacatc ctttgaccac tctagagata gagctttccc ttcggggaca  
     1021 aagtgacagg tggtgcatgg ttgtcgtcag ctcgtgtcgt gagatgttgg gttaagtccc  
     1081 gcaacgagcg caacccttat tgttagttgc catcatttag ttgggcactc tagcgagact  
     1141 gccggtgaca aaccggagga aggtggggat gacgtcaaat catcatgccc cttatgacct  
     1201 gggctacaca cgtgctacaa tgggaagtac aacgagtcgc tagaccgcga ggtcatgcaa  
     1261 atctcttaaa gcttctctca gttcggattg caggctgcaa ctcgcctgca tgaagccgga  
     1 3 2 1  a t c g c t a g t a  a t c g c g g a t c  a g c a c g c c g c  g t a t t g c g a c 
 
EC11: 
        1 gattgcgcgt gctatacatg cagtcgaacg ctttttcttt caccggagct tgctccaccg  
       61 aaagaaaaag agtggcgaac gggtgagtaa cacgtgggta acctgcccat cagaagggga  
      121 taacacttgg aaacaggtgc taataccgta taacactatt ttccgcatgg aagaaagttg  
      181 aaaggcgctt ttgcgtcact gatggatgga cccgcggtgc attagctagt tggtgaggta  
      241 acggctcacc aaggcaacga tgcatagccg acctgagagg gtgatcggcc acactgggac  
      301 tgagacacgg cccagactcc tacgggaggc agcagtaggg aatcttcggc aatggacgaa  
      361 agtctgaccg agcaacgccg cgtgagtgaa gaaggttttc ggatcgtaaa actctgttgt  
      421 tagagaagaa caaggatgag agtaaaatgt tcatcccttg acggtatcta accagaaagc  
      481 cacggctaac tacgtgccag cagccgcggt aatacgtagg tggcaagcgt tgtccggatt  
      541 tattgggcgt aaagcgagcg caggcggttt cttaagtctg atgtgaaagc ccccggctca  
      601 accggggagg gtcattggaa actgggagac ttgagtgcag aagaggagag tggaattcca  
      661 tgtgtagcgg tgaaatgcgt agatatatgg aggaacacca gtggcgcatg cggctctctg  
      721 gtttgtaact gacgctgagg ctcgaaagct tggggagcga acaggattag ataccctggt  
      781 agtccacgcc gtaaacgatg agtgctaagt gttggagggt ttccgccctt cagtgctgca  
      841 gcaaacgcat taagcactcc gcctggggag tacgaccgca aggttgaaac tcaaaggaat  
      901 tgacgggggc ccgcacaagc ggtggagcat gtggtttaat tcgaagcaac gcgaagaacc  
      961 ttaccaggtc ttgacatcct ttgaccactc tagagataga gcttcccctt cgggggcaaa  
     1021 gtgacaggtg gtgcatggtt gtcgtcagct cgtgtcgtga gatgttgggt taagtcccgc  
     1081 aacgagcgca acccttattg ttagttgcca tcatttagtt gggcactcta gcgagactgc  
     1141 cggtgacaaa ccggaggaag gtggggatga cgtcaaatca tcatgcccct tatgacctgg  
     1201 gctacacacg tgctacaatg ggaagtacaa cgagttgcga agtcgcgagg ctaagctaat  
     1261 ctcttaaagc ttctctcagt tcggattgta ggctgcaact cgcctacatg aagccggaat  
     1 3 2 1  c g c t a g t a a t  c g c g g a t c a g  c a c g c c g c g t  a t t g c c t c 
 
EC12: 
        1 gtaggcggcg tgctatacat gcaagtcgaa cgcttctttc ctcccgagtg cttgcactca  
       61 attggaaaga ggagtggcgg acgggtgagt aacacgtggg taacctaccc atcagagggg  
      121 gataacactt ggaaacaggt gctaataccg cataacagtt tatgccgcat ggcataagag  
      181 tgaaaggcgc tttcgggtgt cgctgatgga tggacccgcg gtgcattagc tagttggtga  
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      241 ggtaacggct caccaaggcc acgatgcata gccgacctga gagggtgatc ggccacactg  
      301 ggactgagac acggcccaga ctcctacggg aggcagcagt agggaatctt cggcaatgga  
      361 cgaaagtctg accgagcaac gccgcgtgag tgaagaaggt tttcggatcg taaaactctg  
      421 ttgttagaga agaacaagga cgttagtaac tgaacgtccc ctgacggtat ctaaccagaa  
      481 agccacggct aactacgtgc cagcagccgc ggtaatacgt aggtggcaag cgttgtccgg  
      541 atttattggg cgtaaagcga gcgcaggcgg tttcttaagt ctgatgtgaa agcccccggc  
      601 tcaaccgggg agggtcattg gaaactggga gacttgagtg cagaagagga gagtggaatt  
      661 ccatgtgtag cggtgaaatg cgtagatata tggaggaaca ccagtggcga aggcggctct  
      721 ctggtctgta actgacgctg aggctcgaaa gcgtggggag caaacaggat tagataccct  
      781 ggtagtccac gccgtaaacg atgagtgcta agtgttggag ggtttccgcc cttcagtgct  
      841 gcagcaaacg cattaagcac tccgcctggg gagtacgacc gcaaggttga aactcaaagg  
      901 aattgacggg ggcccgcaca agcggtggag catgtggttt aattcgaagc aacgcgaaga  
      961 accttaccaa gtcttgactt cctttgacca ctctagagat agagctttcc cttcggggac  
     1021 aaagtgacag gtggtgcatg gttgtcgtca gctcgtgtcg tgagaagttg ggttaagtcc  
     1081 cgcaaccagc gcaaccctta ttgttacttg ccttcattta gctggtcact ctagcgagac  
     1141 tgctggacga cctgagagga ggaaggtggg gatgacgtcc aaatcatcat gccccttatg  
     1201 acctgggcta cacacgtgct acaatgggaa gtacaacgag tcgctagacc gcgaggtcat  
     1261 gcaaatctct taaagcttct ctcagttcgg attgcaggct gcaactcgcc tgcatgaagc  
     1 3 2 1  c g g a a t c g c t  a g t a a t c g c g  g a t c a g c a c g  c c g c g t a t g c  t c 
 
EC13: 
        1 gctggcgggt gctatacatg cagtcgaacg cttctttcct cccgagtgct tgcactcaat  
       61 tggaaagagg agtggcggac gggtgagtaa cacgtgggta acctacccat cagaggggga  
      121 taacacttgg aaacaggtgc taataccgca taacagttta tgccgcatgg cataagagtg  
      181 aaaggcgctt tcgggtgtcg ctgatggatg gacccgcggt gcattagcta gttggtgagg  
      241 taacggctca ccaaggccac gatgcatagc cgacctgaga gggtgatcgg ccacactggg  
      301 actgagacac ggcccagact cctacgggag gcagcagtag ggaatcttcg gcaatggacg  
      361 aaagtctgac cgagcaacgc cgcgtgagtg aagaaggttt tcggatcgta aaactctgtt  
      421 gttagagaag aacaaggacg ttagtaactg aacgtcccct gacggtatct aaccagaaag  
      481 ccacggctaa ctacgtgcca gcagccgcgg taatacgtag gtggcaagcg ttgtccggat  
      541 ttattgggcg taaagcgagc gcaggcggtt tcttaagtct gatgtgaaag cccccggctc  
      601 aaccggggag ggtcattgga aactgggaga cttgagtgca gaagaggaga gtggaattcc  
      661 atgtgtagcg gtgaaatgcg tagatatatg gaggaacacc agtggcgaag gcggctctct  
      721 ggtctgtaac tgacgctgag gctcgaaagc gtggggagca aacaggatta gataccctgg  
      781 tagtccacgc cgtaaacgat gagtgctaag tgttggaggg tttccgccct tcagtgctgc  
      841 agcaaacgca ttaagcactc cgcctgggga gtacgaccgc aaggttgaaa ctcaaaggaa  
      901 ttgacggggg cccgcacaag cggtggagca tgtggtttaa ttcgaagcaa cgcgaagaac  
      961 cttaccaggt cttgacatcc tttgaccact ctagagatag agctttccct tcggggacaa  
     1021 agtgacaggt ggtgcatggt tgtcgtcagc tcgtgtcgtg agatgttggg ttaagtcccg  
     1081 caacgagcgc aacccttatt gttagttgcc atcatttagt tgggcactct agcgagactg  
     1141 ccggtgacaa accggaggaa ggtggggatg acgtcaaatc atcatgcccc ttatgacctg  
     1201 ggctacacac gtgctacaat gggaagtaca acgagtcgct agaccgcgag gtcatgcaaa  
     1261 tctcttaaag cttctctcag ttcggattgc aggctgcaac tcgcctgcat gaagccggaa  
     1 3 2 1  t c g c t a g t a a  t c g c g g a t c a  g c a c g c c g c g  t a a t g c c a c 
 
EC14: 
        1 gacgcaatta cgcggcgtgc tgatccgcga ttactagcga ttccggcttc atgtaggcga  
       61 gttgcagcct acaatccgaa ctgagagaag ctttaagaga ttagcttagc ctcgcgactt  
      121 cgcgactcgt tgtacttccc attgtagcac gtgtgtagcc caggtcataa ggggcatgat  
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      181 gatttgacgt catccccacc ttcctccggt ttgtcaccgg cagtctcgct agagtgccca  
      241 actaaatgat ggcaactaac aataagggtt gcgctcgttg cgggacttaa cccaacatct  
      301 cacgacacga gctgacgaca accatgcacc acctgtcact ttgcccccga aggggaagct  
      361 ctatctctag agtggtcaaa ggatgtcaag acctggtaag gttcttcgcg ttgcttcgaa  
      421 ttaaaccaca tgctccaccg cttgtgcggg cccccgtcaa ttcctttgag tttcaacctt  
      481 gcggtcgtac tccccaggcg gagtgcttaa tgcgttagct gcagcactga agggcggaaa  
      541 ccctccaaca cttagcactc atcgtttacg gcgtggacta ccagggtatc taatcctgtt  
      601 tgctccccac gctttcgagc ctcagcgtca gttacagacc agagagccgc cttcgccact  
      661 ggtgttcctc catatatcta cgcatttcac cgctacacat ggaattccac tctcctcttc  
      721 tgcactcaag tttcccagtt tccaatgacc ctccccggtt gagccggggg ctttcacatc  
      781 agacttaaga aaccgcctgc gctcgcttta cgcccaataa atccggacaa cgcttgccac  
      841 ctacgtatta ccgcggctgc tggcacgtag ttagccgtgg gctttctggt tagataccgt  
      901 caagggatga ccattctact ctcatccttg ttcttctcta acaacagagt tttacgatcc  
      961 gaaaaccttc ttcactcacg cggcgttgct cggtcagact tgcgtccatt gccgaagatt  
     1021 ccctactgct gcctcccgta gaagtttggg ccgtctctca gtcccaatgt ggccgatcac  
     1081 cgtctcaggt cagctatgaa tgtttgcctt ggagagccgt tacckcacca actagctaat  
     1141 gcaccgcggg tccatccatc agtgacgcaa aagcgccttt caaaccgaaa ccatgcggtt  
     1201 tcgattgtta tacggtatta gcacctgttt ccaagtgtta tccccttctg atgggcaggt  
     1261 tacccacgtg ttactcaccc gttcgccact ccttttcttt cggtggagca agctccggtg  
     1 3 2 1  a a a g a a a a a g  c g t t c g a c t t  g c a t g t a t a g  c a c g c g c c a g  c c 
 
EC15: 
        1 ggctgcgcgt gctatacatg cagtcgaacg cttctttcct cccgagtgct tgcactcaat  
       61 tggaaagagg agtggcggac gggtgagtaa cacgtgggta acctacccat cagaggggga  
      121 taacacttgg aaacaggtgc tataccgcat aacagtttat gccgcatggc ataagagtga  
      181 aaggcgcttt cgggtgtcgc tgatggatgg acccgcggtg cattagctag ttggtgaggt  
      241 aacggctcac caaggccacg atgcatagcc gacctgagag ggtgatcggc cacactggga  
      301 ctgagacacg gcccagactc ctacgggagg cagcagtagg gaatcttcgg caatggacga  
      361 aagtctgacc gagcaacgcc gcgtgagtga agaaggtttt cggatcgtaa aactctgttg  
      421 ttagagaaga ataaggacgt tagtaactga acgtcccctg acggtatcta accagaaagc  
      481 cacggctaac tacgtgccag cagccgcggt aatacgtagg tggcaagcgt tgtccggatt  
      541 tattgggcgt aaagcgagcg caggcggttt cttaagtctg atgtgaaagc ccccggctca  
      601 accggggagg gtcattggaa actgggagac ttgagtgcag aagaggagag tggaattcca  
      661 tgtgtagcgg tgaaatgcgt agatatatgg aggaacacca gtggcgaagg cggctctctg  
      721 gtctgtaact gacgctgagg ctcgaaagcg tggggagcaa acaggattag ataccctggt  
      781 agtccacgcc gtaaacgatg agtgctaagt gttggagggt ttccgccctt cagtgctgca  
      841 gcaaacgcat taagcactcc gcctggggag tacgaccgca aggttgaaac tcaaaggaat  
      901 tgacgggggc ccgcacaagc ggtggagcat gtggtttaat tcgaagcaac gcgaagaacc  
      961 ttaccaggtc ttgacatcct ttgaccactc tagagataga gctttccctt cggggacaaa  
     1021 gtgacaggtg gtgcatggtt gtcgtcagct cgtgtcgtga gatgttgggt taagtcccgc  
     1081 aacgagcgca acccttattg ttagttgcca tcatttagtt gggcactcta gcgagactgc  
     1141 cggtgacaaa ccggaggaag gtggggatga cgtcaaatca tcatgcccct tatgacctgg  
     1201 gctacacacg tgctacaatg ggaagtacaa cgagtcgcta gaccgcgagg tcatgcaaat  
     1261 ctcttaaagc ttctctcagt tcggattgca ggctgcaact cgcctgcatg aagccggaat  
     1 3 2 1  c g c t a g t a a t  c g c g g a t c a g  c a c g c c g c g t  a t g c g a c 
 
EC16: 
        1 gctgcggcgt gctatacatg caagtcgaac gcttctttcc tcccgagtgc ttgcactcaa  
       61 ttggaaagag gagtggcgga cgggtgagta acacgtgggt aacctaccca tcagaggggg  
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      121 ataacacttg gaaacaggtg ctaataccgc ataacagttt atgccgcatg gcataagagt  
      181 gaaaggcgct ttcgggtgtc gctgatggat ggacccgcgg tgcattagct agttggtgag  
      241 gtaacggctc accaaggcca cgatgcatag ccgacctgag agggtgatcg gccacactgg  
      301 gactgagaca cggcccagac tcctacggga ggcagcagta gggaatcttc ggcaatggac  
      361 gaaagtctga ccgagcaacg ccgcgtgagt gaagaaggtt ttcggatcgt aaaactctgt  
      421 tgttagagaa gaacaaggac gttagtaact gaacgtcccc tgacggtatc taaccagaaa  
      481 gccacggcta actacgtgcc agcagccgcg gtaatacgta ggtggcaagc gttgtccgga  
      541 tttattgggc gtaaagcgag cgcaggcggt ttcttaagtc tgatgtgaaa gcccccggct  
      601 caaccgggga gggtcattgg aaactgggag acttgagtgc agaagaggag agtggaattc  
      661 catgtgtagc ggtgaaatgc gtagatatat ggaggaacac cagtggcgaa ggcggctctc  
      721 tggtctgtaa ctgacgctga ggctcgaaag cgtgggggag caaacaggat tagataccct  
      781 ggtagtccac gccgtaaacg atgagtgcta agtgttggag ggtttccgcc cttcagtgct  
      841 gcagcaaacg cattaagcac tccgcctggg gagtacgacc gcaaggttga aactcaaagg  
      901 aattgacggg ggcccgcaca agcggtggag catgtggttt aattcgaagc aacgcgaaga  
      961 accttaccag gtcttgacat cctttgacca ctctagagat agagctttcc cttcggggac  
     1021 aaagtgacag gtggtgcatg gttgtcgtca gctcgtgtcg tgagatgttg ggttaagtcc  
     1081 cgcaacgagc gcaaccctta ttgttagttg ccatcattta gttgggcact ctagcgagac  
     1141 tgccggtgac aaaccggagg aaggtgggga tgacgtcaaa tcatcatgcc ccttatgacc  
     1201 tgggctacac acgtgctaca atgggaagta caacgagtcg ctagaccgcg aggtcatgca  
     1261 aatctcttaa agcttctctc agttcggatt gcaggctgca actcgcctgc atgaagccgg  





        1 gagggcggca tgctatacat gcagtcgagc gaacagacga ggagcttgct cctttgacgt  
       61 tagcggcgga cgggtgagta acacgtgggt aacctaccta taagactggg ataacttcgg  
      121 gaaaccggag ctaataccgg ataatatttc gaaccgcatg gttcgatagt gaaagatggc  
      181 tttgctatca cttatagatg gacctgcgcc gtattagcta gttggtaagg taacggctta  
      241 ccaaggcaac gatacgtagc cgacctgaga gggtgatcgg ccacactgga actgagacac  
      301 ggtccagact cctacgggag gcagcagtag ggaatcttcc gcaatgggcg aaagcctgac  
      361 ggagcaacgc cgcgtgagtg atgaaggtct tcggatcgta ttactttgtt attatggaat  
      421 aacaaacgag aaagtaactg tgcacgtctt gacggtacct aatcagaaag ccacggctaa  
      481 ctacgtgcca gcagccgcgg taatacgtag gtggcaagcg ttatccggaa ttattgggcg  
      541 taaagcgcgc gtaggcggtt ttttaagtct gatgtgaaag cccacggctc aaccgtggag  
      601 ggtcattgga aactggaaaa cttgagtgca gaagaggaaa gtggaattcc atgtgtagcg  
      661 gtgaaatgcg cagagatatg gaggaacacc agtggcgaag gcgactttct ggtctgtaac  
      721 tgacgctgat gtgcgaaagc gtggggatca aacaggatta gataccctgg tagtccacgc  
      781 cgtaaacgat gagtgctaag tgttaggggg tttccgcccc ttagtgctgc agctaacgca  
      841 ttaagcactc cgcctgggga gtacgaccgc aaggttgaaa ctcaaaggaa ttgacgggga  
      901 cccgcacaag cggtggagca tgtggtttaa ttcgaagcaa cgcgaagaac cttaccaaat  
      961 cttgacatcc tttgaccctt ctagagatag aagtttcccc ttcgggggac aaagtgacag  
     1021 gtggtgcatg gttgtcgtca gctcgtgtcg tgagatgttg ggttaagtcc cgcaacgagc  
     1081 gcaaccctta agcttagttg ccatcattaa gttgggcact ctaagttgac tgccggtgac  
     1141 aaaccggagg aaggtgggga tgacgtcaaa tcatcatgcc ccttatgatt tgggctacac  
     1201 acgtgctaca atggacaata caaagggcag cgaaaccgcg aggtcaagca aatcccataa  
     1261 agttgttctc agttcggatt gtagtctgca actcgactac atgaagctgg aatcgctagt  





        1 gtcgcattac gcggcgtgct gatccgcgat tactagcgat tccagcttcg tgcagtcgag  
       61 ttgcagactg cagtccgaac tgagaacagc tttcagagat tcgcttgcct tcgcaggctc  
      121 gcttctcgtt gtactgccca ttgtagcacg tgtgtagccc aggtcataag gggcatgatg  
      181 acttgacgtc atccccacct tcctccggtt tgtcaccggc agtctcatta gagtgcccaa  
      241 cttaatgctg gcaactaata acaagggttg cgctcgttgc gggacttaac ccaacatctc  
      301 acgacacgag ctgacgacag ccatgcacca cctgtcttag cgtccccgaa gggaactttg  
      361 tatctctaca aatggcacta gatgtcaaga cctggtaagg ttcttcgcgt tgcttcgaat  
      421 taaaccacat gctccaccgc ttgtgcgggc ccccgtcaat tcctttgagt ttcaaccttg  
      481 cggtcgtact ccccaggcgg agtgcttaat gcgttagctg cagcactgag aggcggaaac  
      541 ctcccaacac ttagcactca tcgtttacgg catggactac cagggtatct aatcctgttc  
      601 gctacccatg ctttcgagcc tcagcgtcag ttgcagacca gagagccgcc ttcgccactg  
      661 gtgttcttcc atatatctac gcattccacc gctacacatg gagttccact ctcctcttct  
      721 gcactcaaga aaaacagttt ccgatgcagt tcctcggtta agccgagggc tttcacatca  
      781 gacttattct tccgcctgcg ctcgctttac gcccaataaa tccggacaac gcttgccacc  
      841 tacgtattac cgcggctgct ggcacgtagt tagccgtgac tttctggttg attaccgtca  
      901 aataaaggcc agttactacc tctatccttc ttcaccaaca acagagcttt acgatccgaa  
      961 aaccttcttc actcacgcgg cgttgctcca tcagacttgc gtccattgtg gaagattccc  
     1021 tactgctgcc tccggtagga gtttgggccg tgtctcagtc ccaatgtggc cgatcagtct  
     1081 ctcaactcgg ctatgcatca tcgccttggt aagcctttac cttaccaact agctaatgca  
     1141 ccgcggggcc atcccatagc gacagcttac gccgcctttt aaaagctgat catgcgatct  
     1201 gctttcttat ccggtattag cacctgtttc caagtggtat cccagacttt ggggcaggtt  
     1261 ccccacgtgt tactcaccca tccgccgctc gctttcctaa cgtcattacc gaagtaaatc  
     1 3 2 1  t g t t a g t t c c  g c t c g c t c g a  c t t g c a t g t a  t a g c a c g c g c  c a g c c 
 
L3: 
        1  gtcgcattac gcggcgtgct gatccgcgat tactagcgat tccgacttcg tgtaggcgag  
       61 ttgcagccta cagtccgaac tgagaatggc tttaagagat tagcttgacc tcgcggtctc  
      121 gcaactcgtt gtaccatcca ttgtagcacg tgtgtagccc aggtcataag gggcatgatg  
      181 atttgacgtc atccccacct tcctccggtt tgtcaccggc agtcttacta gagtgcccaa  
      241 ctaaatgctg gcaactagtc ataagggttg cgctcgttgc gggacttaac ccaacatctc  
      301 acgacacgag ctgacgacaa ccatgcacca cctgtcattt tgcccccgaa ggggaaacct  
      361 gatctctcag gtgatcaaaa gatgtcaaga cctggtaagg ttcttcgcgt tgcttcgaat  
      421 taaaccacat gctccaccgc ttgtgcgggc ccccgtcaat tcctttgagt ttcaaccttg  
      481 cggtcgtact ccccaggcgg aatgcttaat gcgttagctg cggcactgaa gggcggaaac  
      541 cctccaacac ctagcattca tcgtttacgg catggactac cagggtatct aatcctgttc  
      601 gctacccatg ctttcgagcc tcagcgtcag ttacagacca gacagccgcc ttcgccactg  
      661 gtgttcttcc atatatctac gcatttcacc gctacacatg gagttccact gtcctcttct  
      721 gcactcaagt ttcccagttt ccgatgcact tcctcggtta agccgagggc tttcacatca  
      781 gacttaaaaa accgcctgcg ctcgctttac gcccaataaa tccggataac gcttgccacc  
      841 tacgtattac cgcggctgct ggcacgtagt tagccgtggc tttctggttg gataccgtca  
      901 cgccgacaac agttactctg ccgaccattc ttctccaaca acagagtttt acgacccgaa  
      961 agccttcttc actcacgcgg cgttgctcca tcagacttgc gtccattgtg gaagattccc  
     1021 tactgctgcc tcccgtagga gtttgggccg tgtctcagtc ccaatgtggc cgatcaacct  
     1081 ctcagttcgg ctacgtatca ttgccttggt gagccgttac ctcaccaact agctaatacg  
     1141 ccgcgggtcc atccaaaagc gatagcttac gccatctttc agccaagaac catgcggttc  
     1201 ttggatttat gcggtattag catctgtttc caaatgttat cccccactta agggcaggtt  
     1261 acccacgtgt tactcacccg tccgccactc gttcaaaatt aaatcaagat gcaagcacct  





        1 gacgcatacg cggcgtgctg atccgcgatt actagcgatt ccgacttcgt gtaggcgagt  
       61 tgcagcctac agtccgaact gagaatggct ttaagagatt agcttgacct cgcggtctcg  
      121 caactcgttg taccatccat tgtagcacgt gtgtagccca ggtcataagg ggcatgatga  
      181 tttgacgtca tccccacctt cctccggttt gtcaccggca gtcttactag agtgcccaac  
      241 taaatgctgg caactagtca taagggttgc gctcgttgcg ggacttaacc caacatctca  
      301 cgacacgagc tgacgacaac catgcaccac ctgtcatttt gcccccgaag gggaaacctg  
      361 atctctcagg tgatcaaaag atgtcaagac ctggtaaggt tcttcgcgtt gcttcgaatt  
      421 aaaccacatg ctccaccgct tgtgcgggcc cccgtcaatt cctttgagtt tcaaccttgc  
      481 ggtcgtactc cccaggcgga atgcttaatg cgttagctgc ggcactgaag ggcggaaacc  
      541 ctccaacacc tagcattcat cgtttacggc atggactacc agggtatcta atcctgttcg  
      601 ctacccatgc tttcgagcct cagcgtcagt tacagaccag acagccgcct tcgccactgg  
      661 tgttcttcca tatatctacg catttcaccg ctacacatgg agttccactg tcctcttctg  
      721 cactcaagtt tcccagtttc cgatgcactt cctcggttaa gccgagggct ttcacatcag  
      781 acttaaaaaa ccgcctgcgc tcgctttacg cccaataaat ccggataacg cttgccacct  
      841 acgtattacc gcggctgctg gcacgtagtt agccgtggct ttctggttgg ataccgtcac  
      901 gccgacacag ttactctgcc gaccattctt ctccaacaac agagttttac gacccgaaag  
      961 ccttcttcac tcacgcggcg ttgctccatc agacttgcgt ccattgtgga agattcccta  
     1021 ctgctgcctc ccgtaggagt ttgggccgtg tctcagtccc aatgtggccg atcaacctct  
     1081 cagttcggct acgtatcatt gccttggtga gccgttacct caccaactag ctaatacgcc  
     1141 gcgggtccat ccaaaagcga tagcttacgc catctttcag ccaagaacca tgcggttctt  
     1201 ggatttatgc ggtattagca tctgtttcca aatgttatcc cccacttaag ggcaggttac  
     1261 ccacgtgtta ctcacccgtc cgccactcgt tcaaaattaa atcaagatgc aagcaccttt  
     1 3 2 1  c a a t a a t c a g  a a c t c g t t c g  a c t t g c a t g t  a t a g c a c g c g  c a g c c 
 
L5: 
        1 gcgcatacgc ggcgtgctga tccgcgatta ctagcgattc cgacttcgtg taggcgagtt  
       61 gcagcctaca gtccgaactg agaatggctt taagagatta gcttgacctc gcggtctcgc  
      121 aactcgttgt accatccatt gtagcacgtg tgtagcccag gtcataaggg gcatgatgat  
      181 ttgacgtcat ccccaccttc ctccggtttg tcaccggcag tcttactaga gtgcccaact  
      241 aaatgctggc aactagtcat aagggttgcg ctcgttgcgg gacttaaccc aacatctcac  
      301 gacacgagct gacgacaacc atgcaccacc tgtcattttg cccccgaagg ggaaacctga  
      361 tctctcaggt gatcaaaaga tgtcaagacc tggtaaggtt cttcgcgttg cttcgaatta  
      421 aaccacatgc tccaccgctt gtgcgggccc ccgtcaattc ctttgagttt caaccttgcg  
      481 gtcgtactcc ccaggcggaa tgcttaatgc gttagctgcg gcactgaagg gcggaaaccc  
      541 tccaacacct agcattcatc gtttacggca tggactacca gggtatctaa tcctgttcgc  
      601 tacccatgct ttcgagcctc agcgtcagtt acagaccaga cagccgcctt cgccactggt  
      661 gttcttccat atatctacgc atttcaccgc tacacatgga gttccactgt cctcttctgc  
      721 actcaagttt cccagtttcc gatgcacttc ctcggttaag ccgagggctt tcacatcaga  
      781 cttaaaaaac cgcctgcgct cgctttacgc ccaataaatc cggataacgc ttgccaccta  
      841 cgtattaccg cggctgctgg cacgtagtta gccgtggctt tctggttgga taccgtcacg  
      901 ccgacaacag ttactctgcc gaccattctt ctccaacaac agagttttac gacccgaaag  
      961 ccttcttcac tcacgcggcg ttgctccatc agacttgcgt ccattgtgga agattcccta  
     1021 ctgctgcctc ccgtaggagt ttgggccgtg tctcagtccc aatgtggccg atcaacctct  
     1081 cagttcggct acgtatcatt gccttggtga gccgttacct caccaactag ctaatacgcc  
     1141 gcgggtccat ccaaaagcga tagcttacgc catctttcag ccaagaacca tgcggttctt  
     1201 ggatttatgc ggtattagca tctgtttcca aatgttatcc cccacttaag ggcaggttac  
     1261 ccacgtgtta ctcacccgtc cgccactcgt tcaaaattaa atcaagatgc aagcaccttt  
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     1 3 2 1  c a a t a a t c a g  a a c t c g t t c g  a c t t g c a t g t  a t a g c a c g c g  c a g 
 
L6: 
        1 gccatacgcg gcgtgctgat ccgcgattac tagcgattcc gacttcgtgt aggcgagttg  
       61 cagcctacag tccgaactga gaatggcttt aagagattag cttgacctcg cggtctcgca  
      121 actcgttgta ccatccattg tagcacgtgt gtagcccagg tcataagggg catgatgatt  
      181 tgacgtcatc cccaccttcc tccggtttgt caccggcagt cttactagag tgcccaacta  
      241 aatgctggca actagtcata agggttgcgc tcgttgcggg acttaaccca acatctcacg  
      301 acacgagctg acgacaacca tgcaccacct gtcattttgc ccccgaaggg gaaacctgat  
      361 ctctcaggtg atcaaaagat gtcaagacct ggtaaggttc ttcgcgttgc ttcgaattaa  
      421 accacatgct ccaccgcttg tgcgggcccc cgtcaattcc tttgagtttc aaccttgcgg  
      481 tcgtactccc caggcggaat gcttaatgcg ttagctgcgg cactgaaggg cggaaaccct  
      541 ccaacaccta gcattcatcg tttacggcat ggactaacag ggtatctaat cctgttcgct  
      601 acccatgctt tcgagcctca gcgtcagtta cagaccagac agccgccttc gccactggtg  
      661 ttcttccata tatctacgca tttcaccgct acacatggag ttccactgtc ctcttctgca  
      721 ctcaagtttc ccagtttccg atgcacttcc tcggttaagc cgagggcttt cacatcagac  
      781 ttaaaaaacc gcctgcgctc gctttacgcc caataaatcc ggataacgct tgccacctac  
      841 gtattaccgc ggctgctggc acgtagttag ccgtggcttt ctggttggat accgtcacgc  
      901 cgacaacagt tactctgccg accattcttc tccaacaaca gagttttacg acccgaaagc  
      961 cttcttcact cacgcggcgt tgctccatca gacttgcgtc cattgtggaa gattccctac  
     1021 tgctgcctcc cgtaggagtt tgggccgtgt ctcagtccca atgtggccga tcaacctctc  
     1081 agttcggcta cgtatcattg ccttggtgag ccgttacctc accaactagc taatacgccg  
     1141 cgggtccatc caaaagcgat agcttacgcc atctttcagc caagaaccat gcggttcttg  
     1201 gatttatgcg gtattagcat ctgtttccaa atgttatccc ccacttaagg gcaggttacc  
     1261 cacgtgttac tcacccgtcc gccactcgtt caaaattaaa tcaagatgca agcacctttc  
     1 3 2 1  a a t a a t c a g a  a c t c g t t c g a  c t t g c a t g t a  t a g c a c c c g c  c c g c c 
 
L7: 
        1 gtcgcatacg cggcgtgctg atccgcgatt actagcgatt ccgacttcgt gtaggcgagt  
       61 tgcagcctac agtccgaact gagaatggct ttaagagatt agcttgacct cgcggtctcg  
      121 caactcgttg taccatccat tgtagcacgt gtgtagccca ggtcataagg ggcatgatga  
      181 tttgacgtca tccccacctt cctccggttt gtcaccggca gtcttactag agtgcccaac  
      241 taaatgctgg caactagtca taagggttgc gctcgttgcg ggacttaacc caacatctca  
      301 cgacacgagc tgacgacaac catgcaccac ctgtcatttt gcccccgaag gggaaacctg  
      361 atctctcagg tgatcaaaag atgtcaagac ctggtaaggt tcttcgcgtt gcttcgaatt  
      421 aaaccacatg ctccaccgct tgtgcgggcc cccgtcaatt cctttgagtt tcaaccttgc  
      481 ggtcgtactc cccaggcgga atgcttaatg cgttagctgc ggcactgaag ggcggaaacc  
      541 ctccaacacc tagcattcat cgtttacggc atggactacc agggtatcta atcctgttcg  
      601 ctacccatgc tttcgagcct cagcgtcagt tacagaccag acagccgcct tcgccactgg  
      661 tgttcttcca tatatctacg catttcaccg ctacacatgg agttccactg tcctcttctg  
      721 cactcaagtt ttccagtttc cgatgcactt cctcggttaa gccgagggct ttcacatcag  
      781 acttaaaaaa ccgcctgcgc tcgctttacg cccaataaat ccggataacg cttgccacct  
      841 acgtattacc gcggctgctg gcacgtagtt agccgtggct ttctggttgg ataccgtcac  
      901 gccgacaaca gttactctgc cgaccattct tctccaacaa cagagtttta cgacccgaaa  
      961 gccttcttca ctcacgcggc gttgctccat cagacttgcg tccattgtgg aagattccct  
     1021 actgctgcct cccgtaggag tttgggccgt gtctcagtcc caatgtggcc gatcaacctc  
     1081 tcagttcggc tacgtatcat tgccttggtg agccgttacc tcaccaacta gctaatacgc  
     1141 cgcgggtcca tccaaaagcg atagcttacg ccatctttca gccaagaacc atgcggttct  
     1201 tggatttatg cggtattagc atctgtttcc aaatgttatc ccccacttaa gggcaggtta  
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     1261 cccacgtgtt actcacccgt ccgccactcg ttcaaaatta aatcaagatg caagcacctt  
     1 3 2 1  t c a a t a a t c a  g a a c t c g t t c  g a c t t g c a t g  t a t a g c a c g c  g c c t c 
 
L8: 
        1 gttgcaatac gcggcgtgct gatccgcgat tactagcgat tccgacttcg tgtaggcgag  
       61 ttgcagccta cagtccgaac tgagaatggc tttaagagat tagcttgacc tcgcggtctc  
      121 gcaactcgtt gtaccatcca ttgtagcacg tgtgtagccc aggtcataag gggcatgatg  
      181 atttgacgtc atccccacct tcctccggtt tgtcaccggc agtcttacta gagtgcccaa  
      241 ctaaatgctg gcaactagtc ataagggttg cgctcgttgc gggacttaac ccaacatctc  
      301 acgacacgag ctgacgacaa ccatgcacca cctgtcattt tgcccccgaa ggggaaacct  
      361 gatctctcag gtgatcaaaa gatgtcaaga cctggtaagg ttcttcgcgt tgcttcgaat  
      421 taaaccacat gctccaccgc ttgtgcgggc ccccgtcaat tcctttgagt ttcaaccttg  
      481 cggtcgtact ccccaggcgg aatgcttaat gcgttagctg cggcactgaa gggcggaaac  
      541 cctccaacac ctagcattca tcgtttacgg catggactac cagggtatct aatcctgttc  
      601 gctacccatg ctttcgagcc tcagcgtcag ttacagacca gacagccgcc ttcgccactg  
      661 gtgttcttcc atatatctac gcatttcacc gctacacatg gagttccact gtcctcttct  
      721 gcactcaagt ttcccagttt ccgatgcact tcctcggtta agccgagggc tttcacatca  
      781 gacttaaaaa accgcctgcg ctcgctttac gcccaataaa tccggataac gcttgccacc  
      841 tacgtattac cgcggctgct ggcacgtagt tagccgtggc tttctggttg gataccgtca  
      901 cgccgacaac agttactctg ccgaccattc ttctccaaca acagagtttt acgacccgaa  
      961 agccttcttc actcacgcgg cgttgctcca tcagacttgc gtccattgtg gaagattccc  
     1021 tactgctgcc tcccgtagga gtttgggccg tgtctcagtc ccaatgtggc cgatcaacct  
     1081 ctcagttcgg ctacgtatca ttgccttggt gagccgttac ctcaccaact agctaatacg  
     1141 ccgcgggtcc atccaaaagc gatagcttac gccatctttc agccaagaac catgcggttc  
     1201 ttggatttat gcggtattag catctgtttc caaatgttat cccccactta agggcaggtt  
     1261 acccacgtgt tactcacccg tccgccactc gttcaaaatt aaatcaagat gcaagcacct  
     1 3 2 1  t t c a a t a a t c  a g a a c t c g t t  c g a c t g c a t g  t a t a g c a c c c  g c c a t c 
 
L9: 
        1 gtgcatacgc ggcgtgctga tccgcgatta ctagcgattc cgacttcgtg taggcgagtt  
       61 gcagcctaca gtccgaactg agaatggctt taagagatta gcttgacctc gcggtctcgc  
      121 aactcgttgt accatccatt gtagcacgtg tgtagcccag gtcataaggg gcatgatgat  
      181 ttgacgtcat ccccaccttc ctccggtttg tcaccggcag tcttactaga gtgcccaact  
      241 aaatgctggc aactagtcat aagggttgcg ctcgttgcgg gacttaaccc aacatctcac  
      301 gacacgagct gacgacaacc atgcaccacc tgtcattttg cccccgaagg ggaaacctga  
      361 tctctcaggt gatcaaaaga tgtcaagacc tggtaaggtt cttcgcgttg cttcgaatta  
      421 aaccacatgc tccaccgctt gtgcgggccc ccgtcaattc ctttgagttt caaccttgcg  
      481 gtcgtactcc ccaggcggaa tgcttaatgc gttagctgcg gcactgaagg gcggaaaccc  
      541 tccaacacct agcattcatc gtttacggca tggactacca gggtatctaa tcctgttcgc  
      601 tacccatgct ttcgagcctc agcgtcagtt acagaccaga cagccgcctt cgccactggt  
      661 gttcttccat atatctacgc atttcaccgc tacacatgga gttccactgt cctcttctgc  
      721 actcaagttt cccagtttcc gatgcgcttc ctcggttaag ccgagggctt tcacatcaga  
      781 cttaaaaaac cgcctgcgct cgctttacgc ccaataaatc cggataacgc ttgccaccta  
      841 cgtattaccg cggctgctgg cacgtagtta gccgtggctt tctggttgga taccgtcacg  
      901 ccgacaacag ttactctgcc gaccattctt ctccaacaac agagttttac gacccgaaag  
      961 ccttcttcac tcacgcggcg ttgctccatc agacttgcgt ccattgtgga agattcccta  
     1021 ctgctgcctc ccgtaggagt ttgggccgtg tctcagtccc aatgtggccg atcaacctct  
     1081 cagttcggct acgtatcatc gccttggtga gccattacct caccaactag ctaatacgcc  
     1141 gcgggtccat ccaaaagcga tagcttacgc catctttcag ccaagaacca tgcggttctt  
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     1201 ggatctatgc ggtattagca tctgtttcca aatgttatcc cccacttaag ggcaggttac  
     1261 ccacgtgtta ctcacccgtc cgccactcgt tccatgttga atctcggtgc aagcaccgat  
     1 3 2 1  c a t c a a c g a g  a a c t c g t t c g  a c t t g c a t g t  a t a g c a c g c c  g c a g c c 
